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Abstract 
Synthesis and Characterization of a Chondroitin Sulfate Based Hybrid Bio/Synthetic 
Biomimetic Aggrecan Macromolecule 
Sumona Sarkar 
Advisor: Michele Marcolongo, Ph.D. 
 
 
Lower back pain resulting from intervertebral disc degeneration is one of the 
leading musculoskeletal disorders confronting our health system.  In order to 
mechanically stabilize the disc early in the degenerative cascade and prevent the need for 
spinal fusion surgeries, we have proposed the development of a hybrid-bio/synthetic 
biomimetic proteoglycan macromolecule for injection into the disc in the early stages of 
degeneration. The goal of this thesis was to incorporate natural chondroitin sulfate (CS) 
chains into bottle brush polymer synthesis strategies for the fabrication of CS-
macromolecules which mimic the proteoglycan structure and function while resisting 
enzymatic degradation.  Both the “grafting-to” and “grafting-through” techniques of 
bottle brush synthesis were explored.  CS was immobilized via a terminal primary amine 
onto a model polymeric backbone (polyacrylic acid) for investigation of the “grafting-to” 
strategy and an epoxy-amine step-growth polymerization technique was utilized for the 
“grafting-through” synthesis of CS-macromolecules with polyethylene glycol backbone 
segments.   
Incorporation of a synthetic polymeric backbone at the terminal amine of CS was 
confirmed via biochemical assays, 1H-NMR and FTIR spectroscopy, and CS-
macromolecule size was demonstrated to be higher than that of natural CS via gel 
permeation chromatography, transmission electron microscopy and viscosity 
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measurements.  Further analysis of CS-macromolecule functionality indicated 
maintenance of natural CS properties such as high fixed charge density, high osmotic 
potential and low cytotoxicity with nucleus pulposus cells.   
These studies are the first attempt at the incorporation of natural CS into 
biomimetic bottle brush structures.  CS-macromolecules synthesized via the methods 
developed in these studies may be utilized in the treatment and prevention of debilitating 
back pain as well as act as mimetics for other proteoglycans implicated in cartilage, heart 
valve, and nervous system tissue function.   
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Chapter 1 :  Introduction 
 
Lower back pain resulting from intervertebral disc degeneration is one of the 
leading musculoskeletal disorders confronting our health system with one third of the 
population experiencing lower back pain annually (1).  This irreversible process leads to 
loss of mechanical stability with the potential for disc herniation and nerve damage (2).  
While disc degeneration is poorly understood, it has been shown that the proteoglycan 
content of the nucleus pulposus, or inner region of the disc, decreases linearly with age 
and degeneration with almost 40% of proteoglycans lost by the age of 40 (3). This loss of 
proteoglycans leads to a loss of hydration of the nucleus manifested by a reduction of 
disc height and intradiscal pressure (4).  The most common surgical approaches treat the 
end-stage of this degeneration with highly costly and highly invasive spinal fusion 
surgery while early-stage interventions are aimed at treating the symptoms and not the 
causes of back pain (5-6).   
In order to mechanically stabilize the disc early in the degenerative cascade and 
prevent the need for spinal fusion surgeries, we have proposed the development of a 
hybrid-bio/synthetic biomimetic proteoglycan macromolecule for injection into the disc 
in the early stages of degeneration, after a first or second episode of back pain.  The 
biomimetic proteoglycan is based on the major disc proteoglycan aggrecan which is a 
bottle brush macromolecule with a protein core and radiating negatively charged 
chondroitin sulfate (CS) bristles (7).  In the biomimetic approach, the protein core is 
replaced with a synthetic polymeric backbone in order to resist enzymatic and hydrolytic 
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degradation within the nucleus environment while maintaining the hydrating and 
biologically active chondroitin sulfate bristles in their natural bottle brush arrangement.   
The goal of this thesis was to incorporate for the first time, chondroitin sulfate 
chains into bottle brush polymer synthesis strategies for the fabrication of CS-
macromolecules which mimic the aggrecan structure and function.  The feasibility of 
utilizing both the “grafting-to” and “grafting-through” techniques of bottle brush 
synthesis was explored.  CS was immobilized onto a model polymeric backbone of 
poly(acrylic acid) for investigation of the “grafting-to” strategy via carboxyl-amine 
interactions.  For investigation of the “grafting-through” strategy of synthesis, an epoxy-
amine step growth polymerization technique was utilized to synthesize macromolecules 
with CS bristles and poly(ethylene glycol) backbone segments.  Incorporation of a 
synthetic polymeric backbone at the terminal amine of CS was investigated via 
biochemical assays, proton nuclear magnetic resonance analysis and infrared 
spectroscopy, and CS-macromolecule size was demonstrated via gel permeation 
chromatography, transmission electron microscopy and viscosity measurements.  Further 
analysis of CS-macromolecule functionality was conducted in order to characterize 
macromolecule fixed charge density, osmotic potential (via membrane osmometry) and 
cytotoxicity.  These studies are the first attempt at the incorporation of natural CS into 
biomimetic bottle brush structures.  CS-macromolecules synthesized via the methods 
developed in these studies may be utilized in the treatment and prevention of debilitating 
back pain.  With the high social and economic costs of spine disorders, the development 
of an early interventional, minimally invasive treatment of back pain could have far 
reaching benefits for our society.   
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Additionally, macromolecules synthesized in this biomimetic strategy may serve 
to mimic other macromolecules of the proteoglycan family.  The proteoglycan family 
consists of a large array of macromolecules with similar structure, i.e. protein core with 
attached glycosaminoglycan (GAG) chains.  These proteoglycans differ in core protein 
length and amino acid sequence as well as GAG grafting density.  The strategies for 
biomimetic aggrecan synthesis developed here are transferable to the synthesis of a 
family of biomimetic proteoglycan macromolecules that may fill a wide array of 
functions in regenerative and restorative medicine (8).      
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Chapter 2 : Significance 
 
Low Back pain is one of the leading musculoskeletal disorders confronting our 
health system with between 30% and 40% of adults in the U.S. reporting to have 
experienced low back pain in the previous three months (1).  Overall, one in two persons 
reports experiencing back pain at least once a year (Figure 2.1).  Of the various causes of 
low back pain including lumbar back disorders, back injury, and disc disorders, 
degenerative changes of the disc are a leading contributor to spinal fusion surgeries with 
an increasing trend over the past several decades (Figure 2.2) (6).  Lumbar fusion 
procedures on average were reported to cost $63,520 in 2004 with an average hospital 
stay of 4.7 days.  A rising cost of spinal fusion procedures along with a steady increase in 
the number of procedures performed has attributed to an estimated cost of $16.9 billion in 
2004 for primary spinal fusions, a 215% increase from that reported in 1998 (Figure:  
2.3)(1).   
The socioeconomic burden of low back pain and degenerative disc disease is 
especially striking with  55% to 84% of those individuals aged 44 to 65 reporting a 
limited work capacity, attributing their limitation to back pain(1).  In 2004 alone, an 
estimated 186.7 million work days were lost due to back pain(1).  In 2004, the estimated 
annual cost for medical care of spine conditions was $193.9 billion, a rise from the 
$130.2 billion reported in 1996, an increase of 49%.  Earnings loss, due to spine 
conditions was estimated at 22.4 billion per year between 2000 and 2004(1).  With the 
high social and economic costs of spine disorders, the development of an early 
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interventional, minimally invasive treatment of back pain could have far reaching 
benefits for our society.   
Earlier stage interventions are currently being explored, such as nucleus pulposus 
replacement (9-15).  In this procedure the nucleus pulposus is excised and replaced with a 
medical device with the goal of restoring disc biomechanics, providing stabilization to 
the disc and thereby alleviating lower back pain. This technique however results in 
complete removal of the native nucleus tissue, removing the possibility of regeneration 
and fully relying on the implanted material for mechanical and biological function.   
By mechanically stabilizing the disc early in the degenerative cascade, one may 
be able to protect the outer disc tissue, the annulus fibrosus, from an adverse stress state 
which may limit or prevent tearing and subsequent herniation of the disc.  The approach 
proposed here is to develop a hybrid synthetic/bio-based aggrecan-like macromolecule 
for injection into discs in the early stages of degeneration, after a first or second episode 
of lower back pain.  These injections will be minimally invasive, and the implanted 
macromolecule will be able to integrate with surrounding tissues working in concert to 
maintain disc function.     
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Figure 2.1:  Prevalence of self-reported joint pain 
by site for persons aged 18 and over in two national health surveys in the United States between 
1999-2005. (1) 
 
 
 
 
Figure 2.2:  Lumbar fusion rates by primary diagnosis.(6) 
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Figure:  2.3:  Seven year trend in total cost for spinal fusion procedures in the United (1) 
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Chapter 3 :  Background 
 
3.1.
3.1.1. The Vertebral Column 
 Anatomy and Physiology of the Spine  
The human vertebral column, or spine functions to transfer loads and bending 
moments of the head, trunk, and any external loads to the pelvis, allow sufficient 
physiological movement and flexibility of the upper body and protect the spinal cord 
from danger due to motion and trauma (16).  It also serves as protection to other vital 
internal organs and as a base of attachment for upper-body ligaments, tendons, and 
muscles.  These functions help explain its form and structure.  
The spine consists of a series of individual vertebre, the sacrum and the coccyx 
and spans from the skull to the pelvis.  Adjacent vertebrae are connected by an 
intervertebral disc (IVD).  The vertebrae are stacked on top of each other and are grouped 
into five distinct regions—there are cervical, thoracic and lumbar vertebrae, as well as a 
fused sacral, and fused coccyx (Figure 3.1).  From posterior perspective, the spine appears 
to be straight, but lateral view shows four normal curves that mechanically serve to give 
the spinal column increased flexibility and shock-absorption ability. 
3.1.2. The Intervertebral Disc 
The intervertebral disc separates adjacent vertebra and acts as a shock absorber, 
dissipating energy under loading.  The disc is the largest avascular tissue in the human 
body requiring nutrients to enter and waste to be removed primarily through diffusion 
and fluid flow (16).  The disc structure is quite complex combining three distinct regions: 
the nucleus pulposus, an inner gelatinous core; the annulus fibrosus, a surrounding 
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ordered fibrous structure and the bony endplates that are partly cartilaginous and partly 
bony and serve as an interface between the disc and the vertebral bodies (Figure 3.2).  
The cellular content of the disc is very low, less than ca. 0.25% of tissue volume (17).  
The extracellular disc matrix plays the main role in determining the mechanical 
properties of the disc. 
3.1.3. The Nucleus Pulposus 
The central nucleus pulposus (NP) region of the IVD is a gelatinous structure that 
is mostly water (77% of wet weight) but also contains a large constituent of 
proteoglycans (PGs) (14% of wet weight) which are composed of charged 
glycosaminoglycan (GAG) chains covalently attached to a protein core.  Randomly 
organized collagen fibers are also present in the NP (about 4% of wet weight) and 
associate with the proteoglycans to form a loose network (18).  Collagen fibers within the 
NP provide tensile strength while proteoglycans create a large osmotic swelling pressure 
and draw water into the tissue (Figure 3.3).  Charged groups on the GAG chains of the 
PGs carry with them mobile counter ions like Na+ which draw water is drawn into the 
tissue because of the osmotic imbalance generating a hydrostatic pressure within the NP 
(7).   
3.1.4. The Annulus Fibrosus 
The annulus fibrosus (AF) of the intervertebral disc is a structure that serves to 
contain the gelatinous nucleus pulposus. The chemical composition of the AF comprises 
65-90% wet weight of water, 50-70% dry weight of collagen, 10-20% dry weight of 
proteoglycans, and non-collagenous proteins such as elastin (19).  The structure of the AF 
is laminate in nature, consisting of a minimum of 15 (posterior) and 25 (lateral) 
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concentric layers. The layers are made up of type I collagen fibers which alternate in 
angles from 30o at the peripheral AF to 44o at the central AF with reference to the 
transverse plane of the disc (Figure 3.4) (19).   Spinal compression generates a hydrostatic 
pressure in the NP which places the annulus into tension thereby resisting the applied 
load (Figure 2.4.1.) (20).  When a compressive load (C) is placed on the IVD, a 
hydrostatic pressure (P) is generated in the NP and tensile stress (T) on the annulus.  The 
AF has a very highly organized structure which results in complex anisotropic behavior 
with loading.  
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Figure 3.1:  Regions of the human spine  
with respect to the vertebrae and corresponding intervertebral discs 
(http://healthbase.wordpress.com/2007/06/13/spinal-fusion-surgery/) 
 
 
 
 
 
 
12 
 
 
 
Figure 3.2:  The Intervertebral disc location  
between adjacent vertebrae and the individual structures and average dimensions of the IVD (18) 
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Figure 3.3:  Constituents of the nucleus pulposus and subsequent development of hydrostatic 
pressure (7) 
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Figure 3.4:  Load transfer in the IVD and lamellar structure if the annulus fibrosus.  (20) 
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3.2. Intervertebral Disc Degeneration 
 
 
The intervertebral disc of the spine is subject to degenerative changes induced by 
normal aging as well as injury, loading or genetically induced accelerated disc 
degeneration (21).  The exact mechanism of IVD degeneration is not well understood; 
however possible degenerative cascades have been proposed which lead to eventual 
changes in disc mechanical properties (Figure 3.5).  Initial changes in the IVD are thought 
to be brought about by changes in the nutrient flow to and waste product flow out of the 
nucleus.  Calcification of the cartilaginous endplates, the major route of nutrient supply to 
the disc, leads to harsh cellular environments subsequently reducing matrix synthesis and 
increasing enzyme production further reducing proteoglycan, collagen and elastin content 
of the disc, in particular in the nucleus pulposus (3, 21-26) (Figure 3.6).  The loss of PGs 
in the NP has major effects on the load-bearing behavior of the disc, causing the osmotic 
pressure of the disc to fall and reducing the disc water content disrupting the NP’s ability 
to behave hydrostatically under load (Figure 3.7).
Figure 3.5
  Loading can then lead to inappropriate 
stress concentrations along the endplate and in the annulus with progressive changes as 
disc degeneration proceeds ( ).   Changes in stress concentration can lead to 
damage of the annulus fibrosus as well as the endplates with stress concentrations being 
associated with discogenic pain (18).  Several manifestations of disc degeneration and 
damage can be visualized with MRI including herniation of the lumbar disc, degeneration 
of the lumbar disc, signal changes in the vertebral end plates and annular fissures.  
Although these alterations in the IVD are prevalent in the asymptomatic population 
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(found in 25 to 70% of asymptomatic subjects), disc disruptions have been associated 
with back pain and are targets for surgical interventions such as spinal fusion, total disc 
replacement, nucleus replacement and annulus repair (27). 
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Figure 3.5:   Disc degeneration and mechanical consequences 
(A) Cascade of events in IVD degeneration (28) and (B) changes in mechanical properties of the 
IVD with degeneration (normal disc to degenerated disc from top to bottom) (29) 
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Figure 3.6:  Changes in major biomacromolecule concentrations in the annulus fibrosus and 
nucleus pulposus of the intervertebral disc with aging (3, 24-26) 
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Figure 3.7:  Change in water content in the IVD and associated change in glycosaminoglycan 
content in the IVD with aging and degeneration. (30) 
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Degeneration of the intervertebral disc is often associated with back pain, making 
the IVD a target for surgical intervention.  Over 300,000 lumbar discectomy surgeries are 
performed annually in the United States accounting for over 34% of all spinal procedures 
conducted (1).  Removal of disc material can have adverse effects, however, on adjacent 
level spinal segments and can lead to instability of the spine (31).   
3.3. Treatment Options 
The first mode of treatment proposed for the treatment of the majority of patients 
who suffer from degenerative disc degeneration is non-operative care.  Conservative 
treatments include anti-inflammatory medication, physical therapy, and injections.  These 
treatments are often effective with 70% of patients pain-free after treatment and as low as 
25% recurrence.  Patients with chronic back pain however are more difficult to treat 
successfully.   
 Of particular interests, as a minimally invasive non-surgical procedure to reduce 
back pain is injection therapy.  Injection therapies for chronic low back pain include 
injections of anti-inflamitory agents, medications, irritants, or proteolytic enzymes into 
soft tissues outside or within the spine (32).  Epidural steroid injections for managing 
chronic low back pain are one of the most commonly performed interventions in the 
United States and have indications ranging from sciatica and radiculopathy to herniated 
discs, and spinal stenosis (5, 33).  While these procedures have shown some short term 
(less than 6 weeks) and longer term (6 weeks or longer) effects in providing pain relief, 
evidence of the effectiveness of these procedures is conflicting (5, 33).  Additionally, the 
underlying mechanism of action of epidural steroids is not well understood.  One 
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mechanism is that the resulting neural block interrupts nociceptor input and self-
sustaining activity of neurons as well as patterns of neuronal activity (33).  Steroids also 
have anti-inflammatory activity by inhibiting release or synthesis of pro-inflammatory 
mediator as well as providing local reversible anesthetic effects (33).  All of these 
mechanisms of action however do not address the root mechanical or biological causes of 
pain, and simply address the symptoms.   Injections directly into the nucleus region of the 
intervertebral disc are also performed to deliver chymopapain to digest nucleus tissue, 
thereby reducing the pressure of herniated tissue on the spinal nerves.  This procedures 
however has not been shown to be more effective than total discectomy (32).     
Based on carefully considered guidelines, surgical interventions are recommended 
in the event that conservative remedies do not address the clinical needs of the patient.  
The following is a review of current surgical and implantable interventions for the 
treatment of back pain. 
 Arthrodesis or spinal fusion is the traditionally accepted surgical intervention 
technique advocated in cases of isolated disc degeneration in the cervical or lumbar spine. 
The procedure involves the removal of a motion segment through the use of bone grafts 
and sometimes through internal fixation. Indications for the procedure are instability of a 
motion segment caused by traumatic injury or degeneration (34). A successful fusion 
procedure eliminates motion that causes pain and offers the ability to restore 
intervertebral height and alignment (35).  
Early spinal implants were based on metals due to the utility of metals in other 
orthopedic devices.  The complex loading nature and function of the spine however 
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necessitated the development of novel materials and techniques in surgical spine 
interventions.  Failures of earlier devices have especially expanded the breadth of 
materials utilized in spinal interventions.  Adjacent level disc degeneration with spinal 
fusion, expulsion of implant materials through surgical sites and subsidence of implants 
into the endplates have driven the development of new surgical techniques and provided 
the impetus for the development of novel spine materials.  This is especially illustrated by 
the development of in situ curing hydrogel and non-hydrogel nucleus replacements where 
materials were designed such that they could be delivered with minimal damage to the 
annulus fibrosus.  Another drive in materials for spine implants is the utilization of tissue 
engineering and molecular approaches.   
 
3.3.1. Spinal fusion 
Spinal fusion and stabilization utilizes a wide range of devices such as screws, 
wires, artificial ligaments and vertebral cages (36).  The instrumentation used in fusion 
surgery is designed to stabilize the spine during fusion and promote osseous fusion (37).  
Early spinal fusion devices were based on metals commonly utilized in other orthopedic 
surgeries such as in hip implants.  Metals are still widely used in spine fusion implants 
today; however advances have been made implant design and material development in 
order to address the unique needs of the spine including maintenance of spine flexibility 
and to avoid the occurrence of adjacent area damage. 
Spinal Cages and Interbody Spacers.  The removal of the intervertebral disc in 
order to address discogenic back pain and disc herniation will lead to the loss of disc 
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height and lead to spinal instability.  Cage structures have been developed to assist in 
implanting allo- and autologous bone graft interbody spacers.  These cages enhance 
stabilization of the spinal segment and prevent postoperative collapse.  The BAKTM 
interbody fusion system for example is a cage structure made of porous Ti-6Al-4V shell 
with a cavity for the placement of bone grafts (38).   
Spinal fusion has its limitations.  No significant improvement has been seen in the 
success rate of fusion procedures despite the advances made in terms of surgical 
techniques and instruments.  Spinal fusion is also associated with accelerated adjacent 
level disc degeneration, long post-operative recuperation times and high cost  (39). 
3.3.2. Total Disc Arthroplasty 
 The total disc arthroplasty procedure aims to potentially eliminate a painful disc 
while preserving/restoring motion (35). The goals of arthroplasty include successful pain 
relief and functional recovery, acceptable levels of morbidity associated with the 
procedure (equal to or less than those seen in fusion), shorter post-operative recuperation 
times and easily implantable surgical techniques (39).  The biomechanical objectives of 
disc arthroplasty are the restoration of disc function to relieve abnormal stress or strain 
caused by degeneration. More importantly, it is essential that the procedure not cause any 
detrimental biomechanical effects on surrounding structures within the motion segment 
and on adjacent levels(39).  
As an example, The Charite` Artifical Disc (marketed by DePuy Spine) was 
designed with the goal of replicating the kinematics of the disc. The basic design of the 
device incorporates two metallic end plates made of cobalt-chromium alloy (34) which 
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are attached to adjacent vertebral bodies, and articulate against a central polymeric core 
made up of ultra high molecular weight polyethylene (UHMWPE) (40).  The Charite` 
Aritficial disc has undergone four iterations in design since its inception and offers the 
largest and longest clinical trial of any existing artificial disc (34, 41). There have been a 
number of clinical studies undertaken to document the performance of the SB  Charite` 
III (Figure 3.8).  Most of these studies have demonstrated that the Charite` artificial disc 
has the potential to preserve motion and survive long term implantation in the body with 
good to excellent outcomes. However, cohort studies undertaken have shown variability 
in the complication and success rates of the device, which raises concerns regarding the 
repeatability and reproducibility of the procedure.  
            
3.3.3. Nucleus Replacement 
Nucleus replacement offers a less invasive alternative to disectomy with fusion or 
total disc replacement.  Nucleus replacement devices aim to replace herniated or 
surgically removed NP tissue with a prosthesis that can function as a load sharing device 
(12-13, 42-43).  The goal is to help prevent further collapse and degeneration of the 
remaining disc as well as restore the biomechanical function of the annulus by placing the 
annular fibers in tension (44).   
The original nucleus replacement technologies aimed to primarily mimic the 
geometry of the nucleus pulposus.  These approaches held the premise that by replacing 
the lost nucleus material and restoring disc height, pressure on impinged nerves would be 
relieved, alleviating back pain (12).  Stainless steel balls and other metal devices were 
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used for this purpose however, these metal devices, due primarily to their high stiffness, 
could not restore normal load distribution and often resulted in implant migration and 
subsidence (45).  As a result, designs incorporating elastomers and viscoelastic behaviors 
have been investigated for nucleus replacement (12, 34, 41, 44-46). 
Several requirements have been established for the NP device and its materials.  
The implant should be biocompatible without causing local cell death or systemic 
toxicity.  The device must also be durable and exhibit fatigue resistance as it is likely to 
experience loads of over 100 million cycles over 40 years (44).  The material should 
exhibit low wear characteristics and avoid the formation of particulates.  It is also 
important that implant have a similar stiffness as the native nucleus tissue to avoid stress 
shielding and bone resorption that may lead to endplate subsidence and extrusion of the 
implant (44).  The device should also fill the disc space to prevent implant movement and 
restore disc height while avoiding overfilling the cavity which can result in significant 
increases in the stiffness of the joint (13). 
Nucleus replacement devices can be subdivided into several categories based on 
their primary mode of function (mechanical or elastomeric), material and mode of 
delivery.  Mechanical nucleus devices can be either one piece or two pieces.  The Regain 
is a solid 1-piece mechanical nucleus composed of a carbon substrate with a pyrolytic 
carbon coating.  Its geometry is convex such that it can conform to the natural convexity 
of the vertebral endplates.  This device is currently in pilot feasibility studies (47).  The 
Nubac Disc Arthroplasty Device is a two-piece mechanical nucleus and is a PEEK-on-
PEEK articulating device.  This device has a ball and socket design with a large surface 
contact area designed to distribute stresses and decrease the risk of subsidence.  Wear of 
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the PEEK material is a concern, however over 100 devices have been implanted 
worldwide and pilot feasibility studies are underway (45, 47-48). 
Elastomeric devices can further be subdivided into hydrogel vs non-hydrorgel 
materials, both of which may be delivered either preformed, or in an injectable, in-situ 
forming material.  Hydrogels are polymers that absorb water and swell when placed in 
fluid environments while non-hydrogels polymers are low-friction materials with shock 
absorbing capabilities.  Some elastomeric devices and their materials are listed in Table 
6.1.   
 Pre-formed Nucleus Replacements.  The prosthetic disc nucleus PDN 
(HydraflexTM and SOLOTM), was the most widely studied nucleoplasty device with over 
5,500 devices implanted world wide (49).  The PDN is composed of a preformed 
hydrogel core consisting of polyacrylonitrile and polyacrylamide with a polyethylene-
woven jacket (Figure 3.9).  This device was implanted dehydrated, and upon implantation 
rehydrated, absorbing up to 80% of its own weight in water.  This device is no longer 
under investigation due to issues with disruption of the woven jacket and subsequent 
fragmentation of the hydrogel core (50).  
In Situ forming Non-Hydrogel Nucleus Replacements.  In efforts to better match 
the mechanical needs of a nucleus replacement and to reduce chance for expulsion novel 
injectable in situ curing materials are being investigated further. It is especially important 
in a nucleus replacement, for the material to resist expulsion from the nucleus cavity 
under repetitive loading.  In situ curing polymers are therefore of great interest as they 
can be administered via minimally invasive techniques, and thereby maintain annulus 
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integrity and reduce risk of expulsion via the surgical site.  In situ forming biomaterials 
are designed to change shape or form either during or after implantation (51).  In situ 
forming biomaterials include polymers or prepolymers that are crosslinked after 
implantation.  NuCoreTM injectable disc nucleus (Figure 3.10), DascorTM (Disc Dynamics, 
Inc. Eden Prairie, MN) prosthetic intervertebral nucleus and Percutaneous Nucleus 
ReplacementTM devices are injectable non-hydrogel devices (44).   HydrafilTM nucleus 
replacement implant and BiodiscTM are injectable hydrogel implants that form in situ (47, 
52-53).   
These NP replacements are currently at different stages of preclinical and clinical 
investigates (Table 3.1).  The Biodisc, PDN, Aquarelle, NeuDisc, PNR, Dascor and 
Newleus are no longer under clinical investigation due to adverse preclinical trials.  The 
most common complication of NP replacement is implant extrusion through the insertion 
defect that must inevitably be created in the annulus.  Endplate failure and subsidence are 
also common modes of failure. 
 
3.3.4. Tissue Engineering and Regenerative Medicine Approaches to Disc Degeneration 
In addition to the replacement of NP with a prosthetic device, tissue engineering 
approaches are also being investigated.  The tissue engineering approach provides the 
possibility to recover the functionality of the degenerated intervertebral disc.  By 
manipulating the discs biology to inhibit further degeneration by the introduction of 
therapeutic agents such as cells, growth factors and scaffolds, tissue engineering 
approaches aim to restore native NP functionality (54).  Many scaffold materials have 
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been investigated to support cell and drug delivery to the NP including 
chitosan/hydroxybutyl chitosan, alginate, collagen/atelocollagen, gelatin, hyaluronan, 
calcium phosphate, polyl-D, L-lactide (PDLA), demineralized bone matrix (DBM) and 
small intestine submucosa (SIS) (54-55).  Although NP tissue engineering provides a 
promising interventional techinique and alternative to implanted NP devices, its clinical 
application is still far away.  Although NP cells have shown promise in in vitro cultures 
poor nutrient supply in the NP area of degenerated discs will limit cellularity and 
functionality of the implanted NP graft material and therefore nutrient availability must 
be addressed for successful implantation (55).  
Regenerative biological solutions aim to stop disease progression at a cellular 
level, addressing the underlying pathology of disc degeneration (56).  Disc disease 
includes the loss of proteoglycans, increased catabolic enzyme activity, increased cell 
senescence and cell death.  A major effort in therapeutic strategies for disc degeneration 
is the restoration of the disc’s structural morphology by restoring the disc matrix and 
reversing the appearance of disc degeneration (57).  In order to achieve this, therapeutic 
strategies either promote native cells to produce more matrix, or promote cells to reduce 
catabolic activity.  Earlier strategies investigated promitotic growth factors, however cell 
mitosis and an increase in cell number may not be beneficial as there is evidence that 
there is an upper limit on cell density in the disc matrix (57).   
Gene therapy for example may improve the function and integrity of the 
degenerated disc by altering cellular gene expression profiles.  Transduction of TGF-β 
using adenovirus vectors (in rabbit models) have resulted in increased expression of 
TGF-β and proteoglycans without eliciting an immune response (56).  In addition, the 
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introduction of some molecules (bone morphogenic protein (BMP-2, BMP-7) and growth 
differentiation factor (GDF-5)) in culture has proven to be highly effective in increasing 
disc matrix production (57).  BMP-7 and GDF-5 in particular are currently in FDA trials 
to test whether single injections of therapeutic molecules can improve disc matrix 
appearance on MRI and improve back pain (57).  In contrast, up regulation of anti-
catabolic cytokines (IL-1 receptor antibody) may neutralize the increased catabolic action 
in the disc (i.e. activity of IL-1 catabolic cytokine), thus correcting the imbalance 
between anabolism and catabolism in the disc (56). These strategies however are 
similarly limited by their dependence on cellular activity in the nutrient deprived disc 
environment.     
 
3.2.4. Summary of current treatment options:  a need for an early interventional strategy 
In the cascade of disc degeneration, the majority of clinically available treatments 
are for the end stages of disc degeneration (Figure 3.11).  At this final stage, the IVD can 
no longer maintain its height or mechanical and stabilizing properties so it is removed 
from the spinal column and replaced by a stabilizing unit.  The adjacent vertebrae can be 
fused together by various means to stabilize the motion segment, or an articulating total 
disc replacement can be used in an attempt to maintain normal spine kinematics.  At 
stages of moderate degeneration nucleus replacement technologies are being investigated 
in both laboratory and clinical settings.  In these approaches, the annulus tissue is kept 
intact (with the exception of a puncture wound) while the degenerated nucleus tissue is 
removed and replaced with a synthetic mechanically functional material.  As more 
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knowledge of the degenerative cascade is gained however the possibility of earlier stage 
treatments (after the first or second episode of back pain) which preserve more of the 
natural disc biology can be envisioned.  Tissue engineering approaches and regenerative 
therapies are currently being investigated for these early stage replacements however 
limitations with the inherent hostile nature of the nucleus pulposus environment pose a 
great challenge to these strategies.  An early interventional minimally invasive strategy 
which restores mechanical stability to the spinal column and integrates with existing 
tissue could be utilized to treat early episodes of back pain while promoting healing 
preventing further degeneration (Figure 3.11).  Such an interventional strategy must be 
robust enough to maintain functionality in the NP environment while integrating with 
existing tissue and supporting regeneration.   
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Figure 3.8:  SB Charite` III, and radiographic image of the implanted device (41). 
 
 
 
 
 
Figure 3.9:  PDN-SOLOTM device in hydrated and dehydrated states.   
Porous polyethylene weave allows fluid to pass into the hydrophilic core allowing the device to 
expand vertically and horizontally (arrow).(44) 
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Figure 3.10:  Photograph of the NuCoreTM (Spine Wave) Injectable Disc Nucleus  
(red) after injection into a nucleated cadaveric spinal motion segment (lateral cross-section) (58). 
 
 
 
 
Figure 3.11:  Cascade of intervertebral disc degeneration and associated treatment options 
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Table 3.1:  Elastomeric Nucleus Pulposus Replacement Devices 
 Delivery Device Material Status 
Hydrogel Injectable Biodisc; Cryolife Albumin and 
glutaraldehyde 
No Longer Under 
Investigation 
Hydrafil; Synthes polyvinyl alcohol/polyvinyl 
pyrollidine copolymer 
In Preclinical 
Studies 
Pre-
formed 
PDN Hydraflex and 
SOLO; Raymedica 
hydrolyzed polyacrylonitrile No Longer Under 
Investigation 
Aquarelle; Stryker polyvinyl alcohol No Longer Under 
Investigation 
NeuDisc; 
Replication 
Medical 
partially hydrolyzed acrylic 
copolymer 
No Longer Under 
Investigation 
Non-
Hydrogel 
Injectable NuCore; Spine 
Wave 
rDNA-based synthetic 
protein copolymer of 
silk/elastin 
In Pilot Clinical 
Studies 
PNR; TranS1 silicone No Longer Under 
Investigation 
Dascor; Disc 
Dynamics 
polyurethane No Longer Under 
Investigation 
Pre-
formed 
Newleus; Zimmer polyurethane No Longer Under 
Investigation 
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3.4.1. Proteoglycan Diversity, Structure and Function 
3.4. Aggrecan structure, assembly, and function 
Proteoglycans (PGs) are defined as proteins that have one or more 
glycosaminoglycan (GAG) chains attached (59).  Matrix proteoglycans can be separated 
into three groups which vary in structure and function:  basement membrane 
proteoglycans, proteoglycans interacting with hyaluronan (HA) and lectins (hyalectans), 
and small leucine-rich proteoglycans (60).  Structurally, proteoglycans differ in the 
sequence and size of their protein core as well as the number and types of GAGs 
attached.  The major classes of associating GAGs are chondroitin sulfate, heparin sulfate, 
keratan sulfate, and dermatan sulfate (60).  GAG chains are attached to PGs via 
glycosidic linkages joining the terminal end of the GAG to an amino acid residue of the 
protein backbone.  Proteoglycans have diverse functionality.  They act to structurally 
organize tissues, influence cell growth, act as growth factor and ion reservoirs (playing a 
role as biological filters and modulating growth factor activity, and imparting osmotic 
pressure), regulate collagen fibrillogenesis and skin tensile strength and influence corneal 
transparency as well as neurite growth (8, 60).  In the intervertebral disc, the main 
proteoglycans are aggrecan, versican, decorin, and biglycan, some of which are 
respresented as schematics in Figure 3.12.  The most abundant disc proteoglycan is 
aggrecan and will be the focus of this study due to its critical role in maintaining disc 
hydration and mechanical function (61).   
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3.4.2. Aggrecan Structure. 
Aggrecan, an aggregating proteoglycan, is the major proteoglycan of the 
intervertebral disc.  Aggrecan consists of a protein core (approximately 300kDa and 
400nm in contour length) to which glycosaminoglycan chains are covalently attached 
resulting in a macromolecule with total molecular mass approximately 2,200kDa  (62-
63).  The protein core consists of several domains which allow for the molecules 
flexibility (IGD) attachment to hyaluronic acid (G1 globular domain) attachment of 
chondroitin sulfate(CS) (CS1 and CS2 domains) and keratan sulfate (KS) (KS domain) 
and cell signaling (G3 globular domain) (Figure 3.13).  N- and O-linked oligosaccharides 
also decorate the aggrecan core protein throughout the CS and KS regions (64).  
Approximately 100 CS glycosaminoglycan (GAG) chains are covalently attached to the 
core protein in the CS region with a grafting density of approximately 0.25 to 0.5 nm-1.  
Each CS chain which consists of 10-50 repeating disaccharide units of glucuronic acid 
(GlcUA) and n-acetylgalactosamine (GalNAc) and is approximately 20kDa with a length 
of 40nm(65).  The KS region of the aggrecan core protein is smaller with only ~30 KS 
chains attached.  KS is a smaller GAG chain of 5-15kDa.  Approximately 8000-10000 
negatively charged groups are present in the aggrecan bottle brush via the charged sulfate 
and carboxylic acids of the attached CS and KS chains (64, 66).  
 
3.4.3. Aggrecan In Vivo Synthesis. 
Aggrecan is assembled intracellularly through a complex series of enzymatic 
reactions.  Synthesis begins with translation of the core protein followed by the addition 
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of a xylose sugar unit to the core protein, where sequence motifs of Ser-Gly-X-Gly or 
(Asp/Glu)-X-Ser-Gly  serve as sites for xylosylation on the serine residue and a 
glycosidic bond is formed between xylose and the hydroxyl group of serine (Figure 3.14) 
(67).  Additional CS linkage sugars are then added to the xylose sugar.  Subsequent CS 
disaccharide polymerization and sulfation occurs on the growing sugar chains building 
the CS bristles out from the core protein resulting in a densely packed bottle brush 
structure (67).  After intracellular assembly, the aggrecan macromolecule is secreted to 
the extracellular space where it is able to assemble into larger aggregate structures with 
hyaluronic acid and link protein (67).  Although aggrecan is able to associate with HA 
and link protein extracellularly, large HA-aggrecan aggregates are only predominant in 
infancy such that by 6 months of age only approximately 30% of the NP is in the 
aggregate form, levels as low as 10% aggregation are seen in the adult NP(68). 
 
3.4.4. Functional molecular biomechanics of aggrecan   
Aggrecan has two main mechanical functions in the disc: 1) it allows water 
uptake by the nucleus due to sulfated groups in the chondroitin and keratin sulfate rich 
regions which, in part, provides intradiscal pressure (20) and 2) it provides electrostatic 
repulsion due to the elegant 3D macromolecular bottle brush structure, which contributes 
to intradiscal pressure and disc height (69-71).  A main constituent of aggrecan is the 
GAG chains which are covalently attached to the aggrecan protein core and comprise 
approximately 80% of the total weight of the molecule.  These GAG chains, in particular 
in the CS rich region are arranged in closely packed arrays creating a bottle brush 
structure.  Along with the hydrating properties of the GAG chains imparted by the 
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charged groups along the molecule, electrostatic forces between closely packed GAG 
chains provide a mechanical resistance to applied force.  Electrostatic forces between CS 
chains account for 50% (290kPa) of the equilibrium compressive elastic modulus as 
predicted by theoretical modeling (70, 72).  These electrostatic repulsion forces however 
will only occur when intermolecular distances are ~5 Debye lengths or less (CS 
concentration of 30mg/mL, 2-4nm spacing between chains)(69).  GAG chains may come 
into close proximity via several modes including adjacent chains on the aggrecan core 
protein, interdigitation of opposing GAGs, and steric interactions between opposing 
GAGs (Figure 3.15).  Interactions between opposing GAG chains have been 
experimentally demonstrated to resist force at short distances, however, when opposing 
aggrecan chains are brought into contact, they exhibit enhanced force resistance at larger 
distances demonstrating the benefit of the more ordered arrangement of CS chains seen in 
the aggrecan bottle brush (Figure 3.16) (73-74).  
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Figure 3.12:  Schematic representation of hyalectans found in the intervertebral disc  
Ig, immunoglobulin-type repeat; LP, link-protein type module; GAG, glycosaminoglycan-binding 
domain, EG, EGF-like module; Lectin, C-type lectin-like module; CR, complement regulatory 
protein; KS, keratan sulfate-attachment module. (59) 
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Figure 3.13:  The bottle brush structure of Aggrecan  
(top) and the chemical structure of chondroitin sulfate (bottom).  Up to 130 CS chains are 
covalently bound to the aggrecan core protein.(69) 
 
 
 
Figure 3.14:  Aggrecan Synthesis in vivo 
Aggrecan Synthesis in vivo is an intracellular process where the core protein is first translated.  
GAG chains are then attached to the core protein via a glycosidic bond formed between xylose 
and the hydroxyl group of serine.  The aggrecan bottle brush is then secreted from the cell and 
associates with HA and other ECM components. (67, 75) 
400nm 
40nm 
GlcUA GalNAc 
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Figure 3.15:  Electrostatic repulsion generated between opposing CS GAG chains.(69) 
 
 
 
 
Figure 3.16:  Opposing CS and aggrecan mechanics  
Opposing CS and aggrecan mechanics as investigated by AFM showing increased interactions for 
the macromolecular interactions. (74) 
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Enzymatic degradation of aggrecan and other proteoglycans and collagens in the 
NP allow for the turnover of matrix material (7).  In addition to matrix synthesis, an 
interplay exists between the secretion of matrix metalloproteinases (MMPs) and a 
disintegrin-like and metaloprotease with thrombospondin motifs (ADMATS) by nucleus 
pulposus cells and the secretion of tissue inhibitors of metalloproteases (TIMPs).   
However, in the IVD where nutrition is limited, NP cells are in a state of senescence.  
The reduced number of active NP cells leads to a decrease in the production of growth 
factors required to stimulate matrix synthesis and are unable to produce aggrecan at the 
necessary rates to maintain normal aggrecan concentration (76-77).  With aging and 
degeneration, enzymatic activity in the disc increases (
3.5. Aggrecan Degradation 
Figure 3.17), resulting in the 
presence of smaller aggrecan fragments and the loss of overall aggrecan 
concentration(78).  Matrix MMPs and ADMATS such as aggrecanases are the main 
enzymes that contribute to the degradation of aggrecan. In particular MMPs 1, 3, 7, 9, 
and 13 have showed increased activity with degeneration as well as aggrecanase 1,4,9,5, 
and 15 (22, 79-80).  TIMPs have also shown upregulation with disc degeneration 
however several MMPs that see upregulation in the NP such as MMP 3 and MMP7 
demonstrate resistance to the upregulated TIMPS 1 and 2.  The major ADAMTS inhibitor 
TIMP 3, does not show a concordant upregulation with degeneration, thus, for several 
ECM enzymes, there is an imbalance between enzyme and inhibitor resulting in 
increased aggrecan breakdown (81).  Enzymatic cleavage of aggrecan is targeted to the 
core protein of the molecule (Figure 3.18) (7).    Several cleavage points exist throughout 
the aggrecan core protein resulting in varying sized fragments of aggrecan that vary in 
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functional capacity as well as ability to migrate out of the nucleus pulposus lowering the 
overall tissue osmotic potential, which is dependent in part, on the macromolecular 
concentration (Figure 3.19).   
 
 
 
Figure 3.17:  MMP expression in cells of the NP  
as measured by the percentage of immunopositive cells (22). 
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Figure 3.18:  Sites of enzymatic cleavage of the aggrecan core protein (7). 
 
 
 
Figure 3.19:  Aggrecan cleavage into smaller molecular weight fragments  
that may diffuse from the tissue. (82) 
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3.6. The environment of the IVD 
As the IVD grows, its relative vascularity decreases limiting its nutrient supply.  
In an adult disc, a major source of nutrition is through the cartilage endplates superior and 
inferior to the disc, via the vascular supply of the vertebrae.  As the disc ages, endplate 
calcification occurs, further compromising the already limited nutrient supply and waste 
removal routes for the disc and especially, the NP.  The decreased nutrient supply as well 
as changes in disc pH limits the ability of disc cells to synthesize matrix and maintain cell 
density.  The reduced oxygen supply that accompanies lack of vasculature causes the disc 
cells to undergo anaerobic metabolism, thereby increasing the production of lactic acid 
and decreasing the pH of the disc (Figure 3.20) (68, 83).  The pH of the disc varies with 
degeneration.  In discs with no visible pathologic changes, pH range is observed between 
6.8-7.4, however prolapsed and scarred tissue pH has been observed as low as 5.7 to 6.3 
(23, 84).  The ionic concentration in the IVD is higher than surrounding tissues due to 
sodium and other ions associated with immobile charged GAG chains in the NP matrix.  
Typical NaCl concentration in the NP is 0.3M while that in other tissues is generally 
0.15M (4, 85).   
Transport through the disc endplates largely governs the disc environment.  
Studies into the transport properties of cartilaginous endplates reveals a dependence of 
molecule size, conformation (globular or long chain) and charge on the ability of 
molecules ,to diffuse through the endplate (23).  Smaller molecules (i.e. 100d) can enter 
the matrix to a greater extent than larger ones (i.e. 10kd).  Long chain conformations (i.e. 
different MW PEG chains were investigated) are more restricted from entering the matrix 
than globular conformations (i.e. starch).  Dextrans of MW ranging from 4 to 7 kDa were 
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also investigated for the diffusion into disc matrix through the endplate, and it was found 
that distance traveled by dextran molecules per unit time decreased, again indicating the 
greater mobility of smaller molecules (86).  Due to the constituents of the NP and 
endplate, charge also affects solute mobility where cations penetrate the NP to a greater 
extent than anions (23).  Endplate calcification, integrity and biochemical composition 
can also alter transport where calcification can lead to build up of waste and decrease in 
nutrition, but losses in endplate integrity can cause the loss of larger matrix molecules 
such as proteoglycans.  Hydration of the IVD matrix has also shown to be beneficial in 
promoting solute movement through the IVD. 
Solute transport through the disc is largely governed by diffusion, however 
convective transport is also important for larger molecules.  Cells rely on diffusion for 
their supply of essential nutrients such as oxygen and glucose.  Convective transport 
arises from the diurnal loading cycle where approximately 25% of the fluid of the disc is 
lost and gained over a day and night period.  Convective transport is outward rather than 
inward during the day’s activity and may contribute to the removal of larger species such 
as TIMP-1 (28kDa), cytokines (10-40kDa) and proteoglycans (>40kDa) as investigated 
theoretically. Transport in and out of the IVD is difficult to measure due to the lack of 
appropriate animal models and difficulties in measurements in humans.  Theoretical 
modeling has given some insight, however the complexity of factors influencing solute 
transport has made it difficult to validate a reliable model (23).     
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Figure 3.20:  Nutrient gradient across the NP 
a) Nutrient gradient across the NP from endplate to endplate.  (b) sagital section through a human 
lumbar disc with the direction of the gradient shown in (a) (83) 
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Chondroitin sulfate is a member of the glycosaminoglycans (GAGs) family which 
are carbohydrate polymers of repeating disaccharide units.  Six different types of GAG 
are known: heparin (H), heparin sulfate (HS), chondroitin sulfate, dermatan sulfate (DS), 
keratin sulfate (KS) and hyaluronate (or hyaluronic acid, HA).  The differences between 
the molecules arise from the combination of hexosamine (D-galactosamine (GalN) or D-
glucosamine (GlcN)) and hexuronic acids (D-glucuronic acid (GlcA) or L-iduronic acid 
(IdoA)) in the repeat disaccharide units.  CS is comprised of a repeating disaccharide of 
glucuronic acid (GlcA) and N-acetly-galactosamine (GalNAc).  In CS, sulfate groups 
replace one or more of the OH groups on C4 and C6 of GalNAc and C2 and C3 of GlcA 
(
3.7. Chondroitin Sulfate 
Figure 3.21).  These modifications can generate sixteen isomers of the repeating 
disaccharide, however commonly found CS are listed in Table 3.2.   
 
3.7.1. Localizations and diverse functions of CS 
Chondroitin sulfates are present as a part of PGs in several tissue locations.  They 
are present in intracellular granules of cells such as mast cells, at the cell membrane and 
in the extracellular matrix.  The function of CS and other similar GAGs is closely related 
to their localization.  Chondroitin sulfates and their proteoglycans have several diverse 
functions including structural (69, 73) (charge repulsions), hydrating (7) (increasing 
osmotic potential due to charged moieties), biological (87) (chondro-protective and anti-
inflammatory), and signaling (88) (stimulating matrix synthesis and cell differentiation).  
In the matrix, GAGs contribute to the organization of the ECM and tissues while in the 
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cell membrane they generally function as receptors and co-receptors and participate in the 
regulation of several cellular events.  The interactions depend on specific oligomeric 
GAG domains of approximately five to eight monosaccharides (89).  Chondroitin sulfates 
are attached to proteins in various amounts and in varying ratios to other GAGs such as 
DS and KS.  CS proteoglycans include decorin, biglycan, fibromodulin, lumican, 
aggrecan, versican, brevican, and neurocan.  Several of these CS PGs are found in load 
bearing tissues such as tendon, cartilage and the intervertebral disc and serve varying 
functions (Table 3.3) (90).  Versican in particular, which has core proteins ranging from 
74kDa to 370kDa and approximately 10-30 CS/DS chains sparsely attached is shown 
along with aggrecan to decrease in the NP with increasing degenerative grade (91). 
 
3.7.2. Conformation and functional mechanics of CS 
The x-ray structure of the sodium salt of pure CS-4 based on fiber 
diffraction patterns is available in the protein database (PDB) 
(http://www.rcsb.org/pdb/) (Figure 3.22).  CS takes on a fairly extended 
conformation and adopts a regular three fold helix (the calcium salt takes on a more 
extended two-fold helix conformation).  Intramolecular hydrogen bonds stabilize 
the structure and closely packed CS chains may also interact via intermolecular 
hydrogen bonds (89).  The conformation of CS in solutions of varying pH and ionic 
concentration have been investigated via the end-immobilzation of CS onto 
substrates and subsequent analysis of CS mechanics and height using high resolution 
force spectroscopy techniques and variable angle spectroscopic elliposmetry (VASE).  
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The conformation of CS as well as force generated by opposing GAG layers was found to 
be modulated by both solution pH and ionic concentration (Figure 3.23) (73).   
CS extension (height) was observed to vary with NaCl concentration which is 
consistent with the expected behavior of CS and the effects of salt screening and 
molecular conformation.  In DI water, the acidic groups of GAGs end tend to remain 
protonated (uncharged), thus, the non-ionized GAGs do not attain an extended 
conformation at very low salt concentrations and their height remains low.  As NaCl 
concentration increases, Na+ ions can exchange with dissociated H+ ions and ionization of 
GAG charge groups can occur freely.  In these conditions, CS chains tend to be in a more 
extended, rigid rodlike conformation because the intramolecular electrostatic repulsion 
between neighboring charges on the CS-GAG chains outweighs the entropic forces 
driving the chains to a random coil (69).   At very high NaCl concentrations (> 1M) the 
chains collapse into a more random coil-like configuration as the intra- and 
intermolecular electrostatic repulsions are screened by the salt causing a decrease in 
height.  The effect of charge density on GAG height is also demonstrated via changes in 
solution pH  where changing pH from 3 to 7 doubled the height, reaching a value close to 
the CS contour length (~45nm), indicating that the CS chains were fully extended due to 
increased repulsive interactions between charge groups at pH 7.   
There is also a strong dependence of the CS-CS interaction forces on ionic 
strength and pH suggesting that electrostatic repulsions dominate these interactions.  
Repulsion between opposing GAG chains occurs over a long range, starting at ~ 150nm 
distance, more than twice the CS contour length.  Theoretical modeling has predicted that 
~50% of the total compressive modulus of cartilage is attributable to electrostatic 
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interactions while 10-15% is attributable to steric interactions of GAG chains (70, 72-73).  
Lateral interactions between neighboring CS chains also contribute to the mechanical 
response of CS (69). 
 
3.7.3. Chondroitin Sulfate Stability in Aqueous Solutions 
CS stability has been investigated in aqueous solutions with varied pH and 
temperature (Figure 3.24) (92).  CS was found to be very stable in neutral conditions and 
low temperatures (30 °C), remaining stable up to 1000h while at elevated temperatures 
(60 °C), CS decomposition becomes apparent around 500h.  When CS was exposed to 
highly acidic environments (0.1M HCl, pH 1.5), molecular mass decreased and the 
number of reducing end groups increased.  In addition a decrease in CS sulfation was 
detected.  MW decrease in acidic condition is likely due to hydrolysis of the 
polysaccharide linkages.  In very basic conditions (0.1M NaOH, pH 12.10), a decrease in 
CS MW was also seen as well as an increase in degradation products (detected by an 
increase in absorbance at 232nm corresponding to unsaturated hexuronic acid).  No loss 
in sulfation was detected in basic conditions.  Degradation and decrease in CS MW in 
basic conditions is likely due to breakdown of the glycosydic linkages due to β-
elimination reactions (β-elimination reactions form an unsaturated hexuronic acid at the 
non-reducing end of each newly formed chain).  The combination of elevated 
temperature and extreme pH results in accelerated degradation of CS.  In acidic 
conditions at 30̊C, no depolymerization of CS is seen up to 960h while total degradation 
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occurred after 96h in 60̊C acidic conditions.  Similarly combined basic treatment and 
elevated temperature (60̊C) resulted in CS degradation after approximately 190h. (92)         
 
3.7.4. Age related changes in NP GAG 
CS, KS, and HA are major GAG constituents of the NP.  Aggrecan has both KS 
and CS regions, and the aggregation of aggrecan on HA is mediated by link protein.  The 
ratio of CS to KS changes in the IVD with aging and degeneration.  The very large 
aggregating GAG, HA also shows a marked increase with respect to total GAG ratio 
which may have implications in matrix properties (93).  Younger discs have a greater 
presence of CS while older discs lose CS and gain KS (almost 60% in older discs) (93).  
 CS and KS are based on the same polymer, and their secondary structures are 
very similar in solution, however the synthesis of these distinct GAGs follows two 
different metabolic routes.  KS and CS are both produced from glucose.  Biosynthesis of 
KS converts glucose to galactose with no consumption of oxygen while formation of CS 
requires the oxidation of glucose to glucuronic acid.  It is suggested that KS may be 
preferentially synthesized in aging discs as a functional substitute for CS where oxygen 
supplies are reduced.  Higher lactate concentrations in the disc due to disrupted nutrient 
and waste transport pathways may also change the balance of CS and KS synthesis (93).  
KS however is shorter in length than CS and the function of this GAG in maintaining the 
mechanical properties of the NP is unknown.   
In addition to changes in KS to CS ratio, the structure of CS in aged NP also 
changes.  A decrease in average chain size occurs between fetal and early postnatal ages 
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and at maturity, the CS chain size can decrease from 20kDa to as low as 8kDa.  In 
cartilage, the ratio of CS-4 to CS-6 is also observed to change with an increase in CS-6 in 
older tissue (63).  Age-related changes in GAG content may affect both the hydrating and 
mechanical properties of this molecule and may also affect its interaction with other NP 
ECM molecules. 
Changes in GAG content in the NP is likely due to changes in synthesis and not 
enzymatic or hydrolytic degradation of the GAG chains themselves.  Enzymatic 
degradation of GAGs are largely mediated by glycosidases (i.e. hyaluronidases), 
hydrolytic enzymes present within lysosomes (89).  In mammals, the enzymes are found 
in the liver, spleen, kidney, testes, urine, plasma and skin.  Hyaluronidases cleave bonds 
within the polysaccharide chain and produce oligosaccharides of varied length, however, 
lysosomal enzymes function only in acid pH ranges (3.3-5.5) (94).  The GAGs are 
generally stable at physiological pH and the slightly acidic environment of the NP.   
3.7.5. Pharmaceutical application. 
Chondroitin sulfate is a multi-functional biomolecule utilized in various 
pharmaceutical applications (89, 95-96).  Currently, CS is recommended by the European 
League against Rheumatism (EULAR) as a Symptomatic Slow Acting Drug for 
Osteoarthritis (SYSADOA) drug in Europe in the treatment of knee osteoarthritis (OA) 
and is often used in conjunction with glucosamine as a dietary supplement as a safe and 
effective option for the treatment of OA (96).   
As a pharmaceutical agent, CS is usually ingested as an intact polymer.  CS of 
various types and sources have varying degrees of bioavailability, where for example, 
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tracheal CS causes a rapid increase in plasma CS levels with a peak within 1-5h 
following administration, and returning to baseline after ca. 10h.  Shark CS on the other 
hand has a slower uptake with peak levels not occurring until ca. 16h following 
administration (95).  Although bioavailability data of orally administered CS is difficult 
to acquire, the overall bioavailability of exogenously delivered CS is estimated around 
10-20% (95).   
The direct treatment of symptomatic disc degeneration with glucosamine and CS 
supplementation has been limited likely due to the reduced vascularity of the NP of the 
IVD (the largest avascular structure of the body).  However, in one reported case study, a 
56 year old man who presented with more than 15 years of frequent/recurrent low-back 
pain was treated for 2 years with a glucosamine/CS supplement and observed to have 
increased water retention (and less bulging/protrusion) in partially degenerated discs 
while fully degenerated discs showed no change (97).  Along with the MR imaging (T2 
weighted MR imaging) the patient reported a gradual improvement in the range of 
motion and functioning of his back as well as an increased capability of withstanding 
heavier workloads without pain (97).  Although this study is not conclusive, it 
demonstrates the possible efficacy of administering CS for the rehydration and functional 
recovery of mildly degenerated discs, and their monitoring using T2 MR imaging.  The 
direct administration of organized CS structures may provide added, less transient and 
more direct mechanical benefits.  
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Figure 3.21:  CS repeat disaccharide with possible sulfation points indicated in red. (95) 
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Figure 3.22:  X-ray diffraction structures of CS-4  
(A) side and (B) end views shown in stick representation with carbon in green, oxygen in red, 
nitrogen in blue and cation in purple.  Water in the crystal structure and sodium ions are shown as 
star shapes.  The helix makes a turn every three disaccharides. (89) 
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Figure 3.23: Ellipsometric measurement of end-grafted GAG height 
(A) Ellipsometric measurement of end-grafted GAG height  versus NaCl concentration at pH 
~5.6 for two different grafting densities (s). (B) end-grafted GAG height at pH 3 and pH 7 
([NaCl] = 0.015M) at a grafting density of 6.5nm. (C) Force versus separation distance for GAG-
functionalized tip versus GAG-functionalized substrate (3 = 6.5nm) at pH 5.6 and varying NaCl 
concentration (0.0001M, 0.001M, 0.01M, 0.1M, 1M). (D) Force versus separation distance at 
0.015M NaCl and varying pH. (45nm full extended contour length, repulsive forces observed to 
start at ~150nm) (73). 
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Table 3.2:  Commonly found chondroitin sulfate isomers 
Name  Site of Sulfation  Systematic Name 
Chondroitin sulfate A  carbon 4 of GalNAc sugar chondroitin-4-sulfate (CS-4) 
Chondroitin sulfate C  carbon 6 of the GalNAc 
sugar 
chondroitin-6-sulfate (CS-6) 
Chondroitin sulfate D  carbon 2 of the glucuronic 
acid and 6 of the GalNAc 
sugar 
chondroitin-2,6-sulfate 
Chondroitin sulfate E  carbons 4 and 6 of the 
GalNAc sugar 
chondroitin-4,6-sulfate 
 
 
 
 
Table 3.3:  Chondroitin sulfate proteoglycans and their function in tendon (90) 
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Figure 3.24:  Stability of CS in elevated pH and temperature conditions (92). 
(A) Absorbance at 232nm and (B) reducing end group as a function of time for CS treated under 
basic and acidic conditions.  (C) Abosrbance at 232nm and (D) reducing end groups as a function 
of time of CS under neutral conditions (aldehyde detected by reducing sugar assay indicating CS 
de-polymerization, and absorbance at 232nm detects degradation product, unsaturated hexuronic 
acid) 
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The hydrating and biological functions of CS has made it attractive for the use in 
many applications including tissue engineering (98), tissue adhesion (99), drug delivery 
(100) and wound healing (101).  Several biologic and synthetic based hydrogels with 
immobilized CS have been formed by the modification of the CS disaccharide.  
Incorporated cross-linkable groups include methacrylates (98, 102), NHS (99), and 
dialdehydes (via periodate oxidation) (101) (
3.8. Chondroitin Sulfate networks 
Figure 3.25).  CS has also been physically 
associated into hydrogel networks (100, 103).  The introduction of chemical and physical 
crosslinks into CS allows the cross-linking of CS to other natural or synthetic polymer 
systems to form a hydrogel with enhanced swelling and biological function (Figure 3.26).  
As an example, methacrylates were introduced into CS by the modification of the CS 
hydroxyl with glycidyl methacrylate (reacted at room temperature for 15 days, pH 7.4) 
(102).  Methacrylated CS was subsequently photopolymerized using the UV 
photoinitiator (Irgacure 2959) and 365-nm light at ~10mW/cm2.  Hybrid hydrogels were 
also formed by the reaction of the methacrylated CS with poly(ethylene oxide)-diacrylate 
(PEODA).  Chondrocytes were encapsulated in the gel matrix and found to remain viable 
and hydration of the polymer system was enhanced by CS incorporation.  Although cross-
linked CS hydrogel systems show enhanced swelling and biological function, they do not 
incorporate the ultra-structural organization of CS in the aggrecan bottle brush structure 
which has been shown to be critical in the realization of the molecules mechanical 
function.    
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Figure 3.25: Modified CS for the incorporation in cross-linked CS networks  
(A) dialdehyde (101), (B) CS-NHS (99), (C) CS-methacrylate (104)  
 
 
 
 
 
Figure 3.26:  Chemically/Physically cross-linked CS networks (105) 
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The synthesis of synthetic-based bottle brush polymers or “molecular bottle 
brushes” has been extensively studied and reviewed (106-107).  The three main methods 
are the grafting-to, grafting- through and grafting-from methods of synthesis (Figure 
3.27).  In grafting-to bottle brush bristles in the form of a monotelechelic polymer is 
attached to a functionalized polymeric backbone (108).  In the grafting-through  strategy, 
a macromonomer is combined with initiator in order to induce polymerization of the 
polymerizable end of the macromonomer building the polymeric backbone as the 
macromonomers are joined together, often via free-radical polymerization(109).  In a 
third strategy, grafting-from, a macroinitiator polymeric backbone is combined with 
monomer which is subsequently polymerized off of the backbone via initiation and 
propagation of the free-radical generated by the initiator.  Each of these strategies has its 
limitations and benefits and controls different structural parameters such as chemical 
composition, grafting density, degree of polymerization of side chains, and degree of 
polymerization of the backbone, allowing for the fabrication of a family of bottle brush 
molecules with varying structures and properties (
 3.9. Synthetic bottle brush polymers and aggrecan mimetics 
Table 3.4).  In addition to densely 
packed brushes, sparse brushes, stiff brushes, flexible brushes, multi grafted brushes, 
gradient brushes, stars and networks may also be formed.  The Ortiz group, for example 
(110-112), fabricated a family of end functionalized polymer brushes of poly(2-
hydroxyethyl methacrylate-g-ethylene glycol) with varying backbone length, and brush 
grafting density and demonstrated their mechanical properties in the presence of various 
stimuli.  Synthetic glycopolymer brushes have been fabricated with short monosaccharide 
or oligosaccharide side chains which impart biological function to the polymers, however 
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side chain length is short in comparison to the CS chains of aggrecan inhibiting their 
mechanical function(113-115).  Attempts have also been made for the fabrication of 
proteoglycan-like cylindrical glycopolymer brushes (116) as well as brushes with charged 
sulfonate bristles (117).  These brush structures emulate the architecture of the aggrecan 
brush structure, however, the fully synthetic systems are not able to mimic the biological 
activity of the natural biomolecule.   
 
  
63 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.27:  The three main strategies for the fabrication of bottle brush polymers  
(106). 
 
 
 
Route Method 
“grafting-to” Chemical modification of pre-formed 
polymer with a sugar-containing reagent 
“grafting-
through” 
Sugar-bearing monomers are polymerized 
into linear polymers with pendant sugar 
moieties 
“grafting-from” Polymeric backbone used as a solid 
support for enzymatic or chemo-enzymatic 
oligosaccharide synthesis. 
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Table 3.4: Pros and cons of the different routes to bottle brush synthesis 
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The fabrication of synthetic and natural based glycopolymers is also under 
considerable investigation (113-114, 118-119).  Although glycopolymers refer to a wide 
range of materials including natural and artificial carbohydrate-containing polymers, as 
well as synthetically modified natural sugar-based polymers, glycopolymers can be more 
narrowly defined as polymers with pendant saccaride residues.  The fabrication of 
glycopolymers can also follow the “grafting-to”, “grafting-through” and “grafting-from” 
strategies.  In the “grafting-to” technique glycopolymers are formed by the chemical 
modification of preformed polymers or polymeric substrates with sugar-containing 
reagents.  Although this technique is more simple, it often results in less regular 
structures with limited glycosylation.   
3.10. Glycopolymers  
In the “grafting-through” technique, sugar-bearing monomers are polymerized 
into linear polymers with pendant sugar moieties (Figure 3.28).  Polymerization can be 
achieved through several mechanisms including ring-opening metathesis polymerization 
(ROMP) (120), reversible addition–fragmentation chain transfer (RAFT) polymerization 
(121), atom transfer radical polymerization (ATRP) (122) and cyanoxyl-mediated free-
radical polymerization (Figure 3.29) (123-126).  The “grafting-through” synthesis of 
glycopolymers however has added complexity compared to the fabrication of fully 
synthetic bottle brush polymers.  Carbohydrates contain reactive groups such as 
carboxylic acids and charged sulfates that often require protection during the 
polymeriziation reaction to prevent side reactions.  The final glycopolymer then requires 
further de-protection to return the carbohydrate side chains to their natural state.  The 
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solubility of large carbohydrates in organic solvents is also limited, limiting the types of 
polymer solvent systems that can be utilized in glycopolymer synthesis.   
In a “grafting-from” technique, synthetic saccharide chains can be enzymatically 
grown from a polymeric substrate using the polymeric backbone as a solid support for 
enzymatic or chemo-enzymatic oligosaccharide synthesis.  Two classes of biocatalysts 
are available for the enzymatic synthesis of glycosides, glycosidases and 
glycosyltransferases and the formation of glycosidic bonds (127-128).  Stereoselectivity 
is a concern in the growth of oligosaccharides and care must be taken in to account to 
form the desired alpha or beta linkages.  Glycosidic linkages must also be formed with 
high regioselectivity which requires the use of protecting groups (127).  Although this 
method is most reminiscent of natural proteoglycan and GAG synthesis the degree of 
polymerization of the sugar side chains may be limited and the sugars will be synthetic in 
nature.  
Several strategies have been developed to overcome the complexities associated with 
glycopolymer synthesis, and many families of glycopolymers have been formulated with 
mono- and disaccharide side chains (123-125), however natural CS has yet to be 
synthesized into a bottle brush polymeric structure.  See Appendix 1 for a detailed 
literature review. 
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Figure 3.28: Sugar bearing polymerizable monomers (7)  
and examples of acrylate and methacrylate polymerizable sugar monomers. (113) 
 
 
 
Figure 3.29:  Cyanoxyl-mediated copolymerization of vinyl-glycomonomers 
with acrylamide as reported by Grande et al (125) 
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In order to design a minimally invasive early interventional stragey for the 
treatment and prevention of discogenic back pain, with lasting mechanical and biological 
effects, it is important that the delivered material be resistant to the native IVD 
environment and function within the slightly degenerated environment.  It is also critical 
that the macromolecular ultra-structural organization of CS into the bottle brush structure 
be maintained.  The state of the healthy and degenerated intervertebral disc has been 
thoroughly reviewed, and the mechanical contribution of the major biomacromolecules 
aggrecan and CS assessed (
3.11. Summary 
Table 3.5).  Based on our understanding of these systems we 
have proposed the synthesis of a biomimetic hybrid synthetic/bio based CS brush 
structure for the replacement of aggrecan in the degenerating disc that provides a 
structural improvement over currently synthesized CS architechtures.  Following is the 
contribution of this thesis to the design and development of biomimetic aggrecan 
macromolecules with CS bristles. 
  
69 
 
 
 
Table 3.5:  Key functions of aggrecan and its components 
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Chapter 4 :  Objective and Specific Aims 
 
Several parameters have been set forth for the design of a biomimetic aggrecan 
macromolecule that can restore the function of the nucleus pulposus in the early stages of 
intervertebral disc degeneration (Table 4.1). In order to address these design criteria, the 
fabrication of an enzymatically resistant, hybrid synthetic/bio-based biomimetic 
aggrecan macromolecule, for use in the treatment of intervertebral disc degeneration 
has been investigated (Figure 4.1).  Polymer synthesis and bioconjugation techniques for 
the fabrication of the macromolecule followed by functional characterization of the 
macromolecules is reported.  A key component of this project is the incorporation of 
chondroitin sulfate in biomimetic aggrecan biomacromolecule synthesis.  In order to 
achieve the objective set forth in this proposal, several specific aims were established: 
Specific Aim 1 (Chapter 5) 
Identified a handle for the terminal end functionalization of chondroitin sulfate 
and investigated its utility in the fabrication of biomimetic brush structures.  The 
fabrication of bottle brush polymer with natural chondroitin sulfate side chains requires 
the terminal-end immobilization of CS.  Commercially available natural CS was 
investigated for a terminal primary amine (PA) that may be present as a result of CS 
isolation from donor tissues (89, 129-130).   
The terminal PA was then investigated for its reactivity to different functional 
groups for the formation of covalent linkages with synthetic components.  The feasibility 
of utilizing both the “grafting-to” and “grafting-through” techniques of bottle brush 
synthesis was explored.  CS was immobilized onto model surfaces as well as a model 
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polymeric backbone for investigation of the “grafting-to” strategy.  For investigation of 
the “grafting-through” strategy of synthesis, vinyl monomers were conjugated to the 
terminal primary amine of CS for the synthesis of terminal-end polymerizable CS and 
options for the free-radical polymerization of vinyl-terminated CS were discussed.  The 
terminal primary amine of CS has been used previously for the immobilization of CS onto 
solid substrates (69, 130), however its use in polymer synthesis strategies has not yet 
been explored.   
Specific Aim 2 (Chapter 6) 
Utilizing the CS terminal amine-epoxide reaction investigated in Specific Aim 1, 
explored the fabrication of CS-macromolecles via the “grafting-through” strategy.  The 
step-growth reaction between epoxides and amines was investigated for the synthesis of 
CS-macromolecules.  Since Step-growth polymerization can be conducted in aqueous 
media and under moderate reaction conditions and does not require additional initiators 
for reaction, this reaction strategy may provide a facie route to the synthesis of 
biomimetic aggrecan.   CS was reacted with di-epoxides and reaction kinetics monitored 
using the fluorescamine assay.  Resulting reactions were purified and characterized for 
their chemical composition (via 1H-NMR, and ATR-FTIR) and their molecular size via 
GPC. 
Specific Aim 3 (Chapter 7) 
Characterized the functional properties of the synthesized CS-macromolecules.  
In order to characterize the functional material properties of the synthesized 
biomacromolecule the physical structure and fixed charge density of the CS-
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macromolecules was investigated and viscosity and osmotic pressure of the polymer 
solutions were compared to that of CS.  In order to investigate the biological 
compatibility of the synthesized biomacromolecules, fibroblast and nucleus pulposus cell 
cultures were incubated with CS-macromolecule solutions and investigated for cell 
viability.    
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Figure 4.1:  Schematic of Biomimetic Aggrecan Design.   
See Appendix 2 for alternate view of the CS terminal handle. 
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Table 4.1:  Design of Biomimetic Aggrecan 
Function Mode of Action Biomimetic Aggrecan Criterion 
Structural 
Should be retained by NP 
matrix Large Size  
Should be stable in the NP 
environment Enzymatic/Hydrolytic Resistance 
Mechanical Should induce electrostatic repulsions 
Close Proximity of Charged Groups                                     
~2-4nm spacing between adjacent 
GAG chains 
Hydrating Should generate an osmotic potential 
High Fixed Charge Density 
High Osmotic Potential 
Biological Should maintain a regenerative environment Biocompatible 
Clinical 
Should be minimally 
invasive Injectable 
Should be cost effective Therapeutic dosage reasonably priced for multiple treatments 
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Chapter 5 :  Identification of a Chondroitin Sulfate Terminal Handle and the 
Investigation of its Utility in the Fabrication of Biomimetic Brush Structures 
 
 
Discogenic lower back pain is one of the leading musculoskeletal disorders 
confronting our health system (131).  Intervertebral disc (IVD) degeneration is an 
irreversible process, which leads to a loss in mechanical stability with the potential for 
neurologic compromise.  The most common surgical approaches treat the end-stage of 
this degeneration and include fusion and total disc replacement (132).  Earlier stage 
interventions, which address degeneration of the nucleus pulposus (NP), or inner region 
of the IVD may be employed to mechanically stabilize the IVD and alleviate lower back 
pain  (9-15).   
5.1.  Introduction 
With age and degeneration, a loss of nutrient supply to the disc results in a 
reduction of the synthesis of aggrecan, a major proteoglycan of the nucleus pulposus 
which generally comprises approximately 14% of the NP wet weight (18, 61).  In 
addition, there is a concordant increase in enzymes in the NP that attack the aggrecan 
core protein, resulting in fragmentation of the aggrecan molecule (22, 79-80, 133).  It has 
been shown that the proteoglycan content of the NP decreases linearly with age (134). In 
addition, other investigators have localized a decrease in sulfated chondroitin in the 
nucleus pulposus portions of the disc (135).  This loss of proteoglycans leads to a loss of 
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hydration of the nucleus manifested by a reduction of disc height and intradiscal pressure 
(136).     
   Aggrecan, an aggregating proteoglycan has two main mechanical functions in the 
disc: 1) it allows water uptake by the nucleus due to sulfated groups in the chondroitin 
(CS) and keratin sulfate rich regions which, in part, provides intradiscal pressure (7) and 
2) it provides electrostatic repulsion due to the elegant 3D macromolecular bottle brush 
structure, which contributes to intradiscal pressure and disc height (69-71, 75, 137-138).  
Approximately 100 CS glycosaminoglycan chains are covalently attached via a 
glycosidic bond to the core protein in the CS region with a grafting density of 
approximately 0.25 to 0.5 nm-1 resulting in a densely packed bottle brush structure(67). 
Each CS chain, which consists of 10-50 repeating disaccharide units of glucuronic acid 
(GluUA) and n-acetylgalactosamine (GalNAc), is approximately 20 kDa (65, 139).   
CS has both mechanical and biological function in the intervertebral disc, as well 
as other tissues such as cartilage (7, 69, 73, 140-141). Strategies for the replacement of 
CS in various formulations have been previously investigated including solutions of CS 
with hyaluranon and the modification of hydrogels with CS (98, 101, 105, 142).  The 
incorporation of CS into hydrogel systems often requires the modification of the CS 
disaccharide allowing for the attachment of the CS chain to the hydrogel matrix 
throughout numerous points of the CS backbone (101).  Biological function is enhanced 
by hydrogel delivery of CS but these strategies do not recapitulate the ultra-structural 
bottle brush organization of CS found to be mechanically important in native tissue(143).   
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The fabrication of synthetic and natural based glycopolymers is also under 
considerable investigation (113-114, 118-119).  Several glycopolymers have been 
formulated with mono- and disaccharide side chains (123-125).  Glycopolymers have 
been demonstrated to have biological function, however their use as a mechanically 
stabilizing material has not been investigated and synthesis has been limited to short 
sugar side chains.  Glycopolymers can be synthesized via the “grafting-to” or “grafting-
through” techniques.  In the “grafting-to” technique glycopolymers are formed by the 
chemical modification of preformed polymers or polymeric substrates with sugar-
containing reagents.  Although this technique is straightforward, it often results in less 
regular structures with limited glycosylation.  In the “grafting-through” technique, sugar-
bearing monomers are polymerized into linear polymers with pendant sugar moities.  
Polymerization can be achieved through several mechanisms including ring-opening 
metathesis polymerization (ROMP) (120), reversible addition–fragmentation chain 
transfer (RAFT) polymerization (121), atom transfer radical polymerization (ATRP) 
(122) and cyanoxyl-mediated free-radical polymerization (123-126).  The majority of 
glycopolymers have been synthesized by the polymerization of sugar-containing vinyl 
monomers, however the preparation of the polymerizable sugar-monomers is often a 
complex and multi-step process that requires chemical modification of the sugar moiety.  
Natural CS has yet to be synthesized into a bottle brush polymeric structure. 
All glycosaminoglycans, with the exception of HA, are naturally synthesized 
intracellularly, as proteoglycans, i.e. with a covalent linkage to a core protein (144).  CS 
is linked to the aggrecan core protein at its L-serine residue where a glycosidic bond is 
formed between the linkage CS saccharide xylose and the hydroxyl group of serine (67)  
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In the isolation of CS, the proteoglycan core protein can be broken down by either 
enzymatic digestion or alkaline treatment releasing the GAG chains and leaving the CS 
chain with its linkage region intact and still connected to an amino acid residue (89, 129-
130) (see Appendix 2 for alternate view of CS and the CS terminal amino acid residue).  
The resulting terminal protein residue on the CS chain has been utilized to immobilize CS 
onto agarose membranes using the 1-cyano-4-(dimethylamino)pyridinium 
tetrafluoroborate (CDAP) activating agent to form an isourea bond (130).  CS isolated 
from rat chondrosarcoma cell cultures and digested with proteinase K, to maintain the 
terminal amino acid residue, was also utilized to end-graft CS by first reacting the 
terminal reactive amine group with dithiobis(sulfosuccinimidyl propionate (DTSSP) then 
reducing it to a thiol group for coupling to gold substrates (69, 73).  These studies 
demonstrate the utility of the CS-terminal amino residue.   
Commercially available CS however is inhomogeneous in its physical and 
chemical properties.  Depending on the isolation and purification techniques used, CS has 
variable structure, properties, purity, molecular weight and molecule integrity (89, 95).  
Parameters reported in association with CS production are limited and mainly consist of 
elementary chemical composition, impurities and general ranges of MW (139).  No 
information is provided on the terminal end of CS or if the competence of the linkage 
region of CS after the isolation procedure. 
In this work we investigated commercially available CS for a terminal amino acid 
handle.  A terminal handle may be utilized in order to immobilize CS into brush 
structures which requires the single point immobilization of CS versus the multi point 
immobilization of CS utilized in network formation.  The terminal primary amine of CS 
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was then investigated for its utility in the immobilization of chondroitin sulfate on model 
surfaces, to polymerizable monomers and to a synthetic polymeric backbone.  The 
terminal primary amine of CS was utilized to immobilize CS onto functionalized glass 
surfaces to investigate the utility of the CS terminal primary amine in the immobilization 
of CS via epoxide-amine and aldehyde-amine reactions.  CS was also modified at the 
primary amine via amine-epoxide, amine-aldehyde, and amine-carboxylic acid 
interactions for the synthesis of polymerizable vinyl-CS chains.  The carboxylic acid-
amine reaction was investigated for the synthesis of CS-brush structures via the “grafting-
to” technique using a poly(acrylic acid) polymer backbone.  The studies described here 
demonstrate a facile route to the end functionalization and immobilization of 
commercially available CS.  Based on these studies, several routes to the synthesis of 
chondroitin sulfate based biomimetic aggrecan brush structures have been proposed. 
 
 
Chondroitin-4-sulfate, Chondroitin-6-sulfate and mixed CS powders were 
purchased from two different vendors and originated from different animals and tissues 
(
5.2.  Materials and Methods 
Table 5.1).  L-serine, bovine serum albumin and N-acetyl-D-galactosamine were 
purchased from Sigma Aldrich and used as control samples.  Fluorescamine and all other 
reagents were purchased from Sigma Aldrich and used as received. 
 
 
80 
 
 
5.2.1. Determination of CS primary amine content 
A fluorescamine assay was developed and validated for use in the determination 
of the primary amine (PA) content of CS.  Fluorescamine, a fluorometric reagent (Figure 
5.2), reacts directly with primary amines to yield highly fluorescent derivatives (390nm 
excitation, 475 nm emission) whose resulting fluorescence is proportional to the amine 
concentration  (145).  Reactions of fluorescamine with primary amines proceed at room 
temperature with a half-time of a fraction of a second while excess reagent is destroyed 
with a half-time of several seconds (146).  The fluorescamine reagent is particularly 
suitable for the detection of a single PA in CS as it is sensitive to PAs in the picomolar 
range(145).   
In a general procedure, 150ul of sample solution is plated in triplicate in a flat 
bottom black 96-well plate.  Samples must be prepared in an amine free buffer; buffer 
type and pH may effect fluorescence readings.  An alkaline pH range of 8-9.5 is generally 
ideal for the fluorescamine-amine reaction where lower pH may result in protonated 
amines, making them unavailable for reaction and high pH may cause hydrolysis of the 
fluorescamine reagent before the fluorogenic reaction can occur (147).   Fluorescamine 
solution is prepared at 3mg/ml in DMSO at a minimum of 15mg in 5ml.  Fluorescamine 
is prepared in a non-aqueous solvent in order to fully solublize the reagent and avoid 
immediate hydrolysis (146).  A 50µl aliquot of the fluorescamine solution is added to the 
sample solutions then allowed to react for 5min at room temperature with constant 
agitation on a shaker plate.  Sample fluorescence was measured on an Infinite M200 
TECAN spectrophotometer with excitation/emission of 365/490nm and gain of 80 
(fluorescent sweeps were used to optimize excitation and emission wavelengths for 
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fluorescamine fluorophor detection).   Sample free buffer solution with fluorescamine 
reagent was used as a blank for fluorescence readings.   
Detection of primary amines with fluorescamine was calibrated with solutions of 
known amine content.  L-serine (Figure 5.1, MW, 105.09) which is the attachment site for 
CS to the aggrecan core protein, and contains only one PA per molecule, was used to 
establish a fluorescence vs. [PA] standard curve.  The number of PA/molecule of a 
sample can be calculated from the linear region of the L-serine standard curve.  Bovine 
serum albumin (MW, 66,432 Da) (BSA) was used as a positive control biomolecule with 
a known high PA content and N-acetyl-D-galactosamine (Figure 5.1, MW, 221.2 Da) was 
used as a negative control as it is a secondary amine containing component of CS but 
contains no PAs (Figure 4.1).  Samples were solublized in sodium borate buffer (SBB, 
0.1M, pH 9.4) then diluted in a serial dilution and assayed with the fluorescamine 
reagent.  Fluorescence was normalized to SBB blanks and samples were taken in 
triplicate.  The number of primary amines per molecule was calculated at each 
concentration from the linear region of the L-serine standard curve.  
CSs from various sources were assayed for their primary amine (PA) content 
using the established fluorescamine assay.  Chondroitin-4-sulfate sample MW as 
estimated to be 22 kDa while primarily chondroitin-6-sulfate samples were estimated to 
have a MW of 65 kDa (137, 148).   
CS was first solublized in sodium borate buffer (0.1M SBB, pH 9.4) at various 
concentrations.  Then, 150µl samples of CS solution were added to a 96-well plate and 
incubated with 50µl of 3mg/mL fluorescamine solution (in DMSO) with constant 
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agitation for 5min.  Fluorescence was normalized to SBB blanks and samples were taken 
in triplicate.     
 
5.2.4. Modification of glass surfaces with Chondroitin sulfate 
Epoxide or aldehyde functionalized glass slides (Genetix) were utilized for the 
immobilization of CS (Figure 5.6).  Upon reaction of an aldehyde with a primary amine in 
alkaline conditions (pH greater than 9.0) and with reductive amination with sodium 
cyanoborohydride, a stable secondary amine bond will form (Figure 5.3) thus 
immobilizing CS to the aldehyde glass surface.   Epoxides will react with amines also at 
alkaline pH via the opening of its oxirane ring (Figure 5.4) (149) immobilizing CS to the 
epoxide surface via epoxide amine reactions.  Epoxides may also react with other 
functional groups such as hydroxyls or sulfyhryls, however, a pH  range of 9.0 to 11 is 
more chemoselective for amine reactions (149).  Functionalized glass slides as well as 
non-functionalized glass slides were cut into 1cm x 1cm samples, placed in 6-well plates 
and soaked in 3mL of CS solution in SBB pH 9.4 at varying CS concentration.  Sodium 
cyanoborohydride was added to aldehyde slide samples as described previously.  Well 
plates were placed on a shaker plate and samples were allowed to incubate with constant 
agitation for 4h at room temperature.  Slides were subsequently rinsed thoroughly (3 X in 
SBB) then placed in 3mL of SBB and allowed to rinse for an additional 3h with constant 
agitation to remove any non-covalently bound CS.  Slides were rinsed an additional three 
times in SBB then allowed to air dry.  Non-functionalized glass slides were similarly 
prepared as control samples. 
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5.2.5. Characterization of chondroitin sulfate modified surfaces 
CS modified glass slides were prepared for analysis with Energy-dispersive X-ray 
(EDAX) microanalysis using an environmental scanning electron microscope (ESEM, 
FEI XL30 with EDS).  Glass slides were sputter coated with carbon (25sec) then imaged 
with back scatter in the ESEM at (voltage, 6 keV, spot size 6, working distance 12 mm, 
magnification 1000X corresponding to an area of 121µm x 95µm).  Element peaks were 
identified in the spectra corresponding to C, O, Na, Mg, Al, Si, S, K, and Ca and spectra 
were automatically base-lined and peak areas quantified (spectra collected for a duration 
of 210 live seconds).  Changes in sample sulfur content (detected at 2.31 keV) with CS 
modification was investigated as CS has a large sulfur component.  In a semi-quantitative 
analysis, the net integrated area for sulfur was normalized to the Si net integrated area 
where Si is a major component of the glass slides and should not change greatly with CS 
modification.  Separate samples were analyzed for their hydrophilicity using a contact 
angle goniometer with water as a medium.  Three readings from triplicate samples of 
epoxide, aldehyde and un-functionalized slides soaked in CS and buffer solutions were 
taken.  A decrease in contact angle is indicative of an increase in surface hydrophilicity 
imparted by charged CS molecules covalently attached to the glass surfaces.   
 
5.2.6. Chondroitin sulfate-monomer conjugation 
Several amine reactive chemistries were investigated for the conjugation of 
monomers to the CS chain at its terminal primary amine end.  The monomers acrolein, 
allyl glycidyl ether (AGE) and acrylic acid (Sigma Aldrich) were used.  Acrolein contains 
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an amine reactive aldehyde functionality and a vinyl group, which is polymerizable via 
free radical polymerization (149).  AGE, is an epoxide and vinyl containing monomer, 
which will react with amines at alkaline pH (149).  Acrylic acid is a polymerizable 
monomer with carboxylic acid functional groups.  The carboxylic acid group of acrylic 
acid can be activated to be highly reactive with amines using well characterized 
EDC/sulfo-NHS coupling reactions (Figure 5.5) (149). 
For the conjugation of CS to acrolein and AGE, solutions of monomer at various 
concentrations in 0.1M SBB, pH 9.4, were mixed with solutions of CS in 0.1M SBB pH 
9.4 to achieve varying monomer:CS molar ratios.  For acrolein-CS samples, sodium 
cyanoborohydride (5M in 1N NaOH, Sigma) was added at 20µL/mL in order to stabilize 
the formed Schiff base to a secondary amine bond (149).  Acrylic acid was first activated 
with EDC/sulfo-NHS (2 mM EDC and 5 mM sulfo-NHS in MES buffer (0.05M MES, 
0.5M NaCl), pH 6.0) for 15 min followed by quenching of excess EDC with 2-
mercaptoethanol (10 min at a final concentration 20 mM).  Activated acrylic acid was 
then combined with CS (CS in phosphate buffered solution, pH 7.4) at varying 
monomer:CS molar ratios.  All monomer-CS solutions were placed on a rotator 
(Thermolyne Labquake) and allowed to mix at least 4h.  CS-Acrylic acid solutions were 
then filtered using a sephadex G-25 pre-packed desalting column equilibrated in PBS 
(PD-10, GE Healthcare) to remove excess reactants.  150ul samples of each solution were 
taken in triplicate and assayed with the fluorescamine assay as described in section 2.1 
for their PA content.  The percentage of PAs in the CS sample conjugated to monomer is 
indicated by the percent decrease in PA content which was calculated as:  
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𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝐶𝑜𝑛𝑗𝑢𝑔𝑎𝑡𝑖𝑜𝑛 = 100% ∗ [𝑃𝐴]𝑖𝑛 𝐶𝑆 𝑤𝑖𝑡ℎ𝑜𝑢𝑡 𝑚𝑜𝑛𝑜𝑚𝑒𝑟 − [𝑃𝐴]𝑖𝑛 𝐶𝑆 𝑤𝑖𝑡ℎ 𝑚𝑜𝑛𝑜𝑚𝑒𝑟[𝑃𝐴]𝑖𝑛 𝐶𝑆 𝑤𝑖𝑡ℎ 𝑚𝑜𝑛𝑜𝑚𝑒𝑟  
 
A decrease in the PA content of the CS-monomer solutions with respect to CS 
without monomer is indicative of binding of the monomer to CS at the primary amine.  
Solutions of monomer without CS were also assayed with the fluorescamine reagent and 
found to exhibit no appreciable fluorescent signal at the excitation/emission of interest. 
 
5.2.7. Proton nuclear magnetic resonance (1H-NMR) and Fourier transform infrared 
spectroscopy (FTIR) analysis of AGE-CS conjugation over time 
Samples of CS-AGE conjugate prepared at the 1000:1 ratio were investigated 
with 1H-NMR to further demonstrate CS-monomer conjugation.  Samples were prepared 
as described previously followed by extensive dialysis against DI water (regenerated 
cellulose membrane, MWCO 6-8K) in order to remove un-reacted monomer.  Purified 
samples were lyophilized reconstituted in D2O at approximately 30mg/mL.  1H-NMR 
spectra were taken on a 300MHz NMR spectrometer (UNITYNOVA) at 64 scans and at 
ambient temperature.  Lyophilized samples were also investigated on an attenuated total 
reflectance (ATR)-FTIR (64 scans) for chemical composition and compared to that of 
natural CS. 
 
5.2.8. Conjugation of Chondroitin Sulfate to a poly(acrylic acid) polymeric backbone 
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The polymeric backbone of poly(acrylic acid) (PAA) was chosen for preliminary 
investigation of the synthesis of CS-glycopolymer structures via the “grafting-to” strategy 
via the carboxyl-amine reaction (Figure 5.7).  PAA of 250kDa MW was purchased from 
Sigma (35wt% in H2O, 1.6mM, Sigma #416002) in order to mimic the MW of the natural 
aggrecan protein backbone.  For reaction with CS, PAA (33mg/mL, 0.132mM PAA) was 
first activated with EDC/sulfo-NHS (2 mM EDC and 5 mM sulfo-NHS in MES buffer 
(0.05M MES, 0.5M NaCl), pH 6.0) for 15 min followed by filtering using a sephadex G-
25 pre-packed desalting column (PD-10, GE Healthcare) to remove excess reactants.   
Activated PAA was then combined at a 1:1 v/v ratio with a 20mgml solution of CS 
prepared in PBS.  Solution pH was then adjusted with NaOH to pH 7.4 and the mixture 
was allowed to react over time mixed continuously (Thermolyne Labquake).  Final PAA 
and CS concentrations were 16.5mg/ml (0.066mM) and 10mg/ml (0.45mM) unless 
otherwise noted (reactant ratio of 6.8:1 CS;PAA).  Reaction conditions were varied 
including, time, temperature (4̊C, 21̊C and 37̊C), ionic concentration and CS to PAA 
molar ratio.  Conjugation of CS to the PAA backbone was monitored using the 
fluorescamine assay, where a loss in the PA signal indicates a loss of the PA to the 
reaction.  Reaction was also monitored by monitoring reaction solution viscosity during 
the conjugation period where an increase in solution viscosity is indicative of the 
formation of larger molecules.  A 20ml reaction solution (10mg/ml CS, 15mg/ml PAA) 
was placed in a concentric cylinder configuration rheometer (AR 2000EX, TA 
Instruments).  Shear rate was logarithmically ramped from 10/s to 1000/s every hour over 
a 4 hour period and the viscosity recorded.  In a separate study, the viscosity of an 
activated-PAA-CS solution was measured after 24h of reaction (10mg/ml CS, 15mg/ml 
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PAA) and the viscosity measured in a parallel plate configuration with shear rate 
logarithmically ramped from 10/s to 1000/s (AR 2000EX, 750um Gap, 1mL solution).  
Control solutions of un-activated-PAA-CS mixed solutions, CS solutions and PAA 
solutions were also investigated.  Specific viscosity was calculated relative to a 
PBS/MES solvent system.   
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Figure 5.1:  Chemical Structure of L-serine and N-acetyl-D-galactosamine 
controls for development of the fluorescamine assay (www.sigma.com). 
 
 
 
 
 
 
 
Figure 5.2:  Chemical structure of the fluorescamine reagent 
and its reaction with primary amino groups to generate a fluorophor (146). 
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Figure 5.3:  Aldehyde-amine reaction and reductive amination with sodium cyanoborohydride 
(150) 
 
 
 
 
 
 
Figure 5.4:  Epoxide-amine reaction 
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Figure 5.5:  Carboxyl-amine reaction mediated by EDC and sulfo-NHS (151) 
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Figure 5.6:  Example of “grafting-to” strategy for building CS brushes from glass substrate 
 
“Grafting To” Strategy
92 
 
 
 
Figure 5.7:  “Grafting-to” polymerization strategy using the carboxylic acid to CS amine reaction 
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Table 5.1:  Product Information for Chondroitin Sulfate Samples 
 
  
Vendor Product Number Tissue Source CS Type Estimated MW
Sigma C4384 Shark Cartilage Primarily CS-6 ~65,000
Sigma C9819 Bovine Trachea 60% CS-4, 40% CS-6 ~22,000
Sigma C6737 Bovine Cartilage Primarily CS-4 ~22,000
Calbiochem 230699 Bovine Trachea
Mix of CS-4, CS-6, CS-
4,6, CS-2,6
~22,000
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5.3.1.Primary amine content of CS from various sources 
5.3.  Results 
In order to establish a relationship between fluorescamine fluorescence intensity 
and primary amine content of a chondroitin sulfate sample, L-serine was used to establish 
a standard curve where L-serine is the amino acid residue of CS and contains one primary 
amine (PA) per molecule (Figure 5.8) 
The presence of primary amines in CS from various sources and vendors was 
investigated using fluorescamine.  The concentration of [PA] in sample was calculated 
based on the L-serine standard curve (Figure 5.8).  Fluorescamine signal versus 
concentration of L-serine has both a linear region and a non-linear region at higher 
concentrations where saturation of the fluorescence intensity can be seen (Figure 5.8).  
Fluorescamine signal is linear to approximately 3500 fluorescence units corresponding to 
a serine concentration of 0.625mM.  Molarity of L-serine was converted to molecules of 
primary amine and the linear region of the fluorescence vs. molecules of primary amine 
curve was taken from 1.76x1015 to 5.65x1016 molecules of primary amine.  This 
corresponded to fluorescence intensities of 138 and 3419 normalized fluorescence units 
respectively.  The linear relationship of : 
𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠 𝑜𝑓 𝑝𝑟𝑖𝑚𝑎𝑟𝑦 𝑎𝑚𝑖𝑛𝑒 = 6.341𝐸 14 ∗ 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑒𝑛𝑐𝑒 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 −  
 was established with an R2 of 0.9854.   This linear relationship was used in order to 
determine the primary amine content of different biomoleule samples.   
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Bovine serum albumin (BSA) and N-acetyl-galactosamine (GalNAc) were 
investigated as positive and negative controls for primary amine concentration 
respectively.  As the concentration of BSA was increased, the normalized fluorescence 
for bound fluorescamine detected at excitation/emission of 365/490nm increased linearly 
(R2 > 0.99) indicating a clear presence of PAs within the samples (Figure 1).  No 
correlation was seen between fluorescence from N-acetyl-D-galactosamine (GalNAc) 
samples and GalNAc concentration (R2 = 0.08) and fluorescence signal was low 
indicating no PAs with the CS saccharide.  A strong linear relationship (R2 > 0.99) 
between observed fluorescence and CS concentration for all CS samples indicates the 
fluorescamine assay as an appropriate means to measure small fractions of PA in the 
GAG samples.   
The number of PAs per biomolecule was calculated for each concentration of the 
biomolecule based on the L-serine standard curve and averaged.  The protein BSA was 
used as a positive control and had a high primary amine content (19.74 +/- 4.45 primary 
amines per molecule) as expected from the many primary amine containing amino acid 
residues in the BSA protein backbone.  GalNAc had an average of 0.0 primary amines 
per molecule indicating that the amide of GalNAc in the CS disaccharide will not 
contribute to the CS primary amine signal (Figure 5.2).      
CS-6 from shark cartilage (Sigma) had the highest primary amine content of all 
chondroitin sulfate samples tested with an average number of primary amines per CS 
chain of 10.52 +/- 1.26 (Table 5.3).  CS from bovine trachea from both Calbiochem and 
Sigma had primary amine contents greater than one primary amine per CS chain with 
7.16 +/- 0.95 and 3.08 +/- 0.38 primary amines per CS chains respectively.  CS-4 from 
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bovine cartilage supplied by Sigma had an average number of primary amines per CS 
chain of 1.15 +/- 0.7 (Table 5.3).  For the application of CS to the synthesis of biomimetic 
aggrecan brush structures, the single point, terminal end immobilization of CS is 
required.   
For this purpose a single primary amine in CS was investigated.  CS-4 C6737 
from Sigma demonstrated a single primary amine per CS molecule making it an 
appropriate candidate CS for use in CS brush synthesis. In addition this CS is from a 
mammalian cartilage source, and CS-4 has been widely used in therapeutic settings with 
demonstrated anti-inflammatory and anti-oxidant effects (95).   CS-4 C6737 from Sigma 
will be utilized for all future studies and referred to simply as CS. 
 
5.3.2. Attachment of CS to amine-reactive substrates for the “grafting- to” synthesis 
strategy 
5.3.2.1. EDAX analysis of CS modified glass surfaces.  Semi-quantitative 
elemental analysis of CS modified glass slides was conducted using EDAX in order to 
monitor CS attachment to functionalized surfaces.  Epoxy and aldehyde glass surfaces 
were investigated for their ability to bind primary-amine terminated CS chains.  Element 
peaks from EDAX spectra were identified corresponding to C, O, Na, Mg, Al, Si, S, K, 
and Ca and spectra were automatically base-lined corrected for semi-quantitative 
analysis.  Sulfur was detected at 2.31 keV (Figure 5.11).  Sulfur was present in all surfaces 
investigated in trace (wt % < 1%) amounts.  As seen in Figure 5.11, non-functionalized 
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glass surfaces have a small peak in the sulfur region (Figure 5.11) while the epoxy coated 
slide in 20mg/mL CS has a slightly larger peak in the sulfur region (Figure 5.11).   
EDAX spectra were semi-quantitatively analyzed for their sulfur content, where 
an increase in sulfur signal with CS modification is an indication of CS attachment.  
Sulfur net integrated ratio was measured and normalized to Si net integrated ratio for 
non-functionalized and functionalized glass slides coated with 0, 0.05, 2  and 40mg/mL 
CS (Figure 5.12).  
Epoxy and aldehyde functionalized slides had higher sulfur content after 
treatment with 2 mg/mL CS and 40 mg/mL CS with the greatest sulfur content seen on 
2mg/ml CS treated slides.  Non-functionalized glass slides showed minimal increase in 
sulfur content with all CS treatments.  Although a general trend in the increase in surface 
sulfur content with increased CS treatment concentration was seen, there was no 
significant difference (p> 0.05) between slide types or treatment groups (Figure 5.12).  
Due to the trace amounts sulfur detected in these samples and the depth of detection of 
EDAX (~1-2nm) only qualitative and semi-quantitative analysis can be conducted with 
this technique and results may be masked by background sulfur signals.  Background 
sulfur signals likely arise from trace amounts of sulfur in the glass itself or present as 
residue from manufacturing of the slides.   
5.3.2.2. Contact angle analysis of CS modified epoxy-functionalized surfaces.  To 
further investigate CS binding to amine-reactive surfaces via the CS terminal primary 
amine functionality, epoxy-functionalized, aldehyde-functionalized and non-
functionalized (control) glass slides were treated with CS solutions of varying 
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concentrations and CS attachment determined via contact angle measurements.  A 
decrease in contact angle is expected as CS is deposited onto the substrates since CS is a 
charged molecule and will attract water making the surface more hydrophilic.  CS 
concentrations of 0, 0.125 and 2 mg/mL were investigated.  Slides were rinsed 
thoroughly after treatment with CS to remove any non-covalently bound CS.  On epoxy-
functionalized slides, contact angle without CS was measured at 76.6 +/- 2.8o.  With the 
addition of CS at 0.125mg/ml contact angle was reduced to 63.4 +/- 9.5o and further 
reduced to 38.2 +/- 6.6o with the addition of CS at 2 mg/ml indicating an increase in 
hydrophilicity associated with the deposition of charged CS on the epoxy-functionalized 
surface (Figure 5.13).  Contact angle was significantly different on epoxy slides treated 
with CS with a significant decrease in contact angle seen as CS concentration increased 
(p < 0.01).  Untreated glass slides did not have a significant change in contact angle with 
CS treatment.  Aldehyde-treated slides had a slight decrease in contact angle with CS 
treatement but changes were not statistically significant.  
 
5.3.3. Chondroitin sulfate conjugation to synthetic monomers via the terminal 
primary amine. 
5.3.3.1. Fluorescamine analysis of CS-monomer conjugation.  Three amine 
reactive chemistries were utilized to conjugate various monomers to the CS terminal 
primary amine.  The monomers acrolein, allyl glycidyl ether (AGE) and acrylic acid were 
investigated.  Varying monomer:CS molar ratios were reacted for 4h and investigated for 
PA content of CS before and after conjugation as determined using the fluorescamine 
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assay.  Acrolein was investigated at 17.7:1, 177:1, and 1770:1 molar ratio with CS.  A 
decrease in CS PA signal is seen with the addition of increasing amounts of monomer 
corresponding to an increase in the percent PAs conjugated to monomer as the amount of 
acrolein is increased reaching a maximum of 80% at an acrolein:CS molar ratio of 1770:1 
(Figure 5.14).  A similar trend is seen for CS-AGE solutions and CS-acrylic acid 
solutions.  The effect is less pronounced for acrylic acid solutions, with a maximum of 
26% conjugation seen at a 1000:1 acrylic acid:CS molar ratio.  AGE-CS solutions 
showed the highest conjugation reaching 99% at a 1000:1 AGE:CS molar ratio (Figure 
5.14).  Due to the toxic nature of acrolein as well as cyanoborohydride used in order to 
stabilize the schiff’s base formed in the aldehyde-amine reaction, the acrolein-amine 
reaction was not investigated further, however these studies indicate the ability to 
conjugate CS via the terminal primary amine to synthetic monomers using the aldehyde-
amine reaction.   
The AGE-CS and acrylic acid (AA)-CS reactions were investigated further for 
temporal dependence.  AGE Conjugation was dependent both on concentration and 
reaction time.  For the 1:1 AGE:CS molar ratio, no significant increase in percent 
conjugation is seen after 4h however for the higher ratios of 10:1 and 100:1 AGE:CS, 
percent conjugation significantly increased after up to 72h of reaction.  For 1000:1 
reactions, near complete reaction (~99% conjugation) was seen after 24h of reaction 
(Figure 5.15).  Reaction rate of the CS primary amine to AGE increased with increasing 
AGE:CS ratio and 100:1 and 1000:1 AGE:CS ratios followed one-phase association 
kinetics (Figure 5.15).  Conjugation of CS to acrylic acid was also monitored over time.  
No clear relationship was found between reaction time and conjugation (Figure 5.16).  
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Conjugation significantly increased after 6hr of reaction for all ratios but decreased again 
after 24h of reaction.  Further reaction time did not increase conjugation significantly 
from the 6hr reaction time.  These results indicate that the CS-acrylic acid conjugation 
cannot be significantly increased with increased reaction time. 
5.3.3.2. Qualitative 1H-NMR and ATR-FTIR study of vinyl incorporation in AGE- 
CS conjugates.  Monomer conjugation to CS was further investigated by 1H-NMR and 
ATR-FTIR for the AGE monomer at a 1000:1 AGE:CS molar ratio over time.  Spectra 
were acquired for both CS and AGE conjugates at 300MHz (Figure 5.17).  Several classes 
of protons were resolved and assigned on the basis of their chemical shifts for CS (Figure 
5.17, Top) and on the basis of previous literature findings for CS-4 (152-153) .  A good 
correspondence was seen between literature CS-4 spectra and that obtained in these 
studies.  Chemical shifts were also assigned to protons of the AGE monomer (Figure 
5.17).   
1H-NMR spectra spectra for AGE-CS samples reacted at 0, 2, 4, 6, and 24h were 
investigated for incorporation of the AGE monomer in CS.  1H-NMR spectra for AGE-
CS samples matched well with that of natural CS.  Peaks corresponding to CS protons 
maintained their position (Figure 5.18) as well as integrated area (Figure 5.19) over the 24h 
reaction period indicating stability of the overall CS structure throughout the reaction.  In 
addition, no epoxide peaks in the 3.0-2.5ppm region were resolved, indicating thorough 
purification of un-reacted AGE monomer (Figure 5.18).  Inspection of the 7.0-5.0 ppm 
region of the AGE-CS spectra reveals the progressive incorporation of peaks 
corresponding to the vinyl AGE protons, AGE-1 and AGE-2 (Figure 5.20).   
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In a qualitative analysis, a relationship was suggested between the AGE vinyl 
monomer and CS molecule in the sample.  The peak at 2.0 ppm was assigned to the 
acetamide methyl protons of the GalNAc sugar (GalNAc-7).  Integration of this peak was 
set to 100 and corresponds to three protons for the methyl group.  For CS with MW 
22,000g/mole as assumed in this study, there are approximately 44 dimers (MW per 
dimer is 502g/mole).  Each dimmer has one methyl group arising from the GalNAc, 
therefore, the integrated area of peak GalNAc-7 is attributed to approximately 44 methyl 
groups, resulting in an integrated area of approximately 2.27 per methyl.  As methyl has 3 
protons, this corresponds to an integrated area of 0.75 corresponding to one proton.  To 
estimate AGE vinyl group incorporation into CS, the integrated area of the AGE-2 
proton, attributed to one proton, was ratioed to that of a single proton arising from CS 
(GalNAc-7, calculated at 0.75 integrated area for 1 proton) (Figure 5.21). With increasing 
reaction time, vinyl:CS ratio increases from 0.51:1, 0.67:1, 0.77:1, 0.84:1 and 1.72:1 for 
0, 2, 4, 6, and 24h reaction times respectively.  A ratio above 1, as seen for the 24h 
reaction, indicates the incorporation of more than one vinyl to each CS chain.  
In order to further investigate the incorporation of AGE into CS and possible side 
reactions, ATR-FTIR spectra were obtained for AGE:CS 1000:1 molar ratio reactions 
over a 24h reaction period.  Wavenumber assignments for key peaks corresponding to CS 
(154-157) and AGE (158) are presented in Figure 5.22.  Of particular interest is the C-O 
stretching mode in CS where it has been demonstrated that in the C-O stretching mode, 
shifting occurs with changes to the hydroxyl group orientation (156).  The most likely 
side reaction to occur would be with the primary hydroxyl of the CS GalNAc 
disaccharide (159), however this group is not clearly resolved in the 1H-NMR spectra 
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(combined in the 3.58 and 3.86ppm band), necessitating a secondary means of detection.  
ATR-FTIR spectra for AGE-CS at all reaction time points were consistent with that of 
natural CS (Figure 5.23).  No strong peaks corresponding to the AGE monomer were 
detected in the AGE-CS spectra.  The FTIR peak centered at 1033cm-1 which arises from 
the C-O stretching mode in CS was not significantly shifted in 2, 4, and 6h reaction 
samples (ranging from 1031-1029cm-1), however, after 24h of reaction, a larger shift was 
seen in this peak, with peak maxima shifting to 1024cm-1.  Spectral shifts in this region 
would be expected to occur with changes to the hydroxyl group orientations in CS (156), 
and therefore, the shift in this spectral region for 24h samples indicates possible CS 
hydroxyl group side chain reactions at this time point. 
 
5.3.4. Conjugation of CS to a polymeric backbone for CS-glycopolymer synthesis via the 
“grafting-to” strategy 
The carboxylic acid-primary amine reaction was utilized in order to investigate 
the “grafting-to” method of brush polymer synthesis. Commercially available 
poly(acrylic acid) (PAA, 250,000MW) was utilized due to its water soluble, 
biocompatible and stable nature.  Time, temperature, buffer ionic concentration and 
reactant ratio were investigated for their effect on CS conjugation to PAA.  The 
conjugation of CS to PAA was measured by a change in the fluroescamine signal of CS-
PAA solutions in comparison to control solutions of CS alone.  Reactions were also 
followed rheometrically. 
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5.3.4.1.  Influence of time on CS-PAA reaction.  CS was reacted with activated 
PAA and the reaction monitored over short (< 24h) and long (>24h) time frames.  Percent 
conjugation reached ~77% within 2h and remained fairly constant through 24h of 
conjugation (Figure 5.24).  A maximum of 79% conjugation was reached at 8h of 
conjugation, however, conjugation did not change significantly over the 24hr period 
investigated (p > 0.05).  Over a longer time frame, conjugation decreased to 39% after 
120h.  This decrease may reflect some occurrences of non-covalent bonding or 
protonation of the CS primary amine over the reaction period.  Our results indicate that 
the majority of the CS-PAA reaction occurs in the first few hours of the reaction with no 
increased conjugation over long reaction times.  This may be due to the EDC/sulfo-NHS 
activation life which is generally around 4h caused by hydrolysis of the EDC/sulfo-NHS 
complex  (149).   
5.3.4.2.  Influence of temperature on CS-PAA reaction§.  The effect of reaction 
solution temperature on the conjugation of CS to PAA was also investigated.  
Conjugation was monitored after 8h of reaction for reactions carried out at 4̊C, 21̊C 
(ambient temperature) and 37̊C (Figure 5.25).  Conjugation reached 79.90%, 79.67%, and 
81.13% respectively.  No statistical difference was seen between different reaction 
temperatures (n=3, p > 0.05).   Ambient temperature was used for all further CS-PAA 
conjugation studies. 
5.3.4.3.  Influence of ionic concentration on CS-PAA reaction§.  PAA (15mg/mL, 
final concentration) was prepared similarly and conjugated with CS (10mg/mL) at 
varying Na+ concentrations (various dilutions of phosphate buffered solution buffered to 
pH 7.4) over 8h at room temperature (Figure 5.26).  CS was prepared in PBS buffer 
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solutions of varying concentration and pH adjusted to pH 7.4 with NaOH.  Total Na+ 
concentrations were 0.5669, 0.6962 and 1.8847 for 0.0001X, 1X, and 10X PBS solutions 
respectively.  Ion concentration may affect the conformation of CS chains in solution and 
may play a role in the interaction of CS and PAA which are both charged molecules at 
neutral pH.   Ionic concentration of the reaction medium had a significant effect on the 
conjugation observed via the fluorescamine assay (n = 3, p < 0.05 as determined by one-
way ANOVA and Tukey’s multiple comparison post hoc analysis for comparisons 
between 0.696M Na+ and 1.885M Na+ and, between 0.567M Na+ and 0.696M Na+) .  
Highest average conjugation (77%) was seen for conjugation in a 0.696M Na+ which 
corresponds to a 1X PBS buffer solution.  Average conjugation was decreased for the 
0.567 M Na+ solutions (60%) as well as for 1.885M Na+ (56%).  1X PBS buffer solution 
was used for all further CS-PAA conjugation studies. 
5.3.4.4.  Conjugation of CS to PAA at varying CS:PAA molar ratio§.  Varying CS 
to PAA molar ratio solutions were prepared and conjugated for 8h.    Ratios of 20:1, 10:1 
and 1:1 CS:PAA were investigated in addition to the original 6.8:1 CS: PAA molar ratio.  
Conjugation was lower for the 20:1 and 10:1 molar ratios at 47% and 53% average 
conjugation respectively.  The 1:1 CS:PAA molar ratio formulation had the highest 
conjugation reaching 97%.  All conjugations were statistically different as determined by 
a one-way ANOVA and Tukey’s multiple comparison post-test (n = 3, p < 0.001) except 
for the comparison between 20:1 and 10:1 CS:PAA molar ratios.   
Based on the number of carboxylic acid sites on a single PAA chain and the % 
conjugation of primary amines, the theoretical number of CS chains attached to each 
PAA chain was calculated.  For these theoretical calculations it was assumed that each 
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CS chain had 1 primary amine and that a decrease in primary amine content as detected 
by the fluorescamine assay was a result of the CS primary amine conjugating with a 
carboxylic acid of PAA and remaining bound.  The maximum number of active sites 
(activated acrylic acid (AA) monomers) on the 250kDa PAA is calculated to be 3470 
given an acrylic acid MW of 72Da.  The number of CS bound acrylic acid sites to un-
bound acrylic acid sites was calculated as follows from the CS:PAA ratio and resulting % 
conjugation: 
3470 ∗ [𝑃𝐴𝐴][𝐶𝑆] ∗ % 𝐶𝑜𝑛𝑗𝑢𝑔𝑎𝑡𝑖𝑜𝑛100  
And the number of CS chains attached to each PAA chain can be estimated as follows: 
[𝐶𝑆] ∗ % 𝐶𝑜𝑛𝑗𝑢𝑔𝑎𝑡𝑖𝑜𝑛100[𝑃𝐴𝐴]  
The number of CS chains attached to each PAA chain was calculated for each CS:PAA 
ratio and are reported in Table 5.4.  The number of CS chains attached to each PAA 
polymer ranges from 1 in the 1:1 CS:PAA formulation to 9 in the 20:1 CS:PAA 
formulation.  For 6.8:1, 7.5:1 and 10:1 formulations theoretical calculations estimate 5 
CS chains per PAA chain.  All investigated formulations suggest sparsely grafted 
structure.  
§These studies were conducted as a part of the Master’s Thesis entitled, “Biomimetic Aggrecan Based on a 
Poly Acrylic Acid 9PAA) Core and Chondroitin Sulfate (CS) Bristles” (2010, Drexel Univeristy) by 
Nandita Ganesh 
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5.3.4.5.  Rheological assessment of the CS-PAA reaction.  The rheological 
properties of CS-PAA solutions were investigated during the reaction period in order to 
monitor the formation of CS-PAA reaction products.  A rheometer with a concentric 
cylinders sample set-up was utilized in order to measure the viscosity of CS-PAA 
reaction solutions periodically over a 4h reaction period.  Solution viscosity increased 
from a specific viscosity of 1.194 to 1.229 over the 4h period and followed pseudo-first 
order association kinetics (R2 = 0.99) (Figure 5.28).  Specific viscosity was also 
investigated for CS-PAA reacted solutions after a 24h reaction period (Figure 5.29).  CS-
PAA reacted solution had a specific viscosity of approximately 1.35 after 24h of reaction 
which was higher than that of un-reacted CS-PAA solutions (a solution of CS and un-
activated PAA simply mixed immediately before rheological testing) which had a 
specific viscosity of approximately 0.82.  The specific viscosity of PAA and CS solutions 
were also investigated at the concentrations used in the reaction and found to be 0.59 and 
0.51 respectively.  All solutions maintained a steady-state specific viscosity with respect 
to shear rate over a shear rate range from 50/s to 200/s. 
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Figure 5.8:  L-serine-fluorescamine standard curve 
and linear region of fluorescence v.s. sample primary amine content based on the L-serine 
standard curve. 
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Figure 5.9:  Fluorescamine analysis of control samples bovine serum albumin and GalNAc  
for validation of the fluorescamine assay. 
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Figure 5.10:  Fluorescamine analysis of chondroitin samples from various sources 
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Figure 5.11:   Representative EDAX spectra  
(a) non-functionalized glass slide in 0mg/mL CS and (b) epoxy functionalized glass slides in 
20mg/mL CS solutions.  Spectra were collected at 6keV auto base-lined and semi-quantitatively 
analyzed for elemental analysis.  Elements C, O, Na, Mg, Al, Si, S, K and Ca were detected with 
special attention to Si and S for analysis.  Trace amounts of S are detected at 2.31 keV. 
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Figure 5.12:  Surface sulfur content on functionalized glass surfaces after treatment with CS 
EDAX analysis of functionalized glass surfaces modified with varying concentrations of CS (6 
keV, spot size 6, working distance 12mm, analysis area 121µm x 95µm).  Spectra were semi-
quantified and the ratio of S to Si net integrated area was determined and normalized to samples 
modified with buffer solutions alone. (n = 3, 2-way ANOVA with Bonferroni Post-tests, no 
statistical differences observed) 
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0 mg/ml CS vs 
0.125 mg/ml CS 
0 mg/ml CS vs 
2 mg/ml CS 
0.125 mg/ml CS vs 
2 mg/ml CS 
Un-Treated 
Glass Slide ns ns ns 
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Glass Slide ** *** *** 
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Glass Slide ns ns ns 
** P < 0.01; ***P < 0.001 
 
Figure 5.13:  Contact angle measurements on CS functionalized glass slides 
(n>4, 2-way ANOVA with Bonferroni Post-tests) 
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Figure 5.14:  Conjugation of CS with amine reactive monomers 
Change in primary amine content, as detected by the fluorescamine assay, with the addition of 
amine reactive monomers acrolein, allyl glycidyl ether, and acrylic acid.  % PA conjugated to 
monomer increases with increasing monomer:CS molar ratio.  A higher degree of conjugation is 
realized for acrolein and AGE than for acrylic acid. 
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One-phase association:  Y=Plateau*(1-exp(-K*x)) 
AGE:CS Molar Ratio 1:1 10:1 100:1 1000:1 
Plateau (% Conjugation) 12.48 58.8 81 96.26 
K (1/hr) 0.124 0.01874 0.2031 1.32 
Tau (hr) 8.068 53.36 4.924 0.7575 
95% Confidence Intervals 
Plateau (% Conjugation) 7.126 to 17.83 32.35 to 85.25 76.59 to 85.41 93.65 to 98.88 
K (1/hr) 0.0 to 0.3901 0.001883 to 0.03560 0.1547 to 0.2515 1.155 to 1.485 
Tau (hr) 2.563 to +infinity 28.09 to 531.1 3.977 to 6.464 0.6735 to 0.8655 
R square 0.3991 0.8143 0.9304 0.9357 
 
 
Figure 5.15:  CS-AGE conjugation over time for varying AA:CS molar ratios with one-phase 
association exponential curve fit (n=3, 2-way ANOVA with Bonferroni Post-tests) 
  
1:1 0 2 4 24 48 72 96 100:1 0 2 4 24 48 72 96
0 0
2 ns 2 ns
4 ** ns 4 *** *
24 *** *** ns 24 *** *** ***
48 ** ns ns * 48 *** *** *** ns
72 *** ** ns ns ns 72 *** *** *** ** ns
96 *** ** ns ns ns ns 96 *** *** *** *** ns ns
10:1 0 2 4 24 48 72 96 1000:1 0 2 4 24 48 72 96
0 0
2 ns 2 ***
4 * ns 4 *** ns
24 ns ns ns 24 *** * ns
48 *** *** *** *** 48
72 *** *** *** *** ns 72
96 *** *** *** *** * ns 96
P value P > 0.05 P < 0.05 P<0.01 P<0.001
Summary ns * ** ***
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1:1 2 6 24 48 10:1 2 6 24 48 100:1 2 6 24 48 
2         2         2         
6 ***       6 ***       6 ***       
24 ns ***     24 ns ***     24 ns **     
48 * ns *   48 ** ns *   48 *** ns ***   
 
 
One-phase association:  Y=Plateau*(1-exp(-K*x)) 
  1:1 10:1 100:1 
Plateau (% Conjugation) 2.731 4.936 11.71 
K (1/hr) 0.4182 0.4229 0.4512 
Tau (hr) 2.391 2.365 2.216 
95% Confidence Intervals 
Plateau (% Conjugation) -0.1446 to 5.606 2.048 to 7.825 8.774 to 14.65 
K (1/hr) 0.0 to 2.302 0.0 to 1.485 0.0 to 0.9493 
Tau (hr) 
0.4344 to 
+infinity 
0.6732 to 
+infinity 
1.053 to 
+infinity 
R square 0.08588 0.1815 0.3374 
 
Figure 5.16:  CS-Acrylic Acid conjugation over time for varying AA:CS molar ratios with one-
phase association exponential curve fit (n=3, 2-way ANOVA with Bonferroni Post-test)  
P<0.001
ns * ** ***
P value
Summary
P > 0.05 P < 0.05 P<0.01
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Figure 5.17:  1H-NMR spectra of (Top) CS and (bottom)AGE solutions in D2O with spectral 
assignments.  See Appendix 2 for alternate view of CS. 
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Figure 5.21:  Qualitative analysis of vinyl group incorporation into CS based on 1H-NMR spectral 
analysis of AGE-CS conjugation over time.  Vinyl proton incorporation was based on the 
integrated area of proton 2 of AGE compared the integrated area of 1 proton, estimated from the 
methyl peak at 1.9ppm. 
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Figure 5.24:  CS-PAA conjugation over time 
(Top) Short term conjugation of CS-PAA with linear regression (PAA Concentration 16.5mg/ml 
(0.066mM), CS concentration 10mg/ml (0.45mM))  
 (Bottom) Long term conjugation of CS-PAA with non-linear one-phase exponential decay (PAA 
Concentration 15mg/ml (0.06) CS concentration 10mg/ml (0.45mM)); Room temperature 
reaction in PBS. 
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Figure 5.25:  CS-PAA conjugation with varying temperature (8hr reaction) 
PAA Concentration 16.5mg/ml (0.066mM), CS concentration 10mg/ml§ 
 
 
 
 
 
 
§Data presented previously in Master’s Thesis, “Biomimetic Aggrecan Based on a Polyacrylic 
Acid (PAA) Core and Chondroitin Sulfate (CS) Bristles” (2010, Drexel University) by Nandita 
Ganesh (160). 
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Figure 5.26:  CS-PAA conjugation with varying Na+ Concentration (8hr Reaction) PAA 
Concentration 16.5mg/ml (0.066mM), CS concentration 10mg/ml (0.45mM) § 
 
 
 
 
 
 
 
§Data presented previously in Master’s Thesis, “Biomimetic Aggrecan Based on a Polyacrylic 
Acid (PAA) Core and Chondroitin Sulfate (CS) Bristles” (2010, Drexel University) by Nandita 
Ganesh (160). 
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Figure 5.27:  CS-PAA conjugation with varying CS:PAA molar ratio (8hr Reaction) 
Reaction in 1X PBS buffer at 21̊C§ 
 
 
 
 
 
 
 
§Data presented previously in Master’s Thesis, “Biomimetic Aggrecan Based on a Polyacrylic 
Acid (PAA) Core and Chondroitin Sulfate (CS) Bristles” (2010, Drexel University) by Nandita 
Ganesh (160). 
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Figure 5.28:  Rheological investigation of CS-PAA reaction solutions 
(7.5:1 CS:PAA Ratio) with one-phase association exponential curve fitting 
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Figure 5.29:  Specific viscosity over shear rate for a CS-PAA reacted solution 
(7.5:1 CS:PAA Ratio) (no curve fitting) 
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Table 5.2:  Estimated Number of Primary Amines per Molecule for Control Samples  
Based on the L-serine Fluorescamine Standard Curve 
Biomolecule Control Molecular Weight 
Average # PA/ 
Molecule 
Standard 
Deviation 
Serine Amino Acid 105.09 1.17 0.12 
Bovine Serum Albumin Protein 66,400 23.41 0.60 
GalNAc Saccharide of CS 221.2 0.00 0.05 
 
 
 
 
 
 
 
 
 
Table 5.3: Estimated Number of Primary Amines per Molecule for Chondroitin Sulfate Samples 
 Based on the L-serine Fluorescamine Standard Curve 
Chondroitin 
Sulfate Tissue Source CS Type 
 Average # PA/CS 
Chain 
Standard 
Deviation 
Sigma C4384 Shark Cartilage Primarily CS-6 10.52 1.26 
Sigma C9819 Bovine Trachea 
60% CS-4, 40% 
CS-6 3.08 0.38 
Sigma C6737 Bovine Cartilage Primarily CS-4 1.15 0.07 
Calbiochem 
230699 
Bovine 
Trachea 
Mix of CS-4, 
CS-6, CS-4,6, 
CS-2,6 
7.16 0.95 
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Table 5.4:  Theoretical estimation of number of CS chains attached per PAA chain  
after 8hr reaction; §Samples reacted for 24h. 
CS:PAA Molar 
Ratio 
Average % 
Conjugation 
# AA sites/ 
# CS bound AA Sites 
~ # CS Chains attached per 
PAA Chain 
1:1 97 3577 1 
6.8:1 77 663 5 
§
7.5:1 64 723 5 
10:1 54 643 5 
20:1 47 369 9 
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Commercially available CS with a terminal primary amine was investigated for its 
utility in the fabrication of biomimetic aggrecan bottle-brush structures.  A major hurdle 
in the synthesis of polymers with carbohydrate pendant groups (glycopolymer) is the 
synthesis and preparation of the reactive carbohydrate or glycomonomer (123-126).  The 
glycomonomer must either be reactive to polymeric substrates or be polymeriziable into a 
polymeric backbone (118).  To date, chondroitin sulfate has not been investigated as a 
glycol-monomer for glycopolymer bottle brush synthesis.  In this report, we have 
identified a terminal primary amine in commercially available CS and determined the 
ability to covalently link CS to synthetic materials via this this terminal-end functionality.  
Three amine-reactive chemistries were investigated for reaction with the terminal primary 
amine of CS and the attachment of polymerizable vinyl groups.  These chemistries were 
further investigated for the immobilization of CS onto amine-reactive surfaces and a 
polymeric backbone. 
5.4.  Discussion 
 
5.4.1. CS Terminal Primary Amine 
CS is primarily obtained by isolation from tissue sources.  It is inhomogeneous 
across tissue sources, as well as across isolation techniques and a minimal amount of data 
is provided on the physical and chemical properties of the biomolecule when purchased 
(95, 139).  For our studies, we required that a primary amine be available on the terminal 
end of CS.  Although it is likely a serine residue is present based on reported cleavage 
techniques to remove CS from the protein backbone, exact isolation technique and 
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protein residue content is not reported for commercially-available CS (89, 129, 139).  
Variations in the isolation procedure may result in the introduction of additional PAs 
throughout the CS chains as well as cleavage of the linkage region from the CS main 
chain (89).  Although these small variations are not generally disruptive to the overall 
structure and function of the CS molecule and therefore not reported, they are critical for 
our investigation.   
CS was investigated from two vendors, Calbiochem and Sigma and three tissue 
sources, bovine trachea, bovine cartilage and shark cartilage.  The fluorescamine assay, 
which is sensitive to primary amines at the picomolar level was used to detect PAs in the 
CS macromolecule (145).  CS-6 from shark cartilage which is a larger type of CS (~65K 
MW) had the highest number of primary amines per chain.  Due to the larger size of this 
CS as well as its high primary amine content, with CS was not pursued for the synthesis 
of biomimetic aggrecan.  However, with further purification, and mild isolation 
techniques, the utilization of CS-6 in biomimetic aggrecan may allow for a diverse family 
of biomimetic aggrecans to be synthesized with varying CS chemistry and molecular 
weight.   The primary amine content of CS-4 and mixes of CS from bovine trachea varied 
between vendors with Calbiochem CS-4 having approximately 7 PAs compared to 
approximately 3 for Sigma CS-4 (Table 5.3).  The difference in the number of PAs is 
indicative of the inhomogeneity of the CS isolation techniques.  Calbiochem CS which is 
a less pure mix of different CS isomers may have more PAs due to protein impurities 
within the CS isolate.  Also possible is the deacetylation of the GalNAc of CS.  The 
amide bond in GalNAc is subject to hydrolysis in alkaline solutions, and processing 
conditions may cause breakage of this bond exposing PAs throughout the CS backbone.  
132 
 
 
This is particularly disruptive to the synthesis of CS bottle brush structures since reaction 
chemistries must be limited to a single point on the molecule, preferably on the terminal 
end in order to develop a well controlled, organized structure.  CS-4 from bovine 
cartilage, supplied by Sigma (C6737) was determined to have ~1.15 primary amines per 
CS chain.  This is indicative of a single primary amine per CS chain, and based on 
isolation techniques, the single primary amine is likely at the terminal end of CS and 
arises from a serine residue.  Sigma C6737 which is the sodium salt of chondroitin sulfate 
is marketed as a standard for cetylpyridinium chloride (CPC) titration and is therefore 
likely more purified than other marketed CS.  This purity may have reduced protein 
contamination more apparent in other CS products.  
In the calculation of CS primary amine content, polydisperse molecular weight 
distributions may affect the calculation of the ratio of PAs to CS molecules.  Based on 
reported literature values, a CS MW of 22,000 was assumed for CS-4 and mixed 
populations of CS (65, 139) and 65, 000 for CS-6 however it is expected that there is a 
MW distribution within each CS sample and between vendors’ isolation techniques, 
tissue source and age may result in varying CS MW.  If MW is greatly different between 
products the calculation of the number of PAs per CS molecule may be skewed 
contributing to the discrepancy between calculated values.  Based on the fluorescamine 
analysis of CS primary amine content conducted here, Sigma CS-4 from bovine cartilage, 
supplied by Sigma was chosen for further investigation. 
 
5.4.2. Surface grafting of CS via the terminal primary amine 
133 
 
 
The utility of the CS terminal primary amine in immobilizing CS was investigated 
using model surfaces.  Model surfaces functionalized with amine reactive groups were 
used to investigate the attachment of CS to functionalities that may be incorporated into 
polymeric backbones.  Epoxy and aldehyde functionalized surfaces were treated with CS 
solutions of varying concentration and investigated using EDAX as well as contact angle.  
Reaction conditions were such that amine reactions with the surface would be more 
favorable than reaction with other functional groups of CS such as carboxylic acids and 
hydroxyls.  A pH of 9.4 was used in CS attachment to both surfaces, this is particularly 
important in CS attachment to the epoxide surfaces where epoxides are reactive to both 
hydroxyls and sulfhydryls when pH is high (pH ~ 11) and low (neutral pH) respectively 
(149). 
Semi-quantitative EDAX analysis showed an overall increase in surface sulfur 
content on functionalized slides attributable to the attachment of CS to the surface (Figure 
5.12).  Surfaces were thoroughly rinsed before analysis to remove any adsorbed CS 
chains leaving only covalently bound CS.  Non-functionalized glass slides were 
investigated as a control and they had no discernable increase in sulfur content with CS 
treatment indicating minimal CS signal due to adsorption.  Sulfur signal on epoxy and 
aldehyde functionalized slides varied with CS concentration, however a relationship 
between CS concentration and attachment could not be established since sulfur was only 
present in trace amounts and therefore difficult to accurately quantify.  Although sulfur 
may be present on the surface of the slides at a higher wt% the depth of analysis for 
EDAX is approximately 1 -2µm, therefore signal from the glass may overpower surface 
signal from sulfur.  Depth of analysis of the EDAX for sulfur given 6keV of energy was 
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predicted to be approximately 0.7µm which may account for the sulfur signal seen on 
glass surfaces treated with 0mg/mL CS where sulfur may be present as an impurity in the 
glass.  The sulfur within the glass slides may have reduced the sensitivity of this method 
for detecting change in surface sulfur content with CS treatment however the increase in 
sulfur content on functionalized slides suggests CS attachment.  A more sensitive method 
that may be utilized for the determination of CS surface attachment is x-ray photoelectron 
microscopy which can detect surface chemistries with a depth of analysis of only 1-
10nm. 
To further investigate CS attachment to amine reactive surfaces, epoxy-and 
aldehyde- functionalized surfaces were treated with varying CS concentration of CS and 
surface hydrophilicity was measured using a contact angle meter.  Due to the charged 
nature of CS it is expected that surface hydrophilicity would increase (i.e. contact angle 
would decrease) as CS is deposited onto the surface (Figure 5.13).  A decreasing contact 
angle was seen for epoxy-functionalized surfaces with increased CS concentration.  This 
indicates a strong relationship between CS concentration and attachment of CS to the 
surface suggesting covalent binding of CS.  No such relationship was seen for non-
functionalized glass surfaces which is indicative of simply adsorbed CS.  Although a 
similar trend was seen for aldehyde-functionalized slides, there was no statistical 
difference between aldehyde functionalized slides indicating low levels of CS attachment 
on these surfaces.  These surface studies provide evidence that CS can be immobilized 
onto amine reactive surfaces.  Such immobilization can be transferred to synthetic 
monomers or polymer chains for the synthesis of CS bottle brush polymers via the 
“grafting-through” or “grafting-to” methods.  
135 
 
 
 
5.4.3. Reactivity of the CS terminal primary amine and attachment of a polymerizable 
monomer 
Three different amine reactive chemistries were investigated for the 
functionalization of CS at its terminal primary amine with a polymerizable monomer.  
Aldehyde, epoxide and carboxylic acid reactive groups were investigated by the 
conjugation of CS to acrolien, allyl glycidyl ether and acrylic acid monomers 
respectively.  All three monomers have one amine reactive functionality as well as a 
vinyl leaving group.  The vinyl leaving group may be used subsequently in order to 
polymerize CS into brush structures via the “grafting-through” strategy (113-114, 118).  
The attachment of monomer to the CS primary amine was monitored using the 
fluorescamine assay, where a drop in fluorescence signal from CS samples would be 
expected as monomer binds to the CS PA making it inaccessible to the fluorescamine 
reagent.  As the molar ratios of monomer:CS was increased, an increase in the percent of 
monomer conjugation was also seen (Figure 5.14).  In all cases, conjugation was 
modulated by monomer:CS molar ratio with the maximum conjugation seen at a molar 
excess of monomer at 1000:1.  Higher molar ratios could not be achieved due to 
insolubility of the monomers at higher concentrations.  A large molar excess is likely 
required due to the small concentration of PAs available in comparison to the CS 
disaccharide concentration.   
Acrolein binding to CS via the aldehyde-amine reaction reached 80% at high 
monomer:CS ratios and demonstrates the utility of this binding strategy in modifying and 
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immobilizing CS however, the toxic nature of acrolein and the coupling reagent sodium 
cyanaborohydride made this reaction strategy undesirable for further studies in 
comparison to AGE which also had high conjugation but does not require additional 
coupling reagents.  In addition, the low stability of aldehyde functional groups and the 
complexities associated with the synthesis of water soluble polymers with pendant 
aldehyde groups  (161), the aldehyde reaction  is  less desirable for initial studies into the 
synthesis of biomimetic aggrecan.   
The carboxylic-acid amine reaction was investigated for its temporal dependence.  
Acrylic Acid:CS conjugation only reached a maximum of 15% at a 100:1 molar ratio.  
This may be due in part to the several steps required to activate acrylic acid for reaction 
with PAs.  An EDC/sulfo-NHS coupling reaction was utilized where incomplete 
activation of the carboxylic acids in acrylic acid may have led to fewer active monomers 
available for conjugation.  Carbodiimide coupling of carboxylic acids and amines is often 
used in order to promote the reaction of the two functional groups in order to form amide 
bonds (162).  Amide bonds are very hydrolytically stable having a half life of ca. 600 
years in neutral solutions at 25̊C which makes the amide linkage very attractive for 
bioconjugation applications (163).  In the absence of a coupling agent, carboxylic acids 
and amines do not form amide bonds however interactions between the two species can 
result in the formation of protonated amines.  Protonated amines are not detectable using 
the fluorescamine assay.  Their formation in the AA:CS reaction medium can result in a 
temporary decrease in the fluorescamine signal, transiently increasing the conjugation 
detected.  This may account for the fluctuations in the conjugation seen over time.  No 
clear time dependence was seen for the AA-CS reaction.  Both linear and one phase 
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exponential fits were poor fits (Figure 5.16).  No significant increase in conjugation was 
seen beyond 6h of reaction.  This is in good agreement with the window of reactivity of 
the EDC/sulfo-NHS activation of carboxylic acids which generally ranges from 2-4h 
(149, 162).  Modifications of the EDC/sulfo-NHS activation procedure may improve 
conjugation of the CS primary amine to carboxyl functional groups.  A two-step 
activation procedure was utilized in this study in order to avoid activation of carboxylic 
acids in CS.  Quenching of excess EDC with 2-mercaptoethanol may have reduced 
conjugation between CS and acrylic acid.  Filtration of excess EDC instead of quenching 
may improve the reaction in addition to optimization of EDC/sulfo-NHS reagent 
concentrations.   
Due to the comparatively low conjugation between acrylic acid and CS seen in 
this study, the addition of a vinyl monomer to CS via acrylic acid conjugation is not 
optimal.  These studies however do demonstrate the feasibility of reacting the CS primary 
amine with carboxylic acid functionalities using carbodiimide coupling and this reaction 
was investigated further for the conjugation of CS to poly(acrylic acid) in the “grafting-
to” strategy of polymer synthesis (Figure 5.7). 
The conjugation of AGE to CS was investigated further and the reaction kinetics 
determined for varying AGE:CS molar ratios.  At the molar ratio of 1:1 AGE:CS, no 
clear time dependence was observed (Figure 5.15).  Data could not be accurately fit to 
exponential or linear regressions (R2 = 0.4 and 0.2 respectively).  At low molar ratios, 
reaction between CS and AGE are minimal.  This may be due to the large amount of CS 
present in the solution with respect to the terminal primary amine reactive group and the 
AGE monomer.  For higher ratios the CS-AGE reactions progressed with time and the 
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rate constants increased with increasing AGE:CS molar ratio.  The 10:1 AGE:CS molar 
ratio reaction progressed with time but did not reach a plateau.  Based on an exponential 
fit of moderate accuracy (R2=0.8) this reaction is predicted to reach ~58.8% conjugation 
with a rate constant of 0.019h-1 however the 95% confidence interval for the rate constant 
ranged from 0.002h-1 to 0.036h-1.  The extrapolated time constant had a 95% confidence 
interval between 28h and 53h and therefore may be beyond the scope of the time points 
investigated and thus the rate constant cannot be accurately determined from the time 
range investigated in this study.  These studies were conducted at a CS concentration of 
25mg/ml; increasing the overall concentration of both CS and AGE monomer may aid in 
increasing reaction kinetics by reducing interpolymeric repulsion and increasing the coli-
coil overlap time (164).  Reaction kinetics at higher concentration however cannot be 
monitored using the fluorescamine assay due to the limited linear region of the 
fluorescamine signal to amine concentration standard curve. 
At the 100:1 AGE:CS molar ratio, a maximum of 89% conjugation was reached 
after 96h of reaction.  Based on the one-phase association exponential fit (R2 = 0.93), a 
plateau of 81% conjugation is predicted for this reaction with a rate constant of 0.2h-1 
corresponding to a time constant of 4.9h (95% confidence interval between 4h and 6h).  
This indicates that a maximum conjugation was reached within the time window 
investigated.  These studies at the 10:1 and 100:1 AGE:CS molar ratios demonstrate the 
longevity of the CS-AGE reaction.  At the 1000:1 ratio the reaction proceeds quickly at a 
rate constant of 1.3h-1 reaching a conjugation of over 98% after just 24h.  In the synthesis 
of vinyl-ended CS chains the highest conjugation is desired in order to synthesis a 
majority population of vinyl modified chains, therefore the 1000:1 ratio is most 
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appropriate for this purpose.  Studies at the lower molar ratios however demonstrate the 
ability to utilize the epoxide-amine reaction in synthesis techniques that require long 
reaction times such as the “grafting-to” method of brush synthesis.  In surface brush 
synthesis for example, three regimes of brush synthesis kinetics have been observed 
(165-167).  In the first regime, polymer attachment occurs quickly but results in sparsely 
grafted polymers that take on a flattened mushroom like arrangement.  In the second, 
regime attachment occurs considerably more slowly, on the order of several hours to 
days.  The second regime of attachment is necessary however in order to generate 
densely grafted brushes with extended chain conformations.  In a third regime, 
attachment rate increases again until saturation occurs.  It is therefore necessary, when 
considering reactive chemistry options to consider the rate and longevity of the reaction.  
The epoxide-amine reaction affords long reaction times and can therefore be useful in the 
fabrication of dense structures, especially in the “grafting-to” method of synthesis. 
We further investigated the incorporation of AGE monomer into CS (1000:1 AGE:CS 
molar ratio) over a 24h reaction period using 1H-NMR (Figure 5.18, Figure 5.20) and 
ATR-FTIR (Figure 5.23).  Both 1H-NMR and ATR-FTIR analysis of the AGE-CS 
macromolecule suggested stability of the CS chemical structure over the reaction period. 
Monitoring of vinyl group incorporation into CS suggested progressive incorporation of 
the AGE vinyl group onto CS with up to a 0.84:1 Vinyl:CS ratio seen after 6h.  This ratio 
suggests that approximately 84% of CS molecules have a single vinyl group incorporated 
at this reaction time point.  In conjunction with fluorescamine data demonstrating 
reaction of AGE with the CS primary amine, and ATR-FTIR data indicating minimal side 
reactions with CS hydroxyls, this data indicates, selective reaction of AGE with the Cs 
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terminal primary amine and incorporation of single vinyl groups at the terminal end of 
CS after 6h of reaction.  If a greater number of side reactions were occurring, the amount 
of vinyl proton incorporation into the CS 1H-NMR spectra would be expected to be 
considerably higher.  An example of this can be seen in the 24h reaction of AGE-CS 
(1000:1 AGE:CS molar ratio).  After 24h a ratio of 1.72:1 Vinyl:CS was determined 
indicating, that after 24h of reaction more than one vinyl group is likely incorporated into 
each CS molecule.  This would indicate possible side reactions of the AGE monomer 
with reactive groups other than the single terminal primary amine.  This is further 
supported by the relatively large shift seen in the C-O stretching mode peak of the 24h 
AGE-CS macromolecule, indicating possible side reactions on the CS hydroxyls.  In the 
1000:1 AGE:CS molar ratio reaction, the primary amine reaction rate was determined to 
be 0.75h (Figure 5.15) indicating that majority of the primary amine reaction should 
occur within the first 3h (~95% of the reaction).  The plateau % conjugation for this 
reaction was high, at 96%, therefore, after the initial hours of reaction, very little primary 
amine is available, and excess epoxide may be more likely to react with originally less 
reactive species.  This phenomenon can be seen in the 24h reaction.     
The estimation of vinyl incorporation into the CS macromolecules is semi-
quantitative and sensitive to CS MW, as well as noise in the 1H-NMR signal, signal 
baselining and choice of integration region.  However, in conjunction with fluorescamine 
studies and FTIR analysis, these results provides promising evidence that the AGE 
monomer is conjugating with CS specifically at the CS terminal primary amine.  CS 
spectra after conjugation also matched well with natural CS spectra, indicating no major 
modification of the CS main chain with the AGE-CS monomer conjugation technique.  
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No major peak shifts were detected at the 1033cm-1 peak s of CS-macromolecules up to 
6h of reaction, indicating that there was no significant bonding of the CS hydroxyls by 
the AGE monomer at these time intervals and that incorporation of the AGE vinyl group 
into CS is limited to AGE reaction with the CS terminal primary amine (as detected by 
the fluorescamine assay (Figure 5.15).   
In order to avoid over incorporation of vinyl groups throughout the CS backbone, 
the time of reaction must be monitored and limited.  In this study, a 6h reaction time of 
1000:1 AGE:CS molar ratio reaction was demonstrated to have ~84% conversion of CS 
to vinyl-terminated CS.  Further investigation of other AGE:CS molar ratio reactions (i.e. 
100:1 AGE:CS) over the time course of reaction may reveal further possible time-
concentration combinations that result in vinyl-terminated CS with minimal side 
reactions.  The simple modification of CS to incorporate terminal end polymerizable 
moieties was demonstrated here, and vinyl-terminated CS may be used in future studies 
in order to synthesize CS brush polymers via free-radical “grafting-through” 
polymerization strategies. 
Vinyl-CS can be utilized in free-radical polymerization reactions for the 
fabrication of CS-glycopolymer structures via the “grafting-through” technique (Figure 
5.30).  In free-radical chain polymerization (Figure 5.31), polymerization is initiated by a 
reactive species R* produced from an Initator I (I  R*) where the reactive species may 
be a free radical, cation or anion (168).  R* adds to a monomer molecule by opening the 
π-bond to form a new reactive center.  In general monomers will have the form 
(CH2=CH-X).  This process is repeated as more monomer molecules are successively 
added to continuously propagate the reactive center (Figure 5.31).  Polymer growth is 
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eventually terminated by the destruction of the active center by an appropriate reaction 
depending on the type of reactive center and reaction conditions. 
 Current relevant synthesis systems that have previously been utilized for the 
synthesis of glycopolymers are outlined in (Table 5.5) (113, 118, 123, 125-126).   
Polymerization has been achieved through several mechanisms including ring-opening 
metathesis polymerization (ROMP) (120), reversible addition–fragmentation chain 
transfer (RAFT) polymerization (121), atom transfer radical polymerization (ATRP) 
(122), cyanoxyl-mediated free-radical polymerization and classical free-radical synthesis 
(123-126).   Although several strategies are available that have produced glycopolmyers 
with low poly dispersity and high control, many of these methods are not directly 
amenable to the fabrication of CS bottle-brushes (113, 118, 123). 
The complex nature of CS due to its large molecular weight, charged groups and 
functional groups, poses a challenge to the synthesis of CS bottle-brush structures via 
conventional methods (115). Methods that require functional group protection are 
especially problematic for larger polysaccharides such as CS where many functional 
groups are present and the complete de-protection of the molecule may prove difficult.  
In addition, systems requiring high purity are not desirable, as the CS being utilized is a 
commercially available biomolecule derived from tissue sources and control over 
contaminants is limited.  Finally, CS is highly insoluble in organic solvents, reducing the 
possible polymerization strategies to those amenable to aqueous reactions.  Given these 
limitations, the “living” radical cyanoxyl-mediated polymerization strategy or the 
APS/TMEDA mediated polymerizations may be promising routes to the synthesis of CS 
bottle-brush polymers from the vinyl terminated CS synthesized in this study. 
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5.4.4. Grafting of CS to Poly(acrylic acid) 
The carbodiimide mediated carboxylic acid-primary amine reaction was utilized 
in order to investigate the “grafting-to” method of brush polymer synthesis due to the 
water soluble, stable and biocompatible nature of carboxylic acid polymers.  The 
polymeric backbone of poly(acrylic acid) (PAA) was chosen for preliminary 
investigation of the synthesis of CS-glycopolymer structures via the “grafting-to” strategy 
via the carboxyl-amine reaction  (Figure 5.7).  PAA of 250kDa MW was utilized in order 
to mimic the MW of the natural aggrecan protein backbone.  PAA is a linear polymer 
with pendant carboxylic acid groups and an enzymatically resistant hydrocarbon 
backbone.  It has been used previously in the hydrogel form with bioactive molecules for 
the culture of cells and is shown to be non-toxic in in vitro studies (169).   
Chondroitin sulfate was conjugated to the PAA backbone with high percent 
conjugation, ranging from 40% to over 90% based on reaction conditions.  Reaction 
temperature, which can affect the motion of the polymer chains through Brownian 
Motion, thereby affecting their collision rate and time was investigated but found to have 
no significant effect on conjugation (Figure 5.25).    
Ionic concentration was also investigated for its effect on CS-PAA conjugation. 
Ionic concentration of the reaction solution is an important factor due to the charged 
nature of both the PAA and CS chains.  The ionic concentration can affect the 
conformation of the molecule making the terminal primary amine more or less accessible 
as well as changing the ability of the molecules to interact due to charge repulsions.  In 
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the case of CS, at low salt concentrations (ranging from 0.0001 to 0.01M Na+) and high 
salt concentrations (on the order of 1M Na+) CS chains take on a more collapsed 
conformation due to protonation of the CS chains and salt screening.  At moderate salt 
concentrations (~0.1M Na+) CS chains may take on a more extended rod-like 
conformation  due to intra- and  inter-molecular electrostatic repulsion (73).   Our results 
indicate that Na+ concentration did significantly effect the conjugation of CS and PAA 
(Figure 5.26).  Low and high salt concentrations had lower conjugation than the salt 
concentration of 1XPBS.  All solutions were maintained at a pH of 7.4; lower salt 
concentrations could not be tested with PBS buffer since buffering of the solution to pH 7 
required NaOH which again increases the salt concentration.  In a salt concentration of 
0.69M (1X PBS) CS chains most likely take on an extended conformation.  This 
conformation may allow the terminal primary amine to be more accessibly.  The 
electrostatic repulsions between CS molecules and the charged PAA chain may however 
hinder close packing of the chains in brush formation. 
The ratio of CS:PAA in the reaction medium played a large role in the synthesis 
of CS-PAA conjugates.  As expected lower CS:PAA molar ratio reactions yielded higher 
conjugations due to the large excess of carboxylic acid functional moieties compared to 
primary amines, however, a high conjugation does not always translate to a high ratio of 
CS attachment to the PAA backbone.  From Table 5.4 it can be seen that lower molar 
ratios of CS:PAA had higher conjugation, but the estimated number of CS chains 
attached to each PAA chain was 1-5 in comparison to the high CS:PAA molar ratio of 
20:1 where conjugation was low (~47%) but yielded ~9 CS chains attached to each PAA 
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backbone.  Higher CS:PAA molar ratios may be investigated in order to achieve higher 
grafting density of CS onto the PAA backbone. 
Reaction time was also investigated for the CS-PAA reaction.  As seen with the 
acrylic acid studies, the carbodiimide mediated CS-PAA reaction was not modulated by 
time over a 24hr reaction window.  Longer reaction times were investigated however and 
conjugation was seen to decrease over a 120hr period.  A one-phase exponential decay 
was fit to the data with an R2 = 0.93.  The predicted plateau conjugation from the non-
linear fit was ~21% with a time constant of 103.5h.  This is an over 40% reduction in 
percent conjugation from the originally detected conjugation of ~64% after 24h.  As 
described previously, this drop in percent conjugation may be due to non-covalent 
interactions between the carboxylic acids of PAA and the amines of CS which can 
transiently reduce the fluorescamine signal.  Although conjugation is seen to decrease 
over time, after 120h ~40% conjugation is maintained. 
In addition to fluorometric monitoring of CS-PAA conjugation, rheometric 
studies were conducted on CS-PAA samples reacted in optimal conditions (Ambient 
temperature, 1X PBS, < 24hr reaction, molar ratio of 7.5:1 CS:PAA) in order to follow 
the attachment of CS to the PAA backbone.  The high molar ratio of 20:1 CS:PAA was 
not investigated in this manner because reactions were not purified, and contamination 
with a high percentage of un-attached CS chains may mask rhelogical changes broguh 
about by CS-PAA conjugates.  CS-PAA reaction solutions were investigated over time 
for their viscosity. Viscosity of the reaction solution increased with time and fit well to a 
one-phase association exponential curve (R2 = 0.99).  The rate constant of the reaction 
was 0.78h-1 corresponding to a time constant of 1.3h.  Rheometric investigations of 
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reacting solutions are a good indication of conjugation and polymer formation since 
viscosity is proportional to molecular weight by the Mark-Houwink-Kuhn-Sakurada 
equation (170): 
[𝜂] = 𝐾(𝑀𝜐����)𝑎 
Where [η] is intrinsic viscosity, 𝑀𝜐���� is the viscosity average molecular weight and K and 
α are constants dependent on polymer conformation.  Intrinsic viscosity is the limit of the 
reduced specific viscosity as the concentration approaches zero, and is given by the 
equation: 
[𝜂] =  lim
𝑐→0
(𝜂𝑠𝑝
𝑐
) 
Where c is concentration (g/cm3) and ηsp is specific viscosity.  Viscosity measurement 
were conducted on a mixed solution with possible free PAA chains as well as free CS 
chains, therefore viscosity measurements may have been reduced due to lower molecular 
weight species within the sample.  However, an increase in viscosity for reacted CS-PAA 
samples versus simply mixed CS-PAA samples, demonstrates the formation of larger 
molecular weight species within the solution.  Therefore, rheometric data in conjunction 
with fluorometric analysis of the primary amine chemical reaction further demonstrates 
the covalent conjugation of CS to the PAA backbone.   
Further modifications of the reaction medium as well as the CS:PAA ratio may 
aid in increasing grafting density.  The use of a reaction scheme that allows for longer 
reaction times may also aid in increasing brush density as fabrication of surface brushes 
has demonstrated various stages in brush formation before dense grafting can be achieved 
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(166, 171-173).  These studies demonstrate the feasibility of utilizing the CS primary 
amine in the “grafting-to” approach of brush synthesis; however other chemistries and 
strategies will need to be followed in order to synthesize brush structures with dense 
attachment of CS chains.  The estimated cost of the current “grafting-to” CS-PAA 
synthesis strategy is listed in Table 5.6. 
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Figure 5.30:  Grafting-through polymerization of vinyl terminated chondroitin sulfate 
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Figure 5.31:   Chain growth polymerization and propagation of the reactive center 
as polymerization proceeds (168) 
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(113, 118, 123, 125-126) 
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Table 5.6:  Estimated cost of CS-PAA macromolecule synthesis 
"Grafting-To" Synthesis 
Supplies 
Estimated Cost 
to Synthesize 
1g 
MES Buffer $3.12 
EDC/NHS $1.19 
PD-10 Desalting Column $8.10 
Chondroitin Sulfate $54.20 
Polyacrylic Acid $27.31 
Loss due to Purification Unknown 
Total Cost CS-PAA $93.92 
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The synthesis of a biomimetic aggrecan can have far reaching implications for 
restoring the mechanical function of load bearing tissues, such as the intervertebral disc.  
The modification and subsequent immobilization of CS at its terminal end is important 
for the fabrication of CS brush structures that mimic the bottle brush organization of 
proteoglycans such as aggrecan, where the bottle brush structure is critical for mechanical 
function.  In this work, we have presented a simple method for the end-functionalization 
of CS via a terminal primary amine.  Functionalization was achieved via three distinct 
chemistries and resulted in vinyl-CS macromonomers that may be used in the 
polymerization of CS into brush structures via the “grafting-through” technique.  CS was 
also attached to surfaces and polymeric backbones demonstrating its utility in the 
“grafting-to” method of synthesis.  From these studies, several pathways for the synthesis 
of biomimetic aggrecan can be envisioned as outlined in 
5.5.  Conclusion 
Figure 5.32.  Although the 
“grafting-to” technique of biomimetic aggrecan via caroboxylic acid-amine reactions was 
demonstrated to be feasible in these studies, low conjugation and low grafting density 
was associated with this technique.  The epoxide reaction chemistry investigated here 
resulted in high degrees of conjugation, was demonstrated to be specific to the terminal 
primary amine and can react over a long period of time.  These characteristics make the 
epoxide-amine reaction chemistry promising for the synthesis of biomimetic aggrecan via 
both the “grafting-to” and “grafting-through” techniques of brush synthesis.  In addition, 
the epoxide-amine reaction is unique in that it can be utilized in a step-growth synthesis 
strategy for “grafting-through” polymerization.   
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Figure 5.32:  Flow chart of pathways to biomimetic aggrecan based on covalent binding 
chemistries investigated in this study.  
(Red) Pathways not recommended for further investigation.  (Yellow) Pathways with some 
limitations, recommendations have been made for further investigation.  (Green) Pathways that 
will be investigated further 
 
 
 
154 
 
 
Chapter 6 :  Investigation of the Epoxide-CS Primary Amine Reaction for the 
Synthesis of CS Brush Structures via the “Grafting-Through” Technique 
 
Degeneration of the intervertebral disc is characterized by the loss of 
proteoglycans (PGs), especially aggrecan, in the central nucleus pulposus region of the 
disc.  Aggrecan is a large proteoglycan (PG) found in load bearing tissues.  It is 
composed of a protein core to which chondroitin sulfate (CS) is covalently bound in a 
very dense array (2-4nm spacing).  Charged anionic groups on the CS chains draw water 
into the intervertebral disc and electrostatic repulsions generated between closely packed 
GAG chains resist deformation thereby allowing the tissue to distribute mechanical 
forces(7, 69).  Aggrecan degeneration is mediated enzymatically through cleavage of the 
core protein and leads to numerous degenerative conditions such as arthritis and 
intervertebral disc degeneration (22).  The goal of this project is to develop an 
enzymatically resistant biomimetic replacement for the large PG aggrecan by replacing 
the core protein with a synthetic polymer, while maintaining the biologically active CS 
bristles.   
6.1 Introduction 
To mimic the bottle brush structure of native aggrecan, we have utilized a 
terminal primary amine on CS to selectively immobilize CS by its terminal end.  The CS 
terminal primary amine was investigated previously for reactivity to several functional 
groups including aldehydes, carboxylic acids and epoxides.  The epoxide-amine reaction 
was chosen for further investigation due to its higher reactivity to the CS amine as well as 
its relatively long window of reactivity.  In addition, the reaction of epoxides to amines 
does not require any specific activation.  Simple base catalysis was utilized in the 
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epoxide-amine reaction and the reaction generates no reaction bi-products(174) .  A 
unique property of the epoxy-amine reaction is the ability of epoxides to react to both 
primary amines and the generated secondary amine (174-175).  Epoxides and amines can 
therefore be utilized in step-growth type polymerization.  In the case of a di-epoxide and 
a primary amine, step-growth polymerization will result in linear polymers (176).  
 
6.2.1. Epoxide Reactivity 
6.2.  Background 
Epoxide groups are very reactive due to the strain induced by the bond angles of 
the epoxide ring (Figure 6.1).  The strain energy has been found to be 13kcal/mole for the 
epoxide ring.  Almost all reactions in solution involve opening of the epoxide ring by a 
nucleophile and addition of the molecule.  In the general case of the reaction two 
products are possible (Figure 6.2).  Products resulting from group addition to the carbon 
atom with the greater number of free hydrogen atoms are considered normal (Figure 6.2, 
XVI) while, products in which group addition occurs at the oxygen atom are considered 
abnormal (Figure 6.2, XVII) (159).  Under basic or neutral conditions, the normal isomer 
is usually the major or only product while in acidic conditions, the abnormal product 
becomes more likely (159).  For the purposes of our studies we will assume that reaction 
products consist only of the normal isomer since reactions are conducted in basic 
conditions.   
Epoxides are fairly stable at neutral pH or above but can hydrolyze to a diol at 
acid pH(149, 177).  Epoxides are reactive to many functional groups including amines, 
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hydroxyls, carboxylic acids, phenols, mercaptans and isocyanates(149, 178-179).   
Epoxide reaction with hydroxyls (R—OH) requires high pH conditions, typically in the 
pH range of 11-12 resulting in the creation of an ether bond (149).  Amine nucleophiles 
(R—NH2) react at more moderate alkaline pH values around pH 9.0 to result in 
secondary amine bonds (149).  Sulfyhryls (R—SH) are highly reactive with epoxides at a 
more physiological pH range of 7.5-8.5 and result in thioether bonds(149).  In general, 
epoxide reactivity to nucleophiles follows the trend of increasing basicity for example, 
alcohol > phenol > acid (178) and are most reactive to nucleophiles when base catalyzed 
(174, 178, 180).  When reacting epoxides with the terminal primary amine of CS it is 
important to reduce possible side reactions with other possible nucleophiles of CS, most 
notably the hydroxyls and carboxylic acids of the CS disaccharide.  Therefore, pH was 
controlled for all reactions at pH 9.4 in a sodium borate buffer.   
6.2.2. The Epoxide-Amine Reaction 
The addition of amines and other nucleophiles to epoxides generally requires 
some degree of catalysis by species capable of hydrogen bonding, for example, hydroxyls 
in the solvent, other primary amines, and hydroxyl groups produced in the addition 
reaction (180-181).  Preformed hydrogen-bonded complexes between epoxides and, for 
example, hydroxyls, react with amine groups to form a transition state as seen in Figure 
6.3.  These intermediary transition complexes, formed by hydrogen bonding, help to 
accelerate the rate of the epoxide-amine reaction.   
In a system of epoxides and amines, several reactions can take place as illustrated 
in Figure 6.4.  Primary amines react with the epoxide ring to create a β-hydroxyl group 
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while the amine molecule adds to the epoxide forming a secondary amine linkage.  The 
secondary amine can then be further reacted with additional epoxide to form a tertiary 
amine linkage.  The formed hydroxyl as well as other hydroxyls in the system are 
reactive to the epoxide in a reaction called etherification, however this reaction is much 
slower than the amine addition reactions and the β-hydroxyl formed can actually catalyze 
the amine reaction further, allowing for autocatalyzation of the reaction.  
The addition reaction of secondary amines and epoxides occurs by the same 
mechanism as those seen for the primary amine reaction, however the secondary amine is 
more sterically hindered.  This results in a negative substitution effect on the reactivity of 
the amino hydrogen in secondary amines as compared to the amino hydrogens of the 
primary amine(182).  In the general case, the rate of reaction of an epoxide group with an 
amino hydrogen is slower when substitution on the nitrogen has already occurred.  The 
degree to which the secondary amine reaction is slower than the primary amine has 
showed varied results as it is a difficult properly to measure.  The substitution effect is 
described by the ratio of the rate constant for secondary amine (k2) and primary amine 
(k1) reactions with epoxides, (k2/k1).  The (k2/k1) has been seen to range from 0.1 up to 
approximately 1.1, and therefore some controversy exists as to the magnitude of the 
negative substitution effect (180, 182).  In addition the electrophilicity of the amine 
molecules may have an effect on primary and secondary amine reactions modulating the 
negative substitution effect (183).  This effect however is very important in epoxy-amine 
linear polymerization  and cure systems as the rate of polymerization and structure of 
cross-linked networks will vary greatly depending on the degree of the negative 
substitution effect (180).   
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The kinetic relationship between epoxide reactions with primary and secondary 
amines is illustrated in the example kinetic curves seen in Figure 6.5 (174).  As 
demonstrated, primary amines must first react with epoxides to generate a population of 
secondary amines.  Tertiary amines may form immediately, however the negative 
substitution effect may reduce the rate of this reaction.  Primary amines begin to react 
with epoxides immediately, resulting in a buildup of secondary amines and a reduction in 
the epoxide and primary amine populations.  The tertiary amine population increases 
slowly, and then more quickly as more secondary amines are available for reaction.   This 
kinetic study suggests that there is not necessarily a step wise reaction that requires the 
reaction of epoxides with all of the primary amines in the reaction before secondary 
amines can react to form tertiary amines (174).  These studies demonstrate the relative 
kinetics of the epoxy primary and secondary amine reactions however, they were 
conducted in bulk and on a particular epoxy-amine system so results may not be fully 
transferable to solvent systems and other epoxy-amine reactions.    
 
6.2.3. Step-growth polymerization of epoxides and amines 
The reactivity of epoxides to both protons of the primary amines lends the epoxy-
amine system to use in step growth polymerization.  Step-growth polymerization 
proceeds via a step-by-step series of reactions between reactive sites.  Each step utilizes 
two co-reacting sites and generates a new covalent bond between the pair of functional 
groups.   Step-growth polymerization is a widely used commercial polymer synthesis 
technique and today makes up a multi-billion dollar industry (184).  The work of 
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Carothers and his group at DuPont pioneered this technique in the 1950’s and 60’s with 
the synthesis of materials such as nylon 6,6 and Poly(ethylene terephthalate) (PET) via 
step-growth polymerization (184).   
In the case of the epoxy-amine reaction, an epoxide group reacts with an amine 
proton to create an amine covalent bond and at each step one epoxide and one proton is 
used(175).  The number of reactive sites per monomer (referred to as, functionality) and 
the molar ratio between co-reactive sites are the main factors that control polymer 
structure.  In order to obtain linear polymers, both monomers must be bifunctional (175).  
In the case of epoxy-amine reactions, a di-epoxide which has two epoxide functionalities 
can be reacted with a single primary amine, which has two reactive hydrogen protons, in 
order to generate linear polymers.  For example, linear poly(aniline) has been synthesized 
via the step-growth reaction of diglycidyl ether of bisphenol A (DGEBA) and aniline 
(185).   
In linear step-growth polymerization, the molar mass of the product grows 
gradually, and the polydispersity tends to 2 which represents 100% of monomer 
conversion (175).  Functional groups react to form dimmers, trimers, etc. and very high 
molecular weight products do not appear until the end of the reaction (Figure 6.6).  Step 
growth polymerization is advantageous in a system which incorporates biomolecules 
since it can be conducted in aqueous solutions and does not require initiation and 
propagation of a free-radical.  Free radical propagation in chain growth polymerization 
can be interrupted by other reactive groups in the biomolecule and often requires non-
aqueous reaction conditions.  Chondroitin sulfate, which is primarily soluble in water has 
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limited utility in chain growth polymerization, although some systems (i.e. APS/TMEDA 
mediated polymerization) may be explored.   
Some general considerations for step growth polymerization are that high % 
conversions and long reaction times are necessary in order to achieve high molecular 
weight polymers as demonstrated in Figure 6.6.  In addition side reactions must be 
avoided to avoid branching as well as chain termination (184).  Generally a 1:1 molar 
ratio of reactant functionalities is required for the synthesis of high molecular weight 
polymers, however reactions can proceed even in an excess of one functionality (184, 
186).  Miller et al found that step-growth polymerization of a di-functionalized peptide 
biomolecule and di-functionalized polyethylene glycol monomer in excess of PEG 
resulted in % conversions of only 80% but 40% of the resulting polymer population had a 
MW of 500kDa, a reaction of approximately 100 monomers (186).  These properties of 
step-growth polymerization make it a promising option for use with biomolecules and 
step-growth polymerization was therefore further investigated for synthesizing 
biomimetic chondroitin sulfate brushes. 
 
6.2.4. Step-growth polymerization of CS macromolecules with PEG-DGE 
In the previous study (Chapter 5), a primary amine at the terminal end of CS was 
identified for commercially available CS (CS-4, Sigma C6737).  The epoxide amine 
reaction was demonstrated to reach the highest degree of primary amine conjugation in 
comparison to both aldehyde-amine and carboxylic-acid amine reactions.  In the current 
study, the epoxide-amine reaction was studied further for its utility in the linear step 
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growth polymerization of biomimetic CS-macromolecules using di-epoxide 
poly(ethylene glycol) (Figure 6.7).  CS was reacted with poly(ethylene glycol)-diglycidyl 
ether, and the reaction kinetics investigated.  Products were purified and analyzed for 
molecular weight and chemical structure.    
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Figure 6.1:  Bond lengths and angles in ethylene oxide (the epoxide ring)  
(159) 
 
 
 
 
 
 
Figure 6.2:  Nucleophile addition to an epoxide ring results in two possible products 
normal, XVI and abnormal, XVII (159) 
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Figure 6.3:  Hydrogen bonding in the catalysis of the epoxy-amine reaction  
(180) 
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Figure 6.4:  Possible reactions in an epoxy-amine system.  
(174) 
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Figure 6.5:  Example reaction kinetics of an epoxide amine system 
(equivalent amounts of n-butyl-amine and phenyl glycidyl ether at 50C̊) (174) 
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Figure 6.6:  % Conversion vs molecular weight for typical step-growth polymerization reactions 
(187) 
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Figure 6.7:  Schemiatic of linear step-growth polymerization of amine terminated CS 
using the epoxy-amine reaction. 
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6.3 Methods 
6.3.1. Reaction of CS to PEG based di-epoxides 
 In order to achieve linear polymerization of primary amine terminated CS, CS 
was reacted with several molecular weights of poly(ethylene glycol)-diglycidyl ether 
(PEG-DGE) (Table 6.1) where each diglycidyl ether has two epoxide functionalities.  
PEG based di-epoxides were choosen due to the biocompatibility and hydrophilic nature 
of PEG (188).   In a general synthesis procedure CS was reconstituted from a lyophilized 
state into 0.1M SBB, pH 9.4 at 25mg/mL (1.13mM).  Samples were reacted in 10ml 
volumes in 15ml centrifuge tubes.  The solution was mixed thoroughly via vortex mixing 
to ensure a homogeneous solution.  DGE was then added to the CS solution at a 
particular molar concentration (i.e. 10, 20, 40 100, or 200mM).  The solutions were then 
mixed thoroughly and placed into a water bath (25̊C, 37̊C, or 45̊C) with continuous 
shaking for 96hrs.  Samples were assayed over the reaction period for reaction of the CS 
primary amine using the fluorescamine assay described previously in Chapter 5.  
Reaction rates of the CS primary amine reaction were determined by fitting a one-phase 
association curve to % conjugation data (n >= 4 for each data point) obtained over the 
96hr reaction period.  The GraphPad Prism 5 data analysis software package was utilized 
for curve fitting and data analysis. 
 
6.3.2. Purification of the CS-DGE reaction 
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Un-reacted DGE monomers were removed from the reaction by extensive 
dialysis.  Reaction samples in 20ml volumes were loaded into 6-8K MWCO regenerated 
cellulose dialysis membranes (40mm flat width, 28cm length, pre-wetted in distilled 
deionized (DI) water for 30min).  Dialysis was conducted over 96hrs against 1.65L of DI 
water with daily water changes.  Purified samples are then lyophilized, resulting in a 
white cotton-like powder.  Typical yield from a 20mL reaction is approximately 100mg.   
 
6.3.3. Characterization of CS-macromolecule chemical structure 
Purification and chemical structure of the CS-macromolecules were confirmed via 
1H-NMR (300Mhz UnityInova NMR Spectrometer).  Samples were prepared at 30mg/ml 
in D2O and scanned at ambient temperature.  Scans were taken at a spin of 20 and a 
number of transients of 64.  The ACD/NMR Processor (Academic edition) was used in 
order to analyze peak locations and integrated areas.  Example 1H-NMR spectra for raw 
materials PEG-DGE and chondroitin-4-sulfate are presented in Figure 6.8.  Spectral 
assignments for PEG-DGE were predicted using a NMR-predictor (189) and found to be 
in agreement with previously published NMR assignments for polyethylene glycols and 
epoxides (190).  CS spectral assignments were established based on several previously 
published chondroitin sulfate 1H-NMR studies and are in good agreement with the 
current spectra (152-153, 155, 191-195).   Purified, lyophilized samples were also 
investigated with attenuated total reflectance-fourier transform infrared spectroscopy 
(ATR-FTIR) in order to monitor changes in the chondroitin sulfate chemical signature 
after conjugation with PEG-based diglycidyl ethers.  Scans were taken at number of scans 
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64 and analyzed with Omnic 8.1.11 software (ThermoFischer Scientific).  Example ATR-
FTIR spectra for raw materials chondroitin-4-sulfate and PEG-DGE are presented along 
with spectral assignments in Figure 6.9.  FITR spectra of PEG-DGE have bands that 
correspond both to PEG (196) and epoxide moieties (197) in the mid-IR range.  
Chondroitin sulfate bands corresponding to sulfate, amide, sugar and hydroxyl groups of 
CS have been previously identified and are in good agreement with the current spectra 
(154-157).  Primary amine bands (two bands from 3400-3300 and 3330-3250 cm-1) (198) 
corresponding to the terminal primary amine of CS could not be distinguished in the CS 
spectra due to a broad OH peak between 3600 and 2900cm-1. 
 
6.3.3. Gel Permeation Chromatography of CS-Macromolecules 
Size exclusion chromatography (SEC) is a powerful and important technique for 
characterizing macromolecules.  SEC is a form of liquid chromatographic separation of 
macromolecules where separation is based on molecular size.  Gel permeation 
chromatography (GPC) is a form of SEC and is often taken synonymously with SEC.  
The term “gel” refers to the use of a non-rigid or semiriid organic gel stationary phase.  
The purpose of SEC is to provide molecular weight distributions (MWD) for polymeric 
materials.  Although SEC is based on molecular size it relates to molecular weight 
information by the relationship between linear dimension and molecular weight in a 
freely jointed polymeric chain (random coli).  The root mean square end-to-end distance 
or the radius of gyration is proportional to the square root of the molecular weight, and 
therefore the log of either distance is proportional to ½ the log of the molecular weight. 
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The GPC technique is comprised of four major components, the sample, a 
stationary phase (gel packing material), a liquid mobile phase and a detector.  The 
stationary phase of the GPC column consists of porous particles with controlled pore size.  
This pore size determines the range of molecular weights that can be separated within the 
column.  In a typical experiment, the sample, contained in the liquid mobile phase is 
injected into the column and the mobile phase passes through the column at a fixed flow 
rate, developing a pressure gradient across the length of the column  (Figure 6.10) (199-
200).  The sample polymer molecules pass into the column as a result of the pressure 
gradient.  The smaller macromolecules are able to penetrate the pores of the stationary 
phase as they pass through the column, lengthening their path through the column and 
thus slowing their elution from the column.  Larger macromolecules are too large to be 
accommodated in the stationary phase pores and remain in the interstitial space, giving 
them a minimal path through the stationary matrix resulting in earlier elution from the 
column.  A detector placed at the end of the column responds to the elution of the 
macromolecules in the mobile phase by generating a signal (peak) fir each group of 
macromolecules that passes through generating a chromatogram (Figure 6.10).  The 
differently sized macromolecules elute from the column at different times changing the 
appearance of the chromatographic bands.  Typically, the chromatogram shows a 
continuum of molecular weight components that are not resolved within the single peak, 
however shifts in the peak and changes in peak shape give rise to different forms of 
molecular weight determinations (199-200).   
Several parameters of the GPC method must be determined to ensure proper 
chromoatographic conditions (Table 6.2).  Since SEC is a non-interaction separation 
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mechanism based on the separation of macromolecules by size factors, therefore, any 
mechanism that interferes with a purely size based separation is undesirable.  For 
example, sample interactions with the column, sample aggregation, shape and charge 
interactions can all interfere with the size exclusion mechanism, introducing error into the 
molecular weight distribution determination.  Parameters that must be considered include 
mobile phase composition, stationary phase chemistry, column porosity, flow rate, 
dissolution conditions, temperature, sample stability, samples concentration, sample 
geometry standard selection and detection method (200-201).  In addition to 
consideration s that need to be made for the CS chemistry and structure, an added 
complexity is introduced with the incorporation of an un-charged synthetic polymeric 
component.   
Hybrid materials (i.e. copolymers) and branched polymers present increased 
complication in SEC analysis (200).  Copolymers are characterized by chemical 
composition distribution that is represented by the mass fraction of molecules of a given 
copolymer composition vs. the copolymer composition.  Average composition changes 
along the polymerization process and also possibly with hydrodynamic volume.  Since 
macromolecules in SEC are fractionated according to hydrodynamic volume rather than 
molar mass, copolymer composition can have distorted molecular weight distributions 
(200).  For homopolymers, instantaneous mass is proportional to the differential 
refractometer (DR) signal.  With copolymers, the specific refractive index increment 
depends on the instantaneous composition which may change with hydrodynamic 
volume; therefore the instantaneous MWD is not monodisperse.  The variability in molar 
masses in the detector when a complex polymer is analyzed introduces bias in the MWD 
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(200).  Differential refractometers results are therefore only an estimate for MWD and are 
often combined with other detection methods.  MWD bias is further magnified when 
resolution is poor.  Imperfect resolution can occur from a non-exclusion (secondary) 
fractionation caused by differential column and solvent interactions of the different 
polymers of the copolymer system.  Non-exclusion effects may shift and distort the 
chromatograms, resulting in both positive and negative molecular weight deviations 
(200).  Overall, linear copolymers are more simple for MWD determination than 
branched copolymers.  Branched copolymers of a given molar mass and composition 
have smaller hydrodynamic volume than its linear analogue and volume reduction is 
more apparent with increasing in branching and again changes in hydrodynamic volume 
interrupt the SEC process (200).  A difficulty also arises when determining an appropriate 
MW standard for copolymers, and therefore triple detection SEC (DR, intrinsic viscosity 
and light scattering) is often used to characterize copolymer and branched systems 
without using molecular weight calibrations.  Certain copolymer conditions have been 
identified for the proper determination of MWD with SEC: (1) instantaneous 
distributions of the molecular weights and of the chemical compositions are both narrow 
and (2) the instantaneous average composition varies monotonically with the molecular 
weight (200).  For branched polymers it is important also that the average number of 
branches per molecules increases monotonically with the molar mass and that the average 
composition does not change with molar mass (200).  These conditions are often difficult 
to meet, especially for hybrid bottle brush type polymers, therefore, viscometric and 
imaging techniques (i.e. atomic force microscopy, transmission electron microscopy) are 
often looked to provide structural characterization of these materials (106).   
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The conformation and charges associated with CS and the large size and 
aggregation of PGs introduces complexity into the separation of these molecules (202) 
however several solvent/medium/column systems have been investigated for their 
separation and may be amenable to the separation of the synthesized CS-macromolecules.  
Proteoglycans have been separated in HPLC using the ProPac PA1 anion-exhange 
column using 8M urea as the solid phase in order to dissociate aggregated PGs (203).  
GAG separation and MW calculation has been accomplished using Na2SO4-NaH2PO4, 
pH 6 as the mobile phase and Protein Pak 125 and 300 columns (Waters) in an HPLC 
system (202).  Generally protein standards of varying known molecular mass (670,000 to 
24,000) are used to calibrate SEC of proteoglycans, however they have been 
demonstrated to have skewed results due to the different chemical and structural nature of 
proteins (202-203). 
Given these intricacies of GPC analysis and the complications associated with 
proteoglycan, copolymer, and brush polymer SEC, an analytical techniques contract lab 
was contacted for GPC method development.  Method development for GPC was 
conducted by Jordi Labs (Bellingham, Massachusetts).  Jordi labs is a contract analytical 
services laboratory which also manufactures and distributes its own custom built products 
and columns for GPC.  Jordi labs provides specialized analytical testing of polymers as 
well as method development and was contracted for method development for the GPC 
analysis of three formulations of CS-macromolecules (PAA based, EG-based and PEG-
based CS macromolecules).  Although GPC was attempted on-site at Drexel University, 
difficulties were encountered with CS-macromolecule aggregation and identification of 
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appropriate standards in typical size exclusion columns (Sephacryl 300, molecular weight 
range of 10 to 1500kDa). 
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Figure 6.8:  PEG-DGE (top) and Chondroitin-4-sulfate (bottom) 300MHz 1H-NMR spectra  
with peak assignments (189-190, 193).  See Appendix 2 for alternate view of CS structure. 
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Figure 6.10:  Schemiatic description of the time course and mechanism of size exclusion 
chromatography (199) 
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Table 6.1:  Poly(ethylene glycol)-diglycodyl ethers of varying molecular weight 
 
  
Di-glycidyl Ether  
Molecular 
Weight  
(g/mole)  
Mean Square End-to-End 
Distance  
(Freely-Rotating Chains Model)  
Ethylene Glycol- Diglycidyl Ether  
(EG-DGE)  174.2  0.5nm  
Poly(ethylene glycol)-Diglycidyl-Ether  
(PEG-DGE)  526  5nm  
Poly(ethylene glycol)(1000)-Diglycidyl Ether  
(PEG(1K)-DGE)  1000  12.5nm  
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Table 6.2:  Factors involved in GPC and Key Considerations (201) 
 
Primary factors in GPC Implications and Concepts to Consider 
Mobile Phase Composition Should be a strong Solvent for the polymer being analyzed and Solvent must have 
greater affinity for solvent than stationary phase. 
Column Chemistry Should promote strong interactions between solvent and column and reduce 
interactions between column and sample 
Column Porosity Must cover complete MW range of the sample 
Flow Rate Can be varied over a narrow range without adversely affecting calculated MW. Typical 
flow rates range from 0.5-1.5ml/min. 
Dissolution Conditions 
Conditions used to dissolve sample must avoid sample degradation and aggregation 
Temperature Increasing temperature can prevent column sample interactions and result in improved 
separation.  Solvent viscosity also decreases with temperature reducing back pressure.   
Sample Stability All conditions must be managed to avoid shear degradation, hydrolytic degradation and 
thermal degradation.  In addition, Sample aggregation and crosslinking can increase MW 
overtime and must be avoided. 
Sample Concentration Column overloading can result in degraded resolutions and introduce significant error in 
MW calculations. Typical concentrations range from 0.1-4mg/ml for random coil 
polymers less than 800,000MW to 0.1-0.5mg/ml for high MW polymers while oligomers 
and monomers can be analyzed at higher concentrations. Generally lowest 
concentration should be used 
Sample Geometry/ 
Standard Selection 
Polymeric molecules may adopt a range of conformations including random coil, rigid 
rods, or spheres which can alter the way a polymer travels through a column.   
Standards chosen will ideally have the same chemistry as the sample, but in the case 
similar chemistry is not available, best standards will have the same geometry of the 
sample.   
Detection Method Many universal concentration detection methods are available including the differential 
refractive index detector (DRI) and UV/IR detectors.  A second/third molecular weight 
sensitive detector (triple detection)can be added to the SEC system providing direct 
means of absolute MW determination without external standards  (i.e. Low angle/multi-
angle/right-angle laser light scattering detection, and viscometric detection) 
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6.4.1. Influence of temperature, DGE concentration and DGE molecular weight on CS 
amine-DGE reaction kinetics 
6.4 Results 
CS was reacted to di-epoxides over 96hrs and monitored for primary amine 
content in order to follow the reaction of the CS primary amine with the epoxides.  The 
reaction of CS primary amines to epoxides progressed with time and was modulated by 
both temperature and di-epoxide concentration (Figure 6.11 and Figure 6.12).  One-phase 
association curves were fit to the % conjugation versus reaction time plots.  For PEG-
DGE reactions to CS at 10mM and 20mM DGE concentrations, one-phase association 
were a poor fit for the data at 21̊C (R2 = 0.339 and 0.674 respectively).  This may be due 
to lack of data at longer time points which would be required to fit one-phase association 
curves with slower reaction rates.  At higher reaction temperatures however, the one-
phase association curve fit is more accurate for all DGE concentrations investigated.  
Reaction rate was increased from 0.032/h to 0.057/h at a 10mM PEG-DGE concentration, 
and from 0.056/h to 0.093/h at 20mM PEG DGE concentration.  Reactions conducted 
with 100mM PEG-DGE resulted in relatively fast reaction rates at all temperatures (K = 
0.093/h and K = 0.155/h respectively) with reactions at 45̊C proceeding too quickly to 
determine reaction rate in the time frame investigated.  In addition increased reaction rate 
at the higher temperatures and PEG-DGE concentrations investigated, the predicted % 
Conjugation plateaus were also higher at higher reaction temperatures and DGE 
concentrations (Figure 6.11).  Highest Amine reaction plateaus were predicted to be 81%, 
92% and 99% for 10mM 45̊C, 20mM 45̊C, and 100mM 37̊C PEG-DGE-CS reactions 
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respectively.  Similar trends were seen for EG-DGE-CS reactions conducted at 20mM, 
40mM, and 200mM EG-DGE concentrations where an increase in temperature increased 
reaction rate as did an increase in EG-DGE concentration (Figure 6.12). 
Due to the higher % Conjugations of CS primary amines achievable at 45̊C 
compared to 21̊C and 37̊C as demonstrated by higher predicted plateau % conjugations, 
the 45̊C reaction was investigated further.  Three different DGE backbone monomers of 
varying molecular weight and epoxide spacing were investigated (Table 6.1) for their 
reaction to CS at 45̊C and varying DGE concentrations.  Reactions at 1mM DGE 
concentration (~ 1:1 CS:DGE ratio) did not progress greatly with time and one-phase 
association curves were a poor fit (Figure 6.13).  At higher DGE concentrations, reactions 
for EG- and PEG-DGE MWs progressed with time and were better fits to the one-phase 
association relationship (R2 > 0.9) while PEG(1K)-DGE reactions appeared to react too 
quickly to be fit to a one-phase association in the time frame investigated.  PEG(1K)-
DGE reactions for concentrations at 10mM or above likely have reaction rates faster than 
0.88/h, and Tau of 1.13h.  Experimental limitations for collecting reaction data earlier 
than 2h, make it difficult to accurately predict one-phase association curves for reactions 
occurring with a time constant in the range of PEG(1K)-DGE.  Reactions progressed 
significantly faster for PEG(1K)-DGE reactions compared to EG-DGE and PEG-DGE 
reactions (Table 6.3 A) however, reaction plateaus were similar at 20mM and 100mM 
DGE reactions reaching between 86.69%-89.07% and 96.82%-97.18% conjugation 
respectively (Table 6.3 B).  At 10mM reactions however, EG-DGE reactions had 
comparatively lower % conjugation plateau values as well as reaction rates. (Table 6.3).  
183 
 
 
% Conjugation rate as well as plateau increases with increasing temperature, DGE 
concentration as well as DGE MW (PEG(1K)-DGE > PEG-DGE > EG-DGE). 
 
6.4.2. Purification of CS-macromolecules 
CS and DGE reaction solutions were purified via extensive dialysis against DI 
water.  The dialysis process for PEG-DGE and EG-DGE synthesis was monitored daily 
via 1H-NMR analysis in order to validate the sample purification process (Figure 6.14 and 
Figure 6.16).  MWCO for dialysis bags was between 6000-8000 MW.  Since CS is 
approximately 22,000MW, both CS and synthesized CS macromolecules (PEG-CS, EG-
CS, and PEG(1K)-CS will remain within the sample.  DGE monomers on the other hand 
are much smaller in MW, ranging from ~172 to ~1000 Da.  These DGE monomers can 
pass easily across the chosen membranes and therefore be purified out of the sample.   
For both samples, distinct contributions from the DGE monomer could be seen in 
raw samples (0h of dialysis).  Strong ethylene glycol peaks were resolved at 3.6ppm as 
well as epoxide peaks at 2.9 and 7.7ppm.  CS peaks were also resolved, however, several 
CS peaks were distorted by contaminants seen in the spectra for the PEG-DGE raw 
material (Figure 6.8).  With dialysis, however, CS peaks became better resolved and 
peaks corresponding to the DGE monomers were reduced.  For both DGE monomers, 
epoxide peaks were still present after 24h of dialysis (Figure 6.15 and Figure 6.17) as well 
as some residual contaminant peaks in the 3ppm peak region.  After 48hrs of dialysis, 
PEG-CS and EG-CS 1H-NMR spectra closely resemble that of natural CS, with the 
exception of the incorporation of a distinct ethylene glycol peak at 3.66ppm in the PEG-
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DGE spectrum.  For the EG-DGE sample, only a small change is seen in the spectra in 
the 3.66ppm region, however no distinct peak is present.  Both EG-CS and PEG-CS 
samples were completely purified of un-reacted DGE monomer by 48h of dialysis as 
evidenced by loss of the epoxide peaks, loss of peaks corresponding to DGE monomer 
contaminant, as well as reduction in the ethylene glycol peaks.  After an additional 24h of 
dialysis (72h total), minimal changes to the spectra are seen indicating that additional 
dialysis time is not required for PEG-CS and EG-CS, however, it is important to note that 
additional dialysis does not damage the CS macromolecules.  PEG(1K)-CS was dialyzed 
according to similar procedures and investigated with 1H-NMR after 48h Figure 6.18.  
After 48h of dialysis, small residual epoxide peaks are present in the PEG(1K)-CS 
spectra.  The larger size PEG(1K)-DGE monomer may require more than 48h of 
membrane dialysis for full purification, all samples will therefore be dialyzed for at least 
72h in order to ensure complete purification of unreacted DGE monomer.         
 
6.4.3. 1H-NMR and ATR-FTIR analysis of CS-Macromolecule chemical structure 
Synthesis of PEG-CS and EG-CS were monitored using 1H-NMR over the 96h 
reaction time.  Samples were prepared at 20mM DGE concentrations as previously 
described, and extensively dialyzed after 24, 48, 72, and 96h of reaction, lyophilized, 
then investigated with 1H-NMR (Figure 6.19 and Figure 6.20).  In both EG-CS and PEG-
CS synthesis, peaks corresponding to CS were distinctly maintained.  For PEG-CS 
samples, progressive increase in the 3.66ppm peak height can be seen indicating 
increased addition of PEG into the PEG-CS samples with time (Figure 6.19).   For EG-CS 
185 
 
 
samples a distinct ethylene glycol peak was not resolved, this may be due to the relatively 
small ethylene glycol sequence in the EG-DGE monomer.  It is still likely that EG-DGE 
was incorporated into the EG-CS samples, as evidenced by small spectral change in this 
region and fluorescamine reaction kinetics data which indicates strong reaction of the CS 
primary amine with EG-DGE.  In order to better assess the changes to the CS molecule 
with the incorporation of PEG-DGE and EG-DGE, 1H-NMR peak integrated areas were 
determined for key peaks corresponding to CS (Figure 6.21).  For PEG-CS samples, 
minimal change was seen in integrated area of peaks corresponding to the GalNAc H1, 
GalNAc H2 and H3, and GlcUA H2 protons over the 96h reaction time.  A small increase 
is seen in the GlcUA H3 proton integrated area.  Interestingly, a progressive increase in 
the GlcUA H4,5 and GalNAc H5 and H6 regions is seen over the reaction time, this peak 
region is also the region which contains the polyethylene glycol peak centered at 
3.66ppm.  The successive increase of this peak region likely indicates addition of PEG 
onto CS over the reaction time.  EG-CS samples showed larger variability in peak 
integrated areas for all peaks over the 96h reaction time.  The peak region containing the 
3.66 ethylene glycol signal did not show a progressive increase in integrated area, likely 
due to the relatively small portion of ethylene glycol in the EG-DGE monomer.  For both 
PEG-DGE and EG-DGE all peaks showed slight fluctuations in integrated area with 
reaction time, however, the only progressive trend with reaction time is seen with the 
3.86-4.05 peak region of PEG-DGE.   
Final formulations of EG-CS, PEG-CS and PEG(1K)-CS synthesized with 20mM 
DGE concentration were investigated for their chemical composition via 1H-NMR (Figure 
6.22 and Figure 6.23)and ATR-FTIR (Figure 6.24) after purification.  1H-NMR Peaks 
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corresponding to an ethylene glycol component are evident in both PEG-CS and 
PEG(1K)-CS samples while all CS peaks are maintained (Figure 6.22).  Integration of 1H-
NMR peak areas corresponding to CS protons demonstrates maintenance of the major CS 
protons and relative consistency in peak integrated areas for all formulations except in the 
3.86 to 4.05 peak region.  Peak integrated area in this peak region increases with 
increasing DGE MW, likely due to the distinct ethylene glycol peak centered at 3.66 that 
occurs in this region.  ATR-FTIR spectra for EG-CS, PEG-CS and PEG(1K)-CS 
macromolecules were consistent with that of natural CS (Figure 6.24).  No strong peaks 
corresponding to the EG-DGE, PEG-DGE or PEG(1K)-DGE monomers were detected, 
however a change in peak shape is seen for the CS Amide I band.  Of note, is the lack of 
change in the ATR-FTIR peak centered at 1032cm-1 which arises from the C-O stretching 
mode in CS.  Spectral shifts in this region would be expected to occur with changes to the 
hydroxyl group orientations in CS (156), and therefore, a lack of change in this spectral 
region indicates preservation of the CS hydroxyl groups in EG-CS, PEG-CS and 
PEG(1K)-CS samples .   
6.4.4. Molecular weight characterization of CS-macromolecules 
Gel permeation chromatography (GPC) was conducted by Jordi Labs, a contract 
laboratory specializing in liquid chromatography.  Several attempts were made in order to 
determine the molecular weights of CS-macromolecules synthesized with varying 
synthetic backbones.  The chosen column for GPC size exclusion chromatography was 
the JORDI DVB Sulfonated Mixed Bed column, 250mm x 10mm (ID) (204).  This 
column is base on polymerized divinylbenzene packing material and is utilized in the 
separation of water soluble polymers due to hydrophilic group association to the DVB 
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backbone (204).  A sulfonated column was chosen because sulfonated columns have a 
negatively charged surface which can separate water soluble polymers with negatively 
charged surfaces, for example, organic acids, polysaccharides, starches, cellulose and in 
our case chondroitin sulfate.  Sulfonated columns also allow for the separation of 
negatively charged polymers without the need for high salt concentrations (typical 
solvents for this phases include aqueous/organic mixtures such as water/methanol) 
making them especially useful in light scattering analysis where high salt concentrations 
can compromise the system (204).  A mixed bed column was chosen because the sample 
molecular weight was unknown, and may have had a broad molecular weight 
distribution, which is better detected by the molecular weight range of the mixed bed 
column (10,000 – 700,000) (204).    
A mobile phase of  85/10/5/0.1% Water/Acetonitrile/Isopropyl 
alcohol/Phosphoric acid was chosen for CS and the CS-macrmolecules based on 
solubility and column compatibility.  In addition, sample preparation included filtration 
through a 0.20μm disposable Nylon filters in order to remove debris and aggregates.  
Concentrations ranging from 2.0 – 6.7 mg/ml (Table 6.4) were used for sample loading 
and a system flow rate of 1.2 ml/min was found to be ideal.  Injection size varied from 50 
to 200μL for the different sample solutions ( Table 6.4).  The column temperature was 
maintained at 35° C in order to aid in reducing secondary column associations.  Protein 
standards were not compatible with the chosen column type, polysaccharide standards 
were therefore used as a first attempt in MWD characterization.  Polysaccharide 
standards with a concentration of 1.0 mg/ml were used with the following molecular 
weights: 710K, 380K, 200K, 106K, 45.9K, 22K, 11.2K & 5.6K and an injection size of 
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100 μl.  The sample was monitored at a sensitivity of 8 and a scale factor of 20 with a 
WATERS 410 differential refractometer. Data acquisition and handling was made with 
Jordi GPC software.   
From sample chromatograms, and standard calibration curves, differential weight 
fraction molecular weight distribution plots can be generated for the estimation of sample 
molecular weight distribution and polydispersity (Figure 6.27).  Three different molecular 
weight averages were provided by Jordi labs for the characterization of sample MWD:  
number average molecular weight (Mn), weight average molecular weight (Mw), and Z 
average molecular weight (Mz) and can be calculated as follows (199): 
𝑀𝑛 =  ∑ 𝑁𝑖 𝑀𝑖𝑖
∑ 𝑁𝑖𝑖
= ∑ 𝑊𝑖 𝑖
∑ 𝑊𝑖 𝑀𝑖
�𝑖
= ∑ ℎ𝑖 𝑖
∑ ℎ𝑖 𝑀𝑖
�𝑖
 
𝑀𝑤 =  ∑ 𝑁𝑖 𝑀𝑖2𝑖
∑ 𝑁𝑖𝑖 𝑀𝑖
= ∑ 𝑊𝑖 𝑀𝑖𝑖
∑ 𝑀𝑖𝑖
= ∑ ℎ𝑖 𝑖 𝑀𝑖
∑ 𝑀𝑖𝑖
 
𝑀𝑧 =  ∑ 𝑁𝑖 𝑀𝑖3𝑖
∑ 𝑁𝑖𝑖 𝑀𝑖
2 = ∑ 𝑊𝑖 𝑖 𝑀𝑖2∑ 𝑊𝑖𝑖 𝑀𝑖 = ∑ ℎ𝑖 𝑖 𝑀𝑖2∑ ℎ𝑖𝑖 𝑀𝑖  
Where Ni and Wi are the number and weight respectively of molecules having molecular 
weight Mi and the subscript i is an index representing all of the molecular weights present 
in the sample.  The third representation (farthest right) represents the method for 
obtaining Mn, Mw and Mz from the GPC chromatogram where hi is the height (from 
baseline) of the GPC curve at the ith elution increment and Mi is the molecular weight of 
the eluting species at this increment (Mi is obtained from the standard calibration curve) 
(199).  Mn provides information about the lowest molecular weight portion of the sample 
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while Mw is the average closest to the center of the peak and Mz represents the highest 
molecular weight portion of the sample (199).  Polydispersity index (PDI) which is 
defined as Mw/Mn was also provided by Jordi labs and gives an indication of the 
broadness of the molecular weight ranges in the sample.   
Results from GPC analysis against polysaccharide standards are presented in 
Table 6.5.  This standard was chosen due to limited solubility of other charged standards 
in the chosen mobile phase.  Since, the polysaccharide standards are not charged, it was 
expected that molecular weights would be exaggerated for ionic polymers. CS control 
sample showed a monomodal normal distribution with a weight average molecular 
weight of 295K.  Unfortunately, PAA and PAA CS was observed to elute poorly in the 
chosen SEC system.  PAA did not initially elute through the column however with 
replicate injections a peak was observed which increased in intensity with each injection. 
This is typical of polymers which are absorbing to the column phase. A steady state was 
reached after multiple injections which provided a repeatable result but the weight 
average molecular weight was low (53K) (PAA expected MW 250,000 based on retailer 
information); this again is consistent with nonspecific interactions with the column phase. 
EG-CS and PEG-CS were observed to show repeatable distributions without prior sample 
injections with monomodal distributions. The observed molecular weights were higher 
than for the CS control by nearly 80K.   PAA and PAA-CS samples were not further 
investigated due to their inherent incompatibility with the chosen column.  A separate 
GPC system will likely have to be developed for CS-macromolecules with varying 
synthetic polymeric backbone chemical composition.   
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In order to improve upon these results, polystyrene sulfonated standards were 
investigated as possible compatible standards.  In a second study samples were prepared 
in the same mobile phase, to a concentration of 2.0mg/ml for EG-CS and PEG-CS. CS 
sample were prepared at 2.5mg/ml and all samples were filtered using a 0.2μm disposable 
Nylon filters and run in duplicate in the same solvent. The system was run at a flow rate 
of 1.2 ml/min on a JORDI DVB Sulfonated Mixed Bed column, 250mm x 10mm (ID) 
and again, column temperature was maintained at 35° C.  Polystyrene Sulfonated 
standards with a concentration of 0.5 mg/ml were used at the following molecular 
weights: 1020K, 679K, 305K, 148.5K, 65.4K, 33.5K, 15.8K, 6.43K, 3.42K & 891 with 
an injection size of 100μl.  Samples were similarly monitored at a sensitivity of 8 and a 
scale factor of 20 with a WATERS 410 differential refractometer and data acquisition 
and handling was conducted with Jordi GPC software.   
A chromatogram overlay of polystyrene sulfonate standards and the samples of 
CS, EG-CS and PEG-CS is presented in Figure 6.25.  Peaks of interest are eluted at 
approximately 9min.  Negative peaks eluting later in the chromatogram (~15min) are due 
to solvent effect and are unrelated to the samples.  Similar negative peaks are seen when 
comparing standards to the samples, confirming this assumption.  A well fit polystyrene 
sulfonated calibration curve for molecular weight was established from the standards 
(Figure 6.26) and used for generation of the differential weight fraction (Wf ) molecular 
weight distribution curves for CS (Figure 6.27) and the samples.  Mn, Mw, Mz, and PDI 
were calculated from the chromatographs and results are presented in Table 6.6.  CS Mw 
molecular weight was 29,113, near the expected value of 22K for CS-4 and Mz values for 
CS (average Mz = 62,227) are consistent with contamination with larger MW CS-6 
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which has a MW of ~65K (65, 139).  EG-CS had an average Mw of 38,916 while PEG-
CS had an average Mw of 42,464.    Polydispersity of all samples was between 2.10 and 
2.36.  The use of a polystyrene sulfonated standard increased the accuracy of molecular 
weight results.     
6.4.4.1. Validation of GPC molecular weight estimation of CS and CS-
macromolecules.  GPC evaluation of CS molecular weight was also validated by 
calculation of the viscosity average MW of CS where the Mark-Houwink-Kuhn-Sakurada 
relationship between intrinsic viscosity and molecular weight is (170, 205): 
[𝜂] = 𝐾(𝑀𝜐����)𝑎 
Where [η] is intrinsic viscosity, 𝑀𝜐���� is the viscosity average molecular weight and K and 
α are constants dependent on polymer conformation.  Intrinsic viscosity is the limit of the 
reduced specific viscosity as the concentration approaches zero, and is given by the 
equation: 
[𝜂] =  lim
𝑐→0
(𝜂𝑠𝑝
𝑐
) 
Where c is concentration (g/cm3) and ηsp is specific viscosity (205).  K and α values have 
been determined for CS to be 1.7x10-5 and 1.01 respectively (0.2M NaCl, 25̊C) (206).  
Viscosity measurements were conducted on serial dilutions of natural CS from 0.006g/ml 
to 0.015g/ml (0.2M NaCl solution, 25C̊) on a cone-on-plate rheometer (AR2000ex 
rheometer, TA Instruments, 1̊ Cone angle) with shear rate linearly ramped from 50-200/s 
(5 points collected) .  Concentration range was chosen such that specific viscosity was 
between 0.2 and 1.9 for accurate intrinsic viscosity determination (170).   Average ηsp/c 
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was plotted vs concentration, and the zero concentration viscosity, [η], extrapolated from 
the linear fit (Figure 6.28).  Intrinsic viscosity was determined to be 38.64 ml/g, similar to 
literature values for CS-4 intrinsic viscosity (34ml/g (207)).   Viscosity average 
molecular weight, 𝑀𝜐���� ,for CS was then determined as:   
(𝑀𝜐����) =
⎝
⎜
⎛
[𝜂] 100�
𝐾
⎠
⎟
⎞
1
𝛼
 
where intrinsic viscosity is divided by 100 based on the original calculations of K and α 
by Wasteson et al (206).  𝑀𝜐���� for CS was determined to be 20,580Da.  The general 
relationship of 𝑀𝜐���� to Mn and Mw is, Mn < 𝑀𝜐����< Mw (205).  From GPC analysis, Mn was 
estimated at 12,360Da and 29,110Da respectively.  In these studies, 𝑀𝜐���� falls between the 
Jordi Labs analysis of CS Mn and Mw, validating the GPC technique for evaluation of 
CS molecular weight and estimation of EG-CS and PEG-CS molecular weight.  Possible 
problems associated with EG-CS or PEG-CS interaction with the column or solvent as 
well as macromolecule aggregation were not observed in the respective chromatograms, 
indicating EG-CS and PEG-CS likely flows through the selected column similarly to 
natural CS. Similar studies of 𝑀𝜐����  for EG-CS and PEG-CS cannot be conducted because 
K and α values have not been determined for these macromolecules. 
 
6.4.5. Stability of amine and epoxide reactants 
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In order to better understand the lack of high molecular weight polymer products 
in EG-CS and PEG-CS samples, the reactive groups of the polymer step-growth polymer 
system were investigated for their stability in the reaction conditions.  The  
fluoresecamine assay was used to investigate the stability of the CS terminal primary 
amine in SBB buffer (pH 9.4) at 45̊C over a 96h period in order to mimic the synthesis 
environment (CS concentration 25mg/ml).  An L-serine standard curve was generated 
and the number of primary amines on both CS and L-serine were determined over the 
incubation period (Figure 6.29).  The average number of primary amines per CS molecule 
over the course of 96hrs did not fluctuate significantly (p > 0.05) and the number of 
primary amines detected was not significantly different from L-serine (p > 0.05), which is 
known to have one primary amine per molecule.  It is therefore concluded that CS 
primary amine stability is not compromised in the reaction medium and thus will not 
hinder polymerization via step-growth synthesis.   
Near infrared spectroscopy (near-IR) was used in order to monitor epoxide group 
stability in the SBB aqueous environment (pH 9.4, 45̊ ) over a 96h period (similar to a 
typical DGE-CS reaction).  Distinct epoxide peaks can be resolved in near-IR spectra and 
near-IR is often used as a tool to monitor epoxide-amine reaction kinetics (197, 208).  We 
were unable to use near-IR to monitor the reaction kinetics of CS-DGE reactions due to a 
strong broad CS signal in the near-IR spectral region however, this technique can be used 
to monitor epoxides of DGE monomers in the absence of CS.  In order to investigate 
DGE epoxide stability in the reaction conditions utilized in synthesis, PEG-DGE was 
used as a model DGE.  PEG-DGE samples were prepared at a 1M concentration in SBB 
(0.1M, pH 9.4) and loaded into glass capillary tubes which were sealed on both ends 
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before investigation.  Near-IR spectra were collected at 64 scans with an SBB (0.1M, pH 
9.4) background.  Samples were placed in a water bath at 45̊C between investigations and 
temperature of the near-IR sample holder was maintained at 45̊C during investigations.    
Spectra were collected every 24h over a 96h period and monitored for changes associated 
with the epoxide peaks of PEG-DGE (Figure 6.30).   
In the near-IR spectra of PEG-DGE in SBB, peaks centered around 5850cm-1 
corresponds to the CH stretching and bending of polyethylene glycol (209-211).  This 
peak will likely stay constant in the SBB environment since there is no indication for 
hydrolysis of these bonds in these conditions.  Peaks centered around 6094cm-1 
correspond to the epoxide ring stretching vibrations (first overtones) (208).  This peak is 
not generally used for quantitative kinetic studies of epoxide ring opening due to 
significant overlap with absorptions due to C-H and C-H2 stretching vibrations centered 
around 6000cm-1 (208).  An additional epoxide peak is found centered around 4542cm-1 
and is assigned to epoxide ring stretching and bending vibrations.  Absorption intensity of 
this peak has been shown to decreases systematically during epoxide ring opening 
reactions and is therefore often used to monitor epoxide rings in kinetics studies.  Near-
IR peak at 4397 is assigned to OH absorption interactions and –OH stretching vibrations 
can also be seen around peak wavenumber 7000cm-1.  An increase in hydroxyl (OH) 
absorptions may indicate hydrolysis of epoxide rings since ring opening of epoxides will 
generate hydroxyls, but the OH peaks are susceptible to influence by hydrogen bonding. 
Therefore the OH peaks of the near-IR spectrum cannot be used as a quantitative measure 
of epoxide reactions.  An analysis of near-IR peak height, ratioed to the PEG peak 
indicates that there may be some changes in hydroxyl content and hydrogen bonding in 
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PEG-DGE samples over time in SBB buffer.  A drop is also seen in the 6094cm-1 epoxide 
peak, however a concurrent decrease in the 4542cm-1 peak is not seen.  The 4542cm-1 
peak remains fairly steady indicating overall stability of epoxides in the reaction medium, 
however, from changes to the OH and 6094cm-1 epoxide peaks, it is possible that some 
level of non-specific epoxide ring opening may occur over the CS-DGE reaction period 
reducing the reactivity of the DGE monomers.  This effect however does not appear to be 
significant due to the ability to react amines in DGE solutions over the course of the 96h 
reaction (Figure 6.13) as well as the maintenance of the 4542cm-1 epoxide peak. 
 
6.4.6. Reactivity of DGEs to the serine amine 
 Investigations into CS amine and DGE functional groups demonstrated their 
stability in the reaction medium over the course of the reaction.  The DGE-amine reaction 
was therefore investigated for possible steric interference caused by bulky CS side chains 
in order to better understand the limitations of the epoxy-CS-amine step growth 
polymerization method.  The serine molecule contains the same adjacent functionalities 
to the amine as seen in the terminal primary amine of CS (Figure 6.32).  Conjugation of 
serine to the PEG based diglycidyl ethers should follow the same mechanisms as CS but 
without the steric effects of the bulky and charged CS side chains.    Reaction of EG-
DGE, PEG-DGE and PEG(1K)-DGE to serine (SBB buffer, pH 9.4, 45̊C), were therefore 
monitored using the fluorescamine assay in order to investigate the steric contribution of 
the CS chain in conjugation to DGEs (Figure 6.32).  Serine-DGE reactions proceeded to a 
higher % conjugation than CS at similar concentrations, however, conjugation did not 
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proceed to completion.  Although steric effects may play a part in the lower reactivity of 
CS to DGE compared to serine, an overall low reactivity of DGE to the serine amine is 
apparent.   A further study was conducted for the conjugation of the simplest amino acid 
to DGE in order to investigate possible reaction interference from the free OH of serine 
which is not available in CS.  Glycine was reacted to PEG- DGE similarly to CS and 
serine, and % conjugation was not found to differ greatly from serine conjugation.  
Therefore, an inherent low reactivity of the CS-primary amine to PEG based DGE 
epoxide functional groups may contribute to the low polymerization seen in the step-
growth polymerization of CS and EG, PEG and PEG(1K)-DGEs.  
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Figure 6.13:  Kinetics of CS Primary Amine Reaction to DGE monomers of varying 
poly(ethylene glycol) chain length  
(Data fit to One-Phase Association Exponential Curves) 
 
Best-fit values EG 1mM PEG 1mM PEG 1K 1mM Best-fit values EG 10mM PEG 10mM PEG 1K 10mM
Plateau 12.26 9.428 19.45 Plateau 69.46 76.73 75.41
K 0.03917 0.03807 0.1425 K 0.06038 0.07561 1.298
Tau 25.53 26.27 7.018 Tau 16.56 13.23 0.7705
R square 0.1781 0.1184 0.1899 R square 0.9375 0.9383 0.02821
Plateau 4.635 5.069 3.409 Plateau 2.06 1.899 1.669
K 0.04935 0.06743 0.09338 K 0.006642 0.007056 0.4364
95% Confidence Intervals
Plateau 2.708 to 21.80 -1.014 to 19.87 12.42 to 26.47 Plateau 65.22 to 73.70 72.82 to 80.65 71.97 to 78.85
K 0.0 to 0.1408 0.0 to 0.1770 0.0 to 0.3349 K 0.04670 to 0.07407 0.06107 to 0.09014 0.3989 to 2.197
Tau 7.101 to +infinity 5.650 to +infinity 2.986 to +infinity Tau 13.50 to 21.41 11.09 to 16.37 0.4552 to 2.507
Best-fit values EG 20mM PEG 20mM PEG 1K 20mM Best-fit values EG 100mM PEG 100mM PEG 1K 100mM
Plateau 86.69 89.07 87.97 Plateau 96.82 97.18 96.84
K 0.1089 0.1328 0.8876 K 0.4903 0.5717 1.222
Tau 9.185 7.529 1.127 Tau 2.04 1.749 0.8183
R square 0.9658 0.9356 0.3687 R square 0.9451 0.9281 0.6689
Plateau 1.36 1.654 1.174 Plateau 0.6327 0.5952 0.3837
K 0.006409 0.009216 0.1091 K 0.01842 0.02232 0.06675
95% Confidence Intervals 95% Confidence Intervals
Plateau 83.89 to 89.49 85.66 to 92.47 85.55 to 90.38 Plateau 95.52 to 98.13 95.96 to 98.41 96.05 to 97.63
K 0.09567 to 0.1221 0.1138 to 0.1518 0.6628 to 1.112 K 0.4523 to 0.5282 0.5257 to 0.6176 1.085 to 1.360
Tau 8.192 to 10.45 6.588 to 8.785 0.8990 to 1.509 Tau 1.893 to 2.211 1.619 to 1.902 0.7355 to 0.9220
Std. Error
One-phase association:  Y=Plateau*(1-exp(-K*x))
One-phase association:  Y=Plateau*(1-exp(-K*x)) One-phase association:  Y=Plateau*(1-exp(-K*x))
One-phase association:  Y=Plateau*(1-exp(-K*x))
Std. Error
95% Confidence Intervals
Std. Error
Std. Error
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Figure 6.15: Epoxide chemical shift focus in  1H-NMR of Day-by-day dialysis of PEG-DGE-CS 
reaction purification 
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Figure 6.17:  Epoxide chemical shift focus in  1H-NMR of Day-by-day dialysis of EG-DGE-CS 
reaction purification 
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Figure 6.18:  1H-NMR analysis of PEG(1K)-CS purification via membrane dialysis  
with inset of epoxide region. 
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Figure 6.22:  1H-NMR of Purified EG-CS, PEG-CS and PEG(1K)-CS Synthesized at 20mM DGE 
Concentrations in SBB buffer (pH 9.4, 45C̊, 96h) 
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Figure 6.25:  Chromatograms of CS, EG-CS and PEG-CS in relation to polystyrene sulfonate 
standards 
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Figure 6.26:  Polystyrene Sulfonate Standard molecular weight calibration curve  
for JORDI DVB Sulfonated Mixed Bed column (250mm x 10mm (ID)) eluted with 85/10/5/0.1% 
Water/Acetonitrile/Isopropyl Alcohol/Phosphoric Acid 
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Figure 6.27:  Example of molecular weight distribution curve and graphical representation of Mn, 
Mp, Mw, and Mz 
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Figure 6.28:  Concentration extrapolation of CS Intrinsic Viscosity 
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Figure 6.29:  Fluorescamine analysis of CS primary amine stability over time in pH 9.4, 45C̊ 
buffer conditions 
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Table 6.3:  Summary of (A) Rate Constants and (B) % Conjugation Plateaus for CS Primary 
Amine Reaction to DGE of Varying MW 
A  EG-DGE PEG-DGE PEG (1K)-DGE 
DGE 
Concentration 
K (1/h) 95% CI K (1/h) 95% CI K (1/h) 95% CI 
1mM 0.03917 0.0 to 0.1408 0.03807 0.0 to 0.1770 0.1425 0.0 to 0.3349 
10mM 0.06038 0.0467 to 0.0741 0.07561 0.0611 to 0.0901 1.298 0.3989 to 2.197 
20mM 0.1089 0.09567 to 0.1221 0.1328 0.1138 to 0.1518 0.8876 0.6628 to 1.112 
100mM 0.4903 0.4523 to 0.5282 0.5717 0.5257 to 0.6176 1.222 1.085 to 1.360 
 
B  EG-DGE PEG-DGE PEG (1K)-DGE 
DGE 
Concentration 
Plateau 
(% Conj) 
95% CI Plateau 
(% Conj) 
95% CI Plateau 
(% Conj) 
95% CI 
1mM 12.26 2.708 to 21.80 9.428 -1.014 to 19.87 19.45 12.42 to 26.47 
10mM 69.46 65.22 to 73.70 76.73 72.82 to 80.65 75.41 71.97 to 78.85 
20mM 86.69 83.89 to 89.49 89.07 85.66 to 92.47 87.97 85.55 to 90.38 
100mM 96.82 95.52 to 98.13 97.18 95.96 to 98.41 96.84 96.05 to 97.63 
 
 
 
 
 
 
 
 
Table 6.4:  Table of GPC Sample Loading Parameters  
Sample Name   Concentration 
(mg/ml) 
Injection Volume 
(μl) 
PAA-CS 2 200 
EG-CS 2 50 
PEG-CS 2 50 
Chondroitin Sulfate   2.5 50 
Poly(acrylic acid) 6.7 100 
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Table 6.5:  Molecular Weight distributions calculated relative to polysaccharide standards 
Sample Run # Mn Average Mw Average Mz Average Mw/Mn Average 
CS 
1 223,604 
225,941 
294,116 
295,264 
398,977 
399,448 
1.32 
1.31 
2 228,278 296,411 399,918 1.30 
PAA-CS 
1 18,604 
18,596 
150,817 
149,092 
388,997 
383,587 
8.11 
8.02 
2 18,588 147,367 378,177 7.93 
EG-CS 
1 290,972 
289,574 
372,124 
372,358 
480,044 
481,201 
1.28 
1.29 
2 288,176 372,592 482,358 1.29 
PEG-CS 
1 280,083 
280,938 
376,317 
373,379 
497,440 
491,097 
1.34 
1.33 
2 281,793 370,441 484,754 1.31 
* Relative to Polysaccaride Standards       
 
 
 
 
 
 
Table 6.6:  Molecular weight distributions calculated relative to polystyrene sulfonate standards 
Sample Run # Mn Average Mw Average Mz Average Mw/Mn Average 
CS 
1 12,535 
12,359 
29,260 
29,113 
61,919 
62,227 
2.33 
2.36 
2 12,184 28,966 62,536 2.38 
EG-CS 
1 18,526 
18,508 
39,022 
38,916 
73,034 
73,327 
2.11 
2.10 
2 18,490 38,810 73,620 2.10 
PEG-CS 
1 19,135 
19,363 
42,599 
42,464 
78,924 
78,627 
2.23 
2.19 
2 12,591 42,328 78,330 2.16 
* Relative to Polystyrene Sulfonate Standards      
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In this study, the step-growth grafting-through synthesis of CS-brush 
macromolecules was investigated using the epoxy-amine reaction.  CS with a terminal 
primary amine was reacted to diepoxide monomers; ethylene glycols of varying 
molecular weight terminated on both chain ends with epoxide groups: EG-DGE, PEG-
DGE, and PEG(1K)-DGE.  EG-DGE and PEG-DGE were chosen due to the small 
molecular spacing between epoxide groups (0.5nm and 5nm respectively).  A molecular 
spacing between CS chains of less than 4nm has been predicted to be required in order to 
elicit electrostatic contributions the tissue mechanical properties (69).  PEG(1K) was 
investigated in order to better understand the effects of DGE MW on CS-macromolecule 
synthesis. 
6.5 Discussion 
6.5.1. Reaction kinetics of the CS-DGE reaction 
In step-growth polymerization of an epoxy-amine system, epoxides first react to 
an available primary amine, generating a secondary amine.  A second epoxide can then 
react to the generated secondary amine in order to create a tertiary amine linkage.  These 
reactions can be applied to the CS, diglycidyl ether system as seen in Figure 6.33 to 
generate linear polymers with ethylene/polyethylene backbones and pendant chondroitin 
sulfate bristles.  Epoxide primary amine, and secondary amine reactions are necessary in 
order to build linear chains with several CS pendant groups as illustrated in Figure 6.33.  
Several parameters were investigated for their influence on the CS primary amine 
reaction with DGEs (Represented by reactions 1 and 2 in Figure 6.33).  Temperature, 
DGE concentration and DGE molecular weight were all found to modulate the reaction 
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kinetics of the CS primary amine-epoxide reaction.  As expected, an increase in 
temperature increased the epoxy-primary amine reaction rate (174, 212).  Temperature is 
often used to increase conversion and reaction rates in epoxy polymer systems.  Care 
must be taken however at high temperatures (>147 ̊C) in order to avoid possible side 
reactions such as etherification (174, 179, 181).  In our system, it is especially important 
to keep temperature reasonable in order to avoid the degradation of the CS chains.  CS is 
generally stable up to 200h at temperatures up to 60̊C, while longer incubation times 
leads to degradation (92). Basic conditions also make CS more susceptible to degradation 
at elevated temperatures when compared to neutral conditions (92).  Therefore, 
temperatures above 45̊C were not investigated for their potential impact on CS primary 
amine reaction rate and reaction times were generally kept below 200h.   
Interestingly, temperature did not play a significant role in epoxide-primary amine 
reaction rate when DGE monomer concentrations were high ( > 100mM DGE).  At high 
DGE concentrations, it appears that the monomer concentration outweighs any 
thermodynamic benefits gained by increased temperature reactions.  Although increasing 
temperature was found to be effective in increasing primay amine conjugation at 
moderate DGE concentrations (< 100mM) (Figure 6.11, Figure 6.12), even at elevated 
temperatures (45̊C), an excess of epoxide monomer (>10mM where CS concentration is 
1.13mM) was required in order to achieve high levels of primary amine conversion 
(>80% Conjugation) (Figure 6.13).    
PEG-DGE molecular weight also had a significant effect on primary amine-
epoxide reaction rate with reaction rate increasing with DGE monomer molecular weight 
(Figure 6.13 and Table 6.3).  This dependence on molecular weight may be associated with 
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the unique properties of the PEG spacing unit.  In addition to the chemically stable, inert 
and biocompatible natures of PEG (213-215) which make it desirable for biomedical 
applications, PEG has many unique solution properties and  is available in a range of 
molecular weights (from oligomers to molecular weights of 7 million) where properties 
of PEG tend to vary considerably with molecular weight (216).    In interactions of PEG 
with water and other solutes in aqueous conditions, several considerations must be made.  
Attractive interactions due to the hydrogen-bond formations between ether oxygen of the 
PEG chain and water, water-water interactions, and repulsive interaction between water 
and the alkyl groups of PEG (hydrophobic hydration) may occur in addition to hydrogen 
bonding and hydrophobic attractive interactions between PEG and other solutes (i.e. 
amino acids, and in our case chondroitin sulfate) (217-219).   Attractive interactions 
caused by hydrogen bonding between the ether oxygen of the PEG chains and the 
electrophilic groups of CS as well as hydrophobic interactions between alkyl groups of 
CS and PEG  can increase the entanglements between CS and PEG bring the amine and 
epoxide groups in closer proximity, thereby affecting reaction rate.  Increasing the PEG 
MW may increase these entanglements.  It is known that with increased molecular 
weight, PEG itself shows increased entanglement (aggregation) (216) and increased 
water association (water molecules bound per ethylene glycol segment) (213, 220) .  PEG 
also demonstrates drag reduction (221) and steric stabilization (222) properties which 
increase with increasing PEG MW, and may also contributing to the enhanced 
conjugation with increasing PEG segment MW.  Reactivity of the epoxide groups and 
chemistry of the backbone themselves were not expected to play a role in the MW 
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dependence of reaction kinetics since the chemistry of the DGEs were similar, only 
varying in the number of ethylene glycol units.  
Reaction kinetics of the secondary amine (formed in the reaction of the CS 
primary amine with epoxide (Figure 6.33)) with epoxide could not be monitored in our 
given conditions.  Epoxy-amine primary and secondary reaction kinetics are usually 
investigated with a combination of differential scanning calorimetry(DSC) and Near-IR 
(197, 208, 223).  These investigations however are not applicable to our system due to the 
majority composition of CS within our samples.  The CS signal dominates the near-IR 
spectra as well as the thermal properties obtained in DSC.   
Direct analysis of amines is most routinely used to quantify primary amines (145, 
224).  Some methods have been developed to monitor secondary and tertiary amines 
however they are generally more sensitive to external factors such as water, other amine 
and functional group populations and steric hindrances of the amines themselves (225-
230).  In addition, available methods often require a good deal of sample processing as 
well as complex titrations in order to determine the quantity of the desired amine.  These 
methods are also sensitive to the type of amine (most assay development is conducted on 
aromatic amines) as well as the concentration of amines (methods are not highly sensitive 
to trace concentrations of amine).  These limitations in secondary amine and tertiary 
amine direct monitoring has often limited these techniques to the analysis of amines only 
in the specific settings in which the assay was developed (assays have not become 
commercially available, and papers on secondary and tertiary amine detection method 
development have not been highly cited since their publication in the 1940’s, 1950’s, 
1960’s 1970’s and 1980’s) (225-231).  The analysis of secondary amine reactions in our 
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system of chondroitin sulfate and epoxide reaction in aqueous conditions was therefore 
not feasible and our analysis of reaction kinetics was focused on the initial primary amine 
reaction with epoxide.  The determination of reaction products size and chemical 
composition however give insight to the reactions taking place within our system and 
serve as a secondary means of investigating amine-epoxide reactions.      
6.5.2. Purification of synthesized CS-Macromolecules 
Purification of the epoxide-CS reaction mixture was accomplished by extensive 
membrane dialysis against DI water.  In membrane dialysis, the sample is contained in 
dialysis tubing of a particular molecular weight cutoff.  The MWCO is defined as the 
molecular weight of the solute that is 90% retained by the membrane during a 17 hour 
period.  Molecules that are larger than the MWCO are theoretically retained in the 
dialysis membrane while the driving force of diffusion forces smaller solutes out of the 
membrane tubing.  As a rule of thumb, in order to separate molecules via membrane 
dialysis, there must be at least a 5x difference in molecular weight of the species being 
separated and MWCO is generally chosen such that it is ½ the MWCO of the molecules 
that needs to be retained.   In the current case, CS has an approximate MW of 22K while 
the largest DGE has a MW of approximately 1K making dialysis an appropriate choice 
for purification.  In order to purify CS-macromolecule samples, dialysis was conducted 
within a 6K-8K MWCO regenerated cellulose membrane against DI water.  DI was 
chosen in order to fully purify CS-macromolecules from excess salts introduced in the 
sysnthesis process.  By dialyzing against DI, resulting products will have only the salts 
associated with the CS molecule and resulting yields are not skewed by added salts in the 
system.  Dialysis was monitored daily in order to determine minimal time required to 
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purify un-reacted DGE monomers.  After 48h of dialysis both PEG-CS (Figure 6.14) and 
EG-CS (Figure 6.16) compositions showed no DGE contaminant peaks as well as no 
epoxide peaks (Figure 6.15 and Figure 6.17).  PEG(1K)-CS samples showed trace amounts 
of epoxide and likely require 72h of dialysis (Figure 6.18).   
The dialysis process generates a pressure within the dialysis membrane due to the 
large salt concentration associated to the CS molecules and the lack of salts in the DI 
water.  This pressure swells the dialysis tubing and can sometimes cause it to burst, 
therefore, it is important to only partially fill dialysis tubes, to allow room for DI water o 
enter the tube and dilute the sample.  An additional consequence of the introduced 
swelling pressure is opening of the pores of the dialysis membrane.  The dialysis 
membrane used, is only rated for pressures up to 1.5psi before MWCO is compromised 
(232).  Osmotic pressure of CS solutions at 25mg/ml (the concentration used in synthesis 
and purification) is approximately 11psi in 0.15M NaCl and expected to be higher in zero 
salt conditions (233).  Therefore it is not unlikely that the actual MWCO of the dialysis 
membranes was greater than 6K-8K MWCO.  Monitoring the yield of samples after 
different times of dialysis, it was noticed that significant material loss occurs over the 
dialysis period (Figure 6.34).  It is therefore important to minimize amount of the dialysis 
used to maximize product yield.  Smaller MWCO membranes may also be used, but 
longer dialysis times may be required to complete dialysis.  Dialysis against osmotically 
conditioned solutions of high molecular weight polyethylene glycol or dextrans may also 
be utilized in order to balance the internal and external osmotic pressures of the dialysis 
bags.   
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Dialysis against DI water also has the positive consequence of hydrolysis of 
remaining epoxides due to the slightly acidic nature of DI water (pH ~5) (Figure 6.35).  
This is important for biocompatibility issues, where epoxides are highly reactive 
functional groups and may interfere with normal cellular function (234).  As a result of 
epoxide hydrolysis however, care must be taken to monitor not only the epoxide 1H-
NMR peaks since these peaks may disappear before full purification is reached.  A 
drawback of this purification technique however is that any epoxides that may have been 
remaining at the terminal end of CS as a result of the synthesis procedure would not be 
detected because of hydrolysis.  If dialysis is conducted against SBB (0.1M, pH 9.4), 
epoxides may be preserved and detected (Figure 6.30), but the low concentrations of 
epoxides expected in CS-macromolecule samples may make them difficult to detect over 
signal noise.  Another methods that may be used to determine the end functionality of 
synthesized CS-macromolecule chains is matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI-TOF MS) (235).   
6.5.3. Chemical structure of the CS-Macromolecules 
The chemical structure of CS was monitored over the synthesis process in order to 
investigate the reaction of CS to DGE.  EG-CS, PEG-CS and PEG(1K)-CS 1H-NMR 
spectra matched well with that of un-reacted CS (CS was processed similarly to reacted 
CS but not exposed to DGE).  For EG-CS and PEG-CS monitored over the course of 
synthesis, all peaks corresponding to CS maintained their spectral shifts (Figure 6.19 and 
Figure 6.20) and had only small variations in integrated area (Figure 6.21).  The only trend 
in change in integrated are was noticed for PEG-DGE samples at the PEG spectral shift 
location (3.66ppm) which overlaps with a broad CS band between 3.58 and 3.86ppm.  
228 
 
 
Due to this overlap, the actual amount of PEG incorporated into the CS molecule cannot 
be quantified.  It is interesting to note however, the progressive increase in this peak over 
the reaction time of PEG-DGE to CS.  Fluorescamine analysis of the reaction rate of 
PEG-DGE with CS at 20mM DGE concentration indicates a time constant of primary 
amine reaction of between 6.58h and 8.78h.  This indicates that the system is expected to 
reach approximately 95% of its maximum conjugation within 24h.  1H-NMR results 
suggest however that addition of PEG to the CS molecule (20mM DGE reaction) 
proceeds after the initial 24h period.  This may be due to reactions at the secondary 
amine.  Secondary amines generally react with epoxides at a slower rate than the original 
primary amine due to a negative substitution effect (180-181).  The secondary amine 
hydrogen is more sterically hindered than its predecessor primary amino hydrogen 
reducing the rate of the reaction.  It is therefore necessary to allow epoxy-amine systems 
to react over a relatively long period of time to first allow the primary amines to react and 
allow more time to allow the secondary amines to react.  This phenomenon was seen in 
our current PEG-DGE-CS reaction system where primary amine reactions proceeded 
within the first 24h but additional incorporation of monomer was seen even after 96h of 
reaction.   
It is possible that side reactions could have occurred in this system with other 
epoxide reactive groups.  The most likely side reaction would occur at the GalNAc 
primary hydroxyl (primary hydroxyls are more available for reaction than secondary 
hydroxyls), however this signal is combined in the 3.58 and 3.86ppm band and would be 
obscured by the PEG signal at 3.66ppm.  PEG-CS, EG-CS, and PEG(1K)-CS samples, 
synthesized for 96h with 20mM DGE, were investigated with ATR-FTIR to further 
229 
 
 
investigate any side possible side reactions, especially located at the hydroxyl groups.  In 
particular, in a study conducted to fabricate a hydrogel from CS and PEG-DGE, CS was 
reacted with PEG-DGE at high pH (1M NaOH, pH~14) to induce epoxide reaction with 
hydroxyls to crosslink the CS network.  Changes in FTIR spectra were seen with a shift 
of the C-O stretching (236) from 1035cm-1 to 1100cm-1 (237).  It has also been 
demonstrated that in the C-O stretching mode, shifting occurs with changes to the 
hydroxyl group orientation (156).  Therefore, this peak was monitored for shifts in the 
ATR-FTIR spectra of EG-DGE, PEG-DGE and PEG(1K)-DGE (Figure 6.24).  No major 
peak shifts were detected at the 1032cm-1 peak s of CS-macromolecules indicating that 
there was no significant bonding of the CS hydroxyls by the DGEs investigated.  1H-
NMR analysis (Figure 6.22 and Figure 6.23) and ATR-FTIR analysis (Figure 6.24) of final 
20mM DGE formulations of EG-CS, PEG-CS and PEG(1K)-CS indicate no significant 
reactions of DGE with the CS molecule other than the incorporation of PEG groups onto 
the CS chain.  The incorporation is likely due to primary amine reactions which were 
monitored with the fluorescamine assay.  Secondary amine reactions may also be 
occurring as evidenced by the continued incorporation of PEG into PEG-DGE samples, 
even after primary amine reactions have reached a plateau.   
6.5.4. CS-Macrmolecule molecular weight distribution 
EG-CS and PEG-CS molecular weight distributions were estimated with GPC.  
Method development for GPC was contracted from Jordi Labs due to the complex nature 
of SEC of hybrid molecules.  Stationary phase column material, mobile phase solvents 
and injection procedures were optimized for the elution of CS and CS-macomolecules.  
Initial runs with polysaccharide standards resulted in highly over estimated molecular 
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weight for both CS and CS-macromolecules (Table 6.5) however additional trials with 
polystyrene sulfonated standards resulted in more accurate MWD determinations (Table 
6.6).  GPC measurement of molecular weight values was validated with viscosity average 
molecular weight measurements of CS.  CS Mw was near the expected value of 22K for 
CS-4 and Mz values for CS were consistent with contamination with larger MW CS-6 
(65, 139).  Molecular weight increased with incorporation of PEG based synthetic 
backbones of increasing MW (i.e. PEG-CS > EG-CS > CS).  Based on these MWD for 
CS and the CS-macromolecules, it is likely that the EG-CS and PEG-CS samples 
contained a mix of dimmers (two linked CS chains) and monomers (individual CS chains 
or CS chains linked to one or two DGE monomers) as illustrated in products A, B, C, and 
D of Figure 6.33.   
In addition to GPC quantification of molecular weight, gel electrophoresis and 
dynamic light scattering techniques may be used to obtain molecular size information.  
Both gel electrophoresis (96, 238-239) and dynamic light scattering have been used to 
establish polysaccharide and proteoglycan molecular size (240-241) however their use in 
characterizing heterogeneous synthetic polymer brushes is limited (106).  Conventional 
techniques for the determination of molecular weight and size distribution (i.e. GPC, light 
scattering, viscometry and electrophoresis) are often limited when applied to complex 
macromolecules that involve branching and heterogeneous composition (106).  
Therefore, visualization of individual macromolecules is often utilized to characterize 
brush polymer molecular weight distribution and is recommended as a secondary method 
for the determination of CS- macromolecule size and structure (106).   
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In healthy discs, aggrecan macromolecules can contain approximately 100 CS 
chains and 30 KS chains resulting in aggrecan molecular masses of around 2,000kDa 
(242).  In degenerating NP tissues, enzymatic degradation of aggrecan by MMPs and 
Aggrecanases results in the fragmentation of the aggrecan macromolecule into smaller 
subunits.  Aggrecan fragments in the range of 100kDa to as low as 55kDa have been 
found in NP tissues at both early (Grade 2) and advanced (Grade 4) stages of 
degeneration (78, 243).  This indicates that aggrecan molecules of these sizes can be 
retained in the NP matrix. Therefore, in the synthesis of biomimetic aggrecan 
macromolecules for injection and retention in the NP, macromolecules sizes of greater 
than 55kDa may be applied.  The synthesis strategy utilized in the current study resulted 
in CS-macromolecules of MW ranging from 18,500Da (Mn of EG-CS) to 78,600Da (Mz 
of PEG-CS).  The larger of these molecules may have extended residence time in NP 
tissues; however, they are only a small portion of the synthesized population of 
macromolecules.  The Average Mw of the EG-CS and PEG-CS macromolecules were 
approximately 38,900Da and 42,500Da respectively, indicating that the majority of the 
synthesized macromolecules would be too small to remain in NP tissue over time.   In a 
separate study, injections of CS and injections of a water control were made to a human 
cadaveric intervertebral disc.  After cycling through a diurnal cycle, there was no 
difference in the CS disc from the water control or from the intact condition (data not 
shown).      
In order to investigate possible causes for the low molecular weight polymers 
obtained, a series of studies were conducted.  Both the primary amine group of CS and 
the epoxide groups of the DGE monomers were investigated for their stability in the 
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synthesis reaction conditions.  Both groups were found to be stable over a 96h period as 
determined by the fluorescamine assay for amines (Figure 6.29) and near-IR for epoxides 
(Figure 6.30 and Figure 6.31).  Finally, the contribution of steric hindrances to the 
conjugation of long CS chains to the PEG backbones was investigated by using L-serine 
(the amino acid residue of the CS terminal primary amine) for conjugation as a 
comparison.  L-serine molecules are small and do not have the steric hinderence 
associated with the charges and long chains of CS.  Conjugation was seen to be slightly 
increased for L-serine samples indicating that steric hinderences may be playing in a 
small part in reduced attachment of CS to DGEs.  Conjugation however did not proceed 
to 100% when equimolar and twice equimolar concentrations of amine were combined 
with epoxide (Figure 6.32).  This can introduce a large problem in step-growth 
polymerization, where each un-reactive group will result in dead chains ends, reducing 
the final molecular weight of the polymer.   
In the step-growth polymerization utilized in this synthesis procedure, primary 
amines, secondary amines and epoxides all need to be highly reactive in order to promote 
chain growth and the synthesis of large molecular weight species.  Epoxide-amine 
reactions can be influenced by several factors including, amine structure, epoxide 
structure, solvent nature, and side reactions.  Reaction rate generally increases with the 
basicity of the reacting amine (183).  In our system however, we are limited to the 
inherent properties of the serine residue as our primary amine and its reaction with an 
epoxide for our secondary amine.  Epoxide structure does not have as large of an effect 
on epoxy-amine reactions, however epoxy compounds with aromatic rings in the 
backbone have been known to react more readily.  The addition of aromatic rings in a 
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molecule however generally makes it more hydrophobic and will therefore be difficult to 
solubilize in the CS aqueous medium.   
 Given these considerations of the epoxy-amine reactive system and the serine 
studies conducted indicating that the EG-DGE, PEG-DGE and PEG(1K)-DGE reactions 
to serine amino acid residue may be somewhat inhibited,  a large barrier to the use of this 
step-growth strategy in the synthesis of high molecular weight CS-macromolecule 
species.  More reactive epoxides may be investigated, and it is possible, that intermediary 
steps, which push the epoxy-amine reactions to completion, may be used to build 
polymers in a more step-wise fashion.  These techniques will require long synthesis times 
and careful purification in order to result in high molecular weight polymers.       
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Figure 6.33:  Primary and secondary amine reactions of CS with PEG-DGE 
See Appendix 2 for alternate view of amino acid terminated CS 
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Figure 6.34:  % Yeild of CS-Macromolecules (combined results for EG-CS and PEG-CS)  
over the course of dialysis (starting CS weight of 250mg) 
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Figure 6.35: near-IR analysis of PEG(1K)-DGE in DI water over 96h.   
Epoxides peaks highlighted in Blue.  PEG peak highlighted in purple.  Epoxide Peaks decrease 
with increased time in DI water.  
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 The step-growth polymerization of CS with PEG based diepoxides was 
investigated in this study for the synthesis brush-like CS macromolecules.  The CS DGE 
reaction was demonstrated to be localized primarily to the CS terminal primary amine 
and polymer products were isolated from the reaction with no residual DGE monomer.  
Investigations into the molecular weight distribution of the synthesized CS-
macromolecules indicated that the reaction products consisted primarily of CS monomer 
and dimmers.  The lack of extended monomer addition is likely due to low reactivity of 
the serine residue terminal amine to the DGE epoxide functionalities.  A reduction in 
functional group reactivity can greatly decrease the molecular weights of the polymer 
products.  Although large brush molecules were not likely synthesized, CS-
Macromolecules were synthesized which incorporate a synthetic PEG polymeric 
component generating novel CS macromolecular hybrid structures.  These structures will 
be further investigated in order to understand the impact of the hybrid nature of these 
macromolecules on functional properties such as viscosity, osmotic pressure, and 
cytotoxicity.  In addition, the techniques of reaction analysis, chemical characterization, 
and purification developed in this study will be valuable to the development and 
evaluation of future biomimetic aggrecan synthesis strategies.   
6.6 Conclusions 
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Chapter 7 :  Characterization of CS Macromolecules synthesized via the Epoxy-
Amine Step-Growth “Grafting-Through” technique of Polymer Synthesis 
 
The human intervertebral disc is the primary compression-carrying component of 
the spine.  Its role is to transmit and distribute loads, and allow for the necessary 
flexibility of the spine.  During a diurnal cycle, the intervertebral disc experiences 
approximately 16 hours of functional loading (standing, sitting, etc.), followed by 8 hours 
of recovery (lying prone).  Therefore, the fluid lost during the loading period must be 
replenished in half the time that it is expelled.  As the disc is compressed and fluid is 
exuded, the density of the fixed charges within the nucleus pulposus is increased, creating 
an osmotic gradient with the interstitial fluid surrounding the disc (4).  This osmotic 
potential aids in drawing fluid back into the disc.  Additionally, the chemical and 
structural arrangements of key biomolecules in the nucleus pulposus provide mechanical 
resistance to compressive loads.  In particular, the large bottle brush proteoglycan, 
aggrecan, has two major modes of function in providing mechanical support in the NP:  
1) it allows water uptake by the nucleus due to sulfated groups on the chondroitin and 
keratin sulfate regions which, in part, provide intradiscal pressure and 2) it provides 
electrostatic repulsion due to the 3D macromolecular structure, which contributes to 
intradiscal pressure and disc height.  Specifically, electrostatic forces between closely 
arranged CS chains have been theoretically suggested to account for 50% (290kPa) of the 
equilibrium compressive elastic modulus in disc like tissues (70, 72).    
7.1 Introduction 
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Alterations in the major biochemical constituents of the intervertebral disc 
coincide with aging and disc degeneration, and can subsequently alter the ability of the 
disc to support load (20, 244-246).  While disc degeneration is poorly understood, it has 
been shown that the proteoglycan content of the inner, nucleus pulposus region of the 
disc, decreases linearly with age and degeneration with almost 40% of proteoglycans lost 
by the age of 40 (3, 24). This loss of proteoglycans leads to a loss of hydration of the 
nucleus manifested by a reduction of disc height and intradiscal pressure.  Proteoglycans 
work to resist mechanical forces in the nucleus and provide a hydrostatic pressure to the 
outer annulus fibrosus.  In a dehydrated disc, the function of the nucleus, namely load 
transfer to the annulus through creation of an intradiscal pressure is hindered and the 
mechanics of the degenerated disc are altered compared to those of a healthy disc (29).  
Prior work has investigated the role of the nucleus pulposus in human lumbar 
intervertebral disc mechanics and studies show that the nucleus is critical in providing 
stability to the intervertebral disc (2, 247).   
In order to mechanically stabilize the disc early in the degenerative cascade and 
prevent the need for spinal fusion surgeries, we have proposed the development of a 
hybrid-bio/synthetic biomimetic proteoglycan macromolecule for injection into the 
nucleus pulposus of the intervertebral disc in the early stages of degeneration, after a first 
or second episode of back pain.  The biomimetic proteoglycan is based on the major disc 
proteoglycan aggrecan which is a bottle brush macromolecule with a protein core and 
radiating negatively charged chondroitin sulfate (CS) bristles.  In the biomimetic 
approach, the protein core is replaced with a synthetic polymeric backbone in order to 
resist enzymatic and hydrolytic degradation within the nucleus environment while 
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maintaining the osmotically active chondroitin sulfate bristles in their natural bottle brush 
arrangement.   
While administrations of natural aggrecan may be useful, the cost of the material 
at this point in time is prohibitive for any type of realistic intervention (A1960:  Aggrecan 
from bovine articular cartilage, $225USD/mg from Sigma(248)).  In addition, 
commercially available aggrecan would be subject to the same limitations as the body’s 
own aggrecan, enzymatic degradation of the protein core, which fragments the molecule 
and allows for migration of the fragments from the intradiscal space (18, 23).   
 The function of biomimetic aggrecan in the restoration of NP tissue hydration and 
mechanical properties is several fold (Table 4.1).  The biomimetic aggrecan must be of 
the appropriate size to maintain residence in the NP tissue matrix (generally greater than 
70kDa (78, 243)) and the structure should be similar to that of native aggrecan, with 
charged groups maintained in close proximity (2-4nm spacing between adjacent CS 
molecules (69)).  In addition, the biomimetic aggrecan should be maintained in a fluid 
aqueous matrix in order to ensure integration with the surrounding NP tissue matrix (i.e. 
not a cross-linked network).  The biomimetic aggrecan also must be able to remain stable 
in the harsh hydrolytic and enzymatically active NP environment.  Finally, since the 
biomimetic aggrecan will be integrated into existing NP tissue with a cellular population 
of nucleus pulposus cells (approximately 2,500cells/mm3 (249)), it is important that 
biomimetic aggrecan be biocompatible with minimal cytotoxic effects on NP cells.   
In the previous chapter, biomimetic aggrecan in the form of CS-macromolecules 
with poly(ethylene glycol) based synthetic backbones was synthesized via a step-growth 
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“grafting-through” strategy.  The PEG based backbones are inherently hydrolytically and 
enzymatically stable (215, 250), thereby rendering the CS-macromolecules resistant to 
degradation in the the acidic and enzymatically active NP environment (aggrecanases and 
MMPs in the NP breakdown native aggrecan at specific amino acid sequences of the 
aggrecan core protein (79)).  PEG backbone segment length (i.e. spacing between 
adjacent CS molecules) was also chosen in the range of 0.5 to 5nm (EG-CS and PEG-CS 
formulations respectively) in order to mimic the close packing of CS in aggrecan.  
Investigations into the molecular size of the synthesized CS-macromolecules indicated 
the formation of some larger macromolecular species in the range of 70kDa (in the range 
of aggrecan fragments found in native NP tissue), however the Mw of EG-CS and PEG-
CS molecules were low, approximately 40kDa (i.e. dimmers).  Therefore, future work 
was recommended in order to increase the CS-macromolecule molecular mass.   
The current formulations of CS-macromolecules are novel in their incorporation 
of a synthetic backbone between CS-segments.  Therefore, in the current study these CS-
macromolecules were investigated for the influence of the synthetic backbone on 
macromolecule function with regards to key functional requirements of biomimetic 
aggrecan.  CS-macromolecules were characterized for their physical structure using 
transmission electron microscopy (TEM) and viscosity measurements.  The osmotic 
functions of the macromolecules were investigated by monitoring their fixed charge 
density as well as their osmotic potential.  Finally, CS-macromolecule formulations were 
investigated for their ctyocompatibility. 
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7.2 Methods 
EG-CS and PEG-CS prepared at 20mM DGE and 1.13mM CS concentration 
formulations (SBB Buffer, pH 9.4, 45̊C, 96h synthesis) were utilized in these studies.  
PEG(1K)-CS (20mM formulation) was also investigated in some instances as a point of 
comparison, however it was not extensively investigated due to its long (~12nm) and 
non-physiologically relevant segment length between CS chains.  All plots were 
generated in GraphPad Prism v5.02 and statistical analysis done in GraphPad Prism 
v5.02. 
 
7.2.1. Transmission Electron Microscopy (TEM) Imaging of PEG-CS Macromolecules 
The structure of the CS-macromolecules was investigated via TEM imaging.  PEG-
CS samples were prepared as previously described and purified via gravity column 
filtration (GE PD-10 Desalting Columns).  Desalting removes the majority of PEG-DGE 
monomers however trace monomer contamination may remain (data not shown).  
Samples were lyophilized, and then reconstituted in distilled deionized water at 1mg/ml 
concentrations.  A 10µL volume of PEG-CS solution was pipetted onto a 20-30nm 
carbon coated, 400 mesh copper grid (Electron Microscopy Science) and allowed to 
incubate at room temperature (covered to avoid evaporation) for 1h.  Samples were then 
stained with uranyl acetate solution (10µl of 1mM in distilled deionized water, Electron 
Microscopy Science) and rinsed three times with fresh distilled deionized water.  Images 
were collected on a JEOL JEM2100 Transmission Electron Microscope managed by the 
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Centralized Research Facilities of the Drexel University College of Engineering.  Images 
were kindly taken by trained super user Christopher Winkler of the Dynamic 
Characterization Group in the Department of Materials Science and Engineering at 
Drexel University.   
 
7.2.2. Viscosity of CS-macromolecule solutions 
Viscosity ( η, pa.s) is the resistance of a fluid to flow and is dependent on the 
structure and properties of polymer fluids where: 
𝜂 = 𝜎21
?̇?
 
and η is the dynamic viscosity, σ21 is shear stress and γ is shear rate.  The effect of a 
dissolved solute on a solution is given by the relationships of  relative viscosity, ηrel, and 
specific viscosity ηsp, where 
𝜂𝑟𝑒𝑙 =  𝜂𝜂𝑜  𝑎𝑛𝑑 𝜂𝑠𝑝 =  𝜂𝑟𝑒𝑙 −  1  
 and η is the viscosity of the solution, ηo is the viscosity of the solvent and.  Both relative 
viscosity and specific viscosity are unit-less.   
Viscosity of CS-macromolecule solutions was determined on an AR2000ex rheometer 
(TA Instruments) with cone-on-plate configuration (1̊ Cone angle).  Samples were 
brought into solution at 25mg/ml in 1X PBS buffer and 500µl pipette onto the peltier 
plate surface.  Temperature was controlled at 25̊C and gap distance was 32µm.  Shear rate 
was logarithmically ramped from 10/s to 500/s at 10 points per decade, resulting in the 
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collection of a total of 18pts.  Specific viscosity was calculated relative to PBS buffer 
control samples, and the average steady state specific viscosity calculated (n=3).   
 
7.2.3. Fixed Charge Density of CS-Macromolecules 
Fixed charge density (FCD) in the IVD is a measure of the negative charges/unit 
volume attached to the disc matrix (251).  Electrostatic interactions between fixed 
charges and mobile free ions result in the generation of physiochemical and electro-
kinetic effects including Donnan osmotic and swelling pressures in the tissue (252).  
Fluid and solute transport as well as swelling behavior in the IVD are greatly affected by 
the fixed charged density in the tissue, thus the FCD of the synthesized CS-
macromolecule is an important parameter to maintain in a biomimetic approach (84, 
244).   
The Fixed charge density of a CS solution can be estimated from the GAG 
content of the solution using the relationship between the molecular weight of the CS 
disaccharide and the quantity of charge on each disaccharide unit.  Charges on the CS-4 
disaccharide unit arise from the charged sulfate group in N-acetylgalactosamine 
(GalNAc) as well as the charged carboxylic acid in Glucuronic Acid (GlcUA) resulting in 
2 moles of charge per mole of CS disaccharide.  The molecular weight of the CS 
disaccharide is 502.5g/mole.  The FCD (mEq/g of Macromolecule) can be estimated as:   
𝑐𝐹 = 2 𝑚𝑜𝑙 𝑐ℎ𝑎𝑟𝑔𝑒𝑠502.5𝑔 𝐶𝑆 𝐷𝑖𝑠𝑎𝑐𝑐ℎ𝑎𝑟𝑖𝑑𝑒 ∗ 𝑊𝐺𝐴𝐺𝑔 𝑚𝑎𝑐𝑟𝑜𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒 ∗ 103 
where WGAG is the CS weight in grams in the solution (252-253).   
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CS content (WGAG) of CS-macromolecules was determined using the colorometric 
1,9-dimethyl-methylene blue (DMMB) glycosaminoglycan assay (Blyscan Assay, 
Biocolor, UK). DMMB sees a shift in absorbance when it associates with repeating 
negative charges (sulfates) on the GAG chains that is  detected spectrophotometrically at 
530nm in the 96-well format (254).  The detection range of this assay is 2-50µg/mL with 
a detection limit at about 200ng. Fixed charge density of the CS-macromolecules was 
then calculated and compared to natural CS (n=3).   
 
7.2.4. Osmotic pressure of CS-macromolecule solutions 
Osmotic pressure is the pressure that must be applied to a solution to prevent the 
inward flow of fluid, and in the intervertebral disc, it is very sensitive to GAG 
concentration.  It depends mainly on the concentration of fixed charges on the PGs (i.e. 
fixed charge density), as it arises from the Donnan distribution of ions between PGs and 
the external fluid.  Swelling pressure, the pressure at which there is no driving force for 
fluid flow, results from the osmotic pressure exerted by the PGs and the resulting tension 
in the collagen network of the IVD, which tends to restrain the swelling tendencies of the 
PGs.  At equilibrium, the osmotic pressure of the PGs is balanced by the tensile response 
in the collagen network, opposing swelling (251). 
Osmotic pressure of the CS-macromolecule solutions as well as natural CS was 
measured via membrane osmometry.  A custom built membrane osmometer was designed 
and fabricated from 316 stainless steel in our laboratory (233) (Figure 7.1).  In the 
membrane osmometer system, a 36 Stainless Steel low chamber piece was fitted with an 
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O-ring, stainless steel wire mesh and semi-permeable regenerated cellulose 100-500 
MWCO membrane (Spectrum Labs), then screwed onto the top chamber piece.   The 
chamber was then filled with CS or CS-macromolecule solution (~1ml solution in 0.15M 
NaCl).  The chamber was sealed by fitting a miniature flush diaphragm pressure 
transducer (PX61V Series, Electrical Connector Style, Sealed Gage, 0-200psi range, 
Omega (Figure 7.2)) into the upper chamber piece (pressure is monitored in order to 
ensure limited pressurization).  The pressure transducer was connected to an amplifier 
and data was transferred to acustom written LabView data acquisition software (Figure 
7.3 and Figure 7.4).  Prior to assembly, the pressure transducer voltage output was linearly 
equated to pressure by applying a series of known pressures. The generated conversion 
factor was input into the LabView program in order to convert voltage readings to PSI 
and MPa pressure outputs.  After assembly, the chamber was lowered into a saline bath 
(0.15M NaCl solution) avoiding bubbles.  Data was then collected until pressure readings 
reached a steady-state value.  Measurements were conducted at room temperature (25oC).  
The membrane osmometry system was validated by measuring the osmotic pressure of 
polyethylene glycol (20kDa in 0.15M NaCl) solutions over a range of concentrations 
(233).   
 
7.2.4. Fibroblast and Nucleus Pulposus Cytotoxicity studies 
NIH 3T3 fibroblasts and Primary rat nucleus pulposus cells were used in order to 
ascertain the cytotoxicity of the EG-CS and PEG-CS macromolecule formulations.  
Preliminary studies on the cytotoxicity of EG-DGE and PEG-DGE monomers conducted 
247 
 
 
in order to determine cytocompatible concentration ranges of the DGE monomers.   
Similarly, cells were dosed with EG-CS and PEG-CS and investigated for cell viability 
after 48 h and 72h.  Fibroblasts were seeded at a density of 10,000cells/cm2 on tissue 
culture plastic (12-well plate for Live/Dead Imaging assay, 96-well plate for MTT 
assay)(RPMI media, 5% fetal bovine serum, L-glutamine and 1% pen/strep) and allowed 
to attach for 24h before dosing with varying concentrations of EG-DGE and PEG-DGE 
monomers or EG-CS and PEG-CS macromolecules.  Samples were sterilized via 
exposure to UV for 2h.  Primary Nucleus Pulposus Cells cultures were also dosed with 
EG-CS and PEG-CS and assayed for viability after 72h with the MTT assay.  NP cell 
culture was carried out in collaboration with Thomas Jefferson University, Jefferson 
Medical College Department of Orthopaedic Surgery (PI:  Makarand V. Risbud, Ph.D, 
graduate student:  Joanna McGough) following previously established methods (255).  
 Cell viability was investigated after 48h using the LIVE⁄DEAD® 
Viability⁄Cytotoxicity Kit from Invitrogen which discriminates live cells from dead cells 
by staining with green-fluorescent calcein-AM to indicate intracellular esterase activity 
(cytoplasm) and red-fluorescent ethidium homodimer-1 to indicate loss of plasma 
membrane integrity (nucleus stain).  Images were collected on an inverted fluorescent 
microscope (FITC and Rhodamine filters for live and dead cell imaging respectively) and 
analyzed using Image J software (ImageJ 1.43u, NIH, USA).  Four randomly chosen 
locations were imaged for each well of the 12-well plate (live and dead cell images).  
Images were then converted into binary black and white images (white regions denoting 
stained cells).  Average cell area for individual cells was determined then total area was 
divided by the area of a single cell to determine the total number of live or dead cells in a 
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single micrograph area.  The % of live and dead cells was then calculated for each of the 
four areas imaged and averaged resulting in % viability for each sample (n=3).    
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay 
kit also from Invitrogen was used in order to colorometrically monitor cell viability and 
proliferation after 48 and 72h dosing with DGE and CS-macromolecue solutions.  
Metabolically active cells convert the water-soluble MTT to an insoluble purple 
formazan. The formazan is then solubilized in DMSO and its concentration determined 
by optical density at 540nm on a spectrophotometer.   
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Figure 7.1:  (Top) Schematic Diagram of Custom Built Membrane Osmometer and Data 
Acquisition System and (bottom) Image of Assembled Osmometer in Saline Bath 
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Figure 7.2:  Pressure Transducer Specifications 
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Figure 7.4:  Input and output pane for LabvView program written for data acquisition and 
processing of membrane osmometer pressure transducer output. 
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7.3.1. TEM Imaging of PEG-CS Macromolecules 
7.3 Results 
TEM images of Uranyl Acetate stained PEG-CS macromolecules were obtained 
after 24h and 72h of synthesis.  TEM of natural CS and natural bovine aggrecan were 
also taken as a point of comparison.  CS appears as small condensed beads under TEM 
(Figure 7.5).  Natural bovine aggrecan takes on a beaded chain like structure and 
aggregates of condensed beads (Figure 7.6).  This is consistent with previous TEM 
imaging studies of cartilage proteoglycans (256-258).  After 24h of synthesis, PEG-CS 
macromolecules have structures similar to that of CS, individual condensed beads (Figure 
7.7).   TEM of PEG-CS macromolecules after 72h of synthesis reveals larger chain like 
aggregates of condensed beads, similar to that of natural bovine aggrecan (Figure 7.8).  
Structures seen in TEM may be a result of sample aggregation with drying, however clear 
differences are seen between CS and aggrecan and PEG-CS synthesized after 24h and 
after 72h indicating the formation of larger structures with PEG-CS synthesis.      
 
7.3.2. Viscosity of CS-macromolecule solutions. 
The specific viscosity of CS-macromolecule solutions were determined in a cone-
on-plate rheometer at 25mg/ml concentrations in PBS (Figure 7.9).  The specific viscosity 
of CS (CS 25mg/ml, ηsp = 1.48) solutions was comparable to that of previous 
measurements (CS 10mg/ml ηsp = 0.54,  CS 50mg/ml ηsp =  4) (240, 259).  The specific 
viscosities of EG-CS and PEG-CS formulations were significantly higher than that of CS 
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by an average of 9% and 11% respectively (Figure 7.9).  PEG(1K)-CS solutions did not 
have a significantly different specific viscosity from natural CS (Figure 7.9). 
 
7.3.3. Fixed Charge Density of CS-macromolecules. 
The fixed charge density (FCD) of EG-CS and PEG-CS macromolecules was 
estimated from the GAG concentration of CS-macromolecule samples.  FCD was 
comparable to CS samples where CS samples had an estimated average FCD of 
3.43mEq/g CS, EG-CS and PEG-CS samples had average FCD of 3.41mEq/g EG-CS and 
3.61mEq/g PEG-CS respectively (Figure 7.10).  FCD was significantly greater for PEG-
CS samples compared to both natural CS and EG-CS (p <0.05).  EG-CS FCD was not 
significantly different from CS samples.  
 
7.3.4. Osmotic Pressure of CS-Macromolecule Solutions. 
A membrane osmometer was custom built in order to directly measure the 
osmotic pressure of CS-macromolecule solutions.  The osmometer was validated with 
PEG solutions (20K MW (Mw = 19,700) PEG in 0.15NaCl solution, room temperature) 
of theoretically predicted osmotic pressure.  PEG osmotic pressure (π, atm) is predicted 
as: 
𝜋
𝑅𝑇
= 𝑐19,700 + 2.59𝑋10−3𝑐2 +  13.5𝑋10−3𝑐3 
where c is PEG concentration in (g/ml), R is the Gas Constant (82.057cm3 atm K-1 mol-1) 
and T is temperature (298.15 Kelvin) (244).  PEG osmotic pressures determined 
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experimentally using the membrane osmometer matched well with predicted values 
(Figure 7.11).  At higher PEG concentrations, (200mg/ml) the osmotic pressure was 
underestimated at 0.412 MPa compared to the predicted value of 0.55MPa indicating the 
upper limit of reliability of the membrane osmometer.  At these higher pressures, the 
integrity of the osmometer seals as well as the membrane may be compromised resulting 
in lower osmotic pressure values.  Between the range of 0.06MPa to 0.28MPa the 
membrane osmometer is able to accurately predict osmotic pressure.   CS solutions were 
also measured for their osmotic pressure in the membrane osmometer system and 
compared to literature findings for CS osmotic pressure also measured via direct 
membrane osmometery.  CS solution osmotic pressure in 0.15M NaCl at room 
temperature was predicted as: 
𝜋 ≈  𝑐1𝑐𝑓 + 𝑐2(𝑐𝑓)2 
where cf is fixed charge density and  c1 and c2 are viral coefficients (0.500+/-0.053 and 
0.645+/-0.091 respectively) determined by Chahine et al. in a custom built membrane 
osmometer system for CS-6 (233).  CS solution osmotic pressures were in general 
agreement with predicted values (Figure 7.11).  Small deviations in CS osmotic pressure 
from predicted values is likely due to the primarily CS-4 population of our CS while 
primarily CS-6 was used for determination of the viral coefficients.  Together these 
studies validate the use of the custom built membrane osmometer system for the 
determination of CS-macromolecules solution osmotic pressure. 
 Osmotic pressure of 50mg/ml (0.15M NaCl, room temperature) CS-
macromolecule solutions was determined directly using the membrane osmometer.  EG-
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CS, PEG-CS and PEG(1K)-CS average osmotic pressures were 0.145MPa, 0.129MPa, 
and 0.128MPa respectively (Figure 7.12).  Average CS osmotic pressure was 0.155MPa.  
PEG-CS and PEG(1K)-CS solutions had significantly lower osmotic pressure than CS 
solutions, while EG-CS did not have significantly different osmotic pressure from CS.  
PEG-CS and PEG(1K)-CS solution osmotic pressures were also significantly lower than 
that of EG-CS (n=3). 
 
7.3.5. Cytotoxicity of DGE monomers and CS-macromolecules. 
Cytotoxicity of DGE monomers and CS-macromolecules was determined by 
dosing Fibroblast and NP cell cultures with varying concentrations of DGE monomer 
(fibroblasts only) and CS-macromolecules.  Live/Dead image analysis (48h) and MTT 
metabolic activity analysis (48h and 72h) of Fibroblast cultures dosed with DGE 
indicated that fibroblasts remain viable (no significant decrease in cell viability or 
metabolic activity from PBS controls) when dosed with 0.001mM concentrations of DGE 
(Figure 7.13).  At higher concentrations of EG-DGE ( > 0.01mM EG-DGE), cell viability 
is compromised as seen by a statistically significant decrease in the % of live cells and 
metabolically active cells when compared to control cultures.  PEG-DGE maintains 
cytocompatibility at 0.01mM and has significantly higher percentage of live and 
metabolically active cells than EG-DGE dosed cultures at 0.01 and 0.1mM 
concentrations (Figure 7.13).  Cytocompatibility of 0.001mM EG-DGE dosed and 
0.001mM and 0.01mM PEG-DGE dosed cultures was maintained after 72h of culture 
while 1mM DGE concentrations were acutely toxic to cells (Figure 7.13).  
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Fibroblast cultures were dosed with varying concentrations of EG-CS and PEG-
CS macromolecules and allowed to culture for 48h.  Cultures were stained for live and 
dead cells to determine cell viability.  Cultures dosed with 0.2mg/ml and 2mg/ml CS, 
EG-CS and PEG-CS appeared maintain cell viability while in 20mg/ml dosed cultures, a 
large number of dead cells is seen in CS cultures, and cells appear more rounded in EG-
CS and PEG-CS cultures (Figure 7.14).  Quantification of Cell viability after 48h of 
dosing demonstrates significantly reduced fibroblast viability in 20mg/ml CS and EG-CS 
cultures, while PEG-CS cultures do not have reduced viability at any concentration tested 
(Figure 7.14).  Due to the overall toxicity seen in 20mg/ml dosed cultures, this 
concentration was not investigated further.  
 Primary nucleus pulposus cell and fibroblasts were both dosed with CS 
and CS-macromolecules for 72 and investigated for culture metabolic activity.  Both 
Fibroblast and NP cell cultures maintained viability at 0.2mg/ml and 2mg/ml for all 
macromolecules investigated (no significant decrease in cell metabolic activity compared 
to TCP controls) (Figure 7.15).  In fibroblast cultures, 0.2mg/ml PEG-CS dosed samples 
had significantly increased cell metabolic activity compared to TCP controls while this 
increase in metabolic activity was seen at 2.0mg/ml PEG-CS in NP cell cultures.  
Fibroblast and NP cell cultures dosed with 10mg/ml CS and EG-CS had significantly 
lower metabolic activity compared to TCP controls while 10mg/ml PEG-CS samples did 
not show any significant cytotoxic effects (Figure 7.15).  NP and Fibroblast Cultures 
dosed with the full range of PEG-CS concentrations maintained cell viability and in some 
instances, increased proliferation in Fibroblast cultures.      
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Figure 7.5:  TEM of CS (A) and close-up of condensed bead structure of CS (B) 
 
 
 
 
 
 
Figure 7.6:  TEM of (A) Several aggrecan molecules clustered together.  (B) Close-up of natural 
bovine ggrecan where condensed beads are arranged in a chain pattern. 
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Figure 7.7:  TEM of PEG-CS macromolecules after 24h of synthesis at lower (A) and higher (B) 
magnification.  PEG-CS appears as small aggregates and individual condensed beads. 
 
 
 
 
 
Figure 7.8: TEM of PEG-CS synthesized for 72h at lower magnification (A) demonstrating 
aggregates of PEG-CS and (B) higher magnification demonstrating beaded chain like structure of 
PEG-CS. 
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Figure 7.9:  (Top) Specific Viscosity with shear rate of CS-macromolecules with varying PEG 
backbone lengths.  (bottom) Specific viscosity of CS-macromolecules relative to CS  
(1-way ANOVA statistical analysis, n=3). 
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Figure 7.10:  Fixed Charge Density of CS-Macromolecules as determined by the Blyscan GAG 
assay. (1-way ANOVA statistical analysis, n=3) 
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Figure 7.11:  (Top) Validation of membrane osmometer using PEG solutions of known osmotic 
pressure (20K MW PEG solutions in 0.15M NaCl, room temperature) (244).   
(Bottom) Validation of CS measurements on membrane osmometer with comparison to predicted 
literature values(233).  Upper and Lower limit of CS osmotic pressure refers to the (+/-) standard 
deviation of the viral coefficients.   
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Figure 7.12:  (Top) Representative Osmotic Pressure curves from Membrane Osmometer of CS-
macromolecule solutions (50mg/ml, 0.15M NaCl, 25C̊, 1mL Volume).  (Bottom) Average Steady 
State Osmotic Pressure of CS-macromolecule solutions (1-way ANOVA statistical analysis n=3). 
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Figure 7.13:  Fibroblast cytotoxicity with exposure to varying concentrations of EG-DGE and 
PEG-DGE as determined by (top) live/dead imaging (Images taken at 10X magnification) and 
(bottom) MTT metabolic activity assay.  (2-way ANOVA statistical Analysis) 
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Figure 7.14:  Live/Dead imaging and % Viability analysis of Fibroblasts dosed with varying 
concentrations of EG-CS and PEG-CS macromolecules after 48h incubation. 
(2-way ANOVA statistical Analysis) 
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Figure 7.15:  72h Cytotoxicity of Fibroblasts and NP Cells dosed with CS-macromolecules at 
varying concentrations as determined by the MTT assay  
(2-way ANOVA statistical analysis)  
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In this study, the physical and function characteristics of CS-macromolecules 
were investigated in relation to the requirements of a biomimetic aggrecan 
macromolecule for the restoration of nucleus pulposus mechanical and osmotic function.  
CS-macromolecules were synthesized with CS chains linked by synthetic ethylene glycol 
chains of length 0.5 to 5nm (EG-CS and PEG-CS formulations respectively).   
7.4 Discussion 
 
7.4.1. Physical structure of CS-macromolecules 
Previous GPC studies suggested that EG-CS and PEG-CS macromolecules 
consisted of a mixed population of chains with single CS attachments (Mn ~ 19KDa), 
two CS attachments (dimmers Mw ~ 42KDa) and possibly small populations of 
macromolecules with more than two CS attachments (Mz~78KDa) (Table 6.6).  PEG-CS 
macromolecules were further investigated for their molecular size and structure by 
visualization with TEM.  TEM images suggest the formation of larger molecular 
structures after 72h of synthesis compared to natural CS and samples synthesized for just 
24h.  Reaction kinetics of the CS primary amine, indicate that the majority of primary 
amine reactions are complete after 24h however, possible secondary amine reactions may 
continue to occur after the 24h period resulting in the step-wise synthesis on some larger 
structures (also supported by 1H-NMR spectral analysis indicating continued 
incorporation of PEG moieties even after the initial 24h primary amine reaction time).  
Under TEM investigation PEG-CS samples take on an aggregated and chain like 
conformations similar to that of natural aggrecan however these structures may be 
268 
 
 
influenced by sample staining and dehydration (258).  The processing of CS-
macromolecules and aggrecan for TEM imaging requires the dehydration of the samples 
and staining with uranyl acetate.  This processing causes condensation of the CS chains 
into bead like structures versus their more natural rod like structures, thereby making it 
difficult to discern the bottle brush arrangement of CS seen in natural aggrecan.  In 
addition drying may result in aggregates that are not necessarily present in solution.  
Cryo-TEM techniques, where samples are placed onto the copper imaging grid in a thin 
layer of water then flash frozen to avoid crystal formation and disruption of the molecule, 
may be used as an alternative to tradition TEM in order to image CS-macromolecules and 
aggrecan in a more natural state (260).  Atomic force microscopy (AFM) has also been 
used to visualize aggrecan structures and may be useful in the investigation of CS-
macromolecules structure (75).  
Viscosity investigations of CS-macromolecule solutions also indicated the 
formation of structures different from natural CS as evidenced by an increase in viscosity 
of EG-CS and PEG-CS compared to CS.  Viscosity of a macromolecule solution is 
influenced by the solute molecular weight as well as its hydrodynamic radius and 
structure (i.e. rigid backbone, worm-like configuration, branching, charge) (170, 261).  
The increased viscosity of PEG-CS and EG-CS confirms observations of increased MW 
as seen in GPC as well as structure formation as seen in TEM. Interestingly, PEG(1K)-
CS samples did not have an increased viscosity in comparison to CS.  Previous primary 
amine reaction studies and 1H-NMR-investigations indicated incorporation of PEG(1K) 
at the CS primary amine, however GPC and TEM studies were not conducted on these 
samples due to the long PEG chain incorporation which is not physiologically relevant.  
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A lack of increased viscosity of these samples indicate that the structures formed in 
PEG(1K)-CS do not have significantly different flow properties from natural CS.  This 
may be due to the relatively long PEG linking chain (~12.5nm) between CS side chains 
compared to EG-CS and PEG-CS macromolecules.  This chain length is compared to the 
radius of gyration of CS-6 which has been estimated at 12.8nm  (207).  The radius of 
gyration of CS-4 (used in the current investigation) is likely smaller than 12nm due to the 
smaller MW of CS-4 compared to CS-6.  Therefore, the PEG distance between CS chains 
in PEG(1K)-CS is longer than that of the CS radius of gyration and interaction distance.  
Because of this large distance between CS chains, strong interactions between individual 
CS chains on the PEG(1K)-CS may not be occurring, reducing the effects of CS linking 
on solution viscosity (262-264).  Also, since large MW species are not likely being 
synthesized in the current samples, the direct influence of MW on viscosity may be low.  
Viscosity can be a powerful tool to probe polyelectrolyte and brush polymer structure 
where the concentration dependence of viscosity is largely influenced by macromolecule 
charge, rigidity and branched structure (205, 261, 263, 265-267).  As larger MW and 
highly branched CS-macromolecules are synthesized, viscosity techniques may be useful 
to characterize the structural properties of the brush-like CS-macromolecules.     
 
7.4.2. Osmotic Function and Fixed Charge Density of CS-macromolecules 
In the function of CS-macromolecules as a biomimetic replacement for natural 
aggrecan in NP tissues it is important the molecules provide the osmotic functions of 
natural aggrecan.  These properties of natural aggrecan are provided by the CS chains 
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attached to the aggrecan core protein (244).  Due to the fixed charges on CS immobilized 
in the NP matrix, counter ions build up in the NP and the tissue is able to draw in fluid (to 
balance the ionic imbalance) until a hydrostatic pressure is generated that resists stresses 
arising from tensile forces of the collagen network and external loads applied by muscles 
and ligaments Figure 7.16.  The osmotic pressure of proteoglycans at concentrations found 
in NP tissues (0.18 – 0.35 meq/gH2O, fixed charge density) has been determined to lie in 
the range of approximately 0.03 to 0.3MPa (268).   
 The osmotic potentials of EG-CS, PEG-CS and PEG(1K)-CS were 
determined in comparison to that of natural CS.  EG-CS macromolecules, which have the 
smallest PEG linkage length, did not have significantly different osmotic pressure than 
CS indicating maintenance of the CS osmotic potential in the EG-CS macromolecule 
formulation (Figure 7.12).  PEG-CS and PEG(1K)-CS macromolecule solution did have 
significantly decreased osmotic pressure compared to CS and EG-CS.  This is likely due 
to the incorporation of larger MW PEG segments in PEG-CS and PEG(1K)-CS (Figure 
7.12).  PEG has the ability to generate an osmotic potential when separated from an ionic 
solution via a semi-permeable membrane, however, the osmotic pressure generated by 
PEG solutions is much lower than that generated by CS of the same concentrations 
(Figure 7.11).  This is due to the high concentration of negative charges along the CS 
backbone.  The incorporation of the synthetic less osmotically-active PEG backbone into 
the CS-macromolecule slightly reduces the osmotic potential of the CS-macromolecules.  
Although there is a slight drop in osmotic potential, CS-macromolecule osmotic potential 
is still in the range of natural CS and much higher than that of 20K MW PEG at the same 
concentration (0.026MPa for 20K MW PEG vs 0.128MPa for PEG-CS and PEG(1K)-
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CS) indicating dominance of the CS portion of the CS-macromolecules in osmotic 
function (Figure 7.12).   
Osmotic pressure measurements can also be used to probe the structural 
properties of macromolecules where the configurational entropy of the macromolecules 
in solution have been theoretically demonstrated to contribute to the osmotic swelling 
pressure of concentrated proteoglycan solutions (269).  It is expected that the 
organization of CS chains into a bottle brush structure will impact the osmotic pressure of 
the macromolecule solutions but it is unlikely that we will see such effects in our 
macromolecules due to the low degree of polymerization in our formulations.  An 
osmotic technique for determining macromolecule structural properties may be useful in 
the future as additional CS-macromolecule species are developed.   
The osmotic function of CS is largely due to the fixed charges along the CS 
backbone.  With aging and degeneration the fixed charge density of the NP decreases.  In 
one study, FCD ranged as high as 1.4mEq/g dry tissue weight in a 14y.o. human lumbar 
NP to as low as 0.15mEq/g dry tissue weight in 91y.o. human lumbar NP thus reducing 
the osmotic potential of the NP (244).   In a recent modeling study conducted by Massey 
et al. (270-271), the effect of FCD restoration on intervertebral disc stress distributions 
was investigated.  Several grades of disc degeneration (Grade 1 (“normal”) to Grade 
5(degenerate)) were modeled (axisymmetric, osmo-poroelastic finite element model) by 
altering tissue material properties, such as modulus, fixed charge density, and tissue 
permeability.  In order to model the effect of FCD restoration on stress distribution in the 
NP and annulus fibrosus (AF), FCD profiles for healthy Grade 1 discs (Figure 7.17) were 
applied to degenerated discs while keeping all other degenerated material properties 
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constant.  Reverting the fixed charge density profile to its original Grade 1 state 
decreased the stress experienced by the annulus fibrosus and drastically changed the 
stress on the nucleus pulposus, even though other material properties were still in a 
degenerated condition (270-271).  This implies that a treatment, which restores fixed 
charge density to the NP may have far reaching effects on both nucleus and annulus 
stress distributions and reactions under loading. 
In order to investigate the use of CS macromolecules for the restoration of FCD to 
degenerated NP, CS-macromolecule FCD was determined and compared to natural CS.  
FCD of EG-CS macromolecules were not significantly different from that of CS while 
PEG-CS macromolecules had slightly higher FCD.  This may be due to small degrees of 
non-specific interactions between the PEG backbone and Blyscan assay reagents.  In both 
cases, CS-macromolecules had FCD comparable to natural CS.  The average FCD of the 
CS-macromolecules was approximately 3.5 mEq/g macromolecule.  Using this FCD 
value, the amount of CS-macromolecule needed to restore FCD as modeled in the study 
of Massey et al. was calculated and is presented in Table 7.1 and compared to that of 
natural aggrcan.  These values are based o the extrapolated FCD for the varying 
degenerative grade tissue models at mid nucleus (Fractional Sagittal Section = 0.5) 
(Figure 7.17).  The worst case scenario of FCD restoration is seen for Grade 5 tissues, 
however it is unlikely that such an intervention would take place since a biomimetic 
aggrecan replacement approach would require a distinct NP region and an intact annulus 
which is not the case for Grade 5 Degeneration.  By Grade 4 or 5 degeneration, the most 
likely intervention would be spinal fusion or total disc replacement.  At the lower grades 
of degeneration, Grade 3 and 2, approximately 21.43 and 10.71mg/g wet tissue of CS-
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macromolecule would be required to restore Grade 1 FCD profiles.  If the NP is 
approximated to be 3g wet weight, approximately 64mg and 32mg of CS-macromolecule 
would be needed to restore Grade 3 and Grade 2 discs respectively.  These are reasonable 
masses that may be implanted via solution injection into the NP where concentrations of 
CS-macromolecule up to 1g/ml are injectable through a 16 gauge needle (data not 
shown).  The cost of therapeutic amounts of natural bovine aggrecan and synthesized CS-
macromolecules was estimated and compared to the cost of the commonly utilized steroid 
injections, for the treatment of back pain (Table 7.2).  Aggrecan costs ($7,837-$31,347 to 
restore Grade 2-Grade 5 respectively) far exceed the currently accepted cost for injectable 
treatments to the spine (~$1,850 (272)) while CS-macromolecule costs are considerably 
less for therapeutic masses ($2.35-$9.39 to restore Grade 2-Grade5 respectively) further 
motivating the usefulness of a biomimetic aggrecan strategy. 
It is important to note that these restorative amounts are based on estimated NP 
volume as well as estimated FCD at the varying degenerative grades.  FCD 
measurements of IVD tissue vary greatly due to differences in tissue processing, FCD 
detection and reporting (i.e. FCD/wet weight, GAG/dry weight etc) as well as natural 
variations in FCD from disc to disc and between spinal level (30, 84, 244, 253, 268, 273).  
In some reports, proteoglycan content in healthy NP has been estimated as high as 
700ug/mg dry tissue, much higher than that utilized in our estimations (30).  However, 
the restorative CS-macromolecule amounts determined here have been demonstrated 
through modeling studies to have significant effects on stress distribution in the NP and 
AF.  In addition, FCD is intimately related to osmotic pressure, where direct relationships 
between fixed charge density and osmotic pressure have been established for GAG 
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solutions (233, 268).  These direct positive outcomes of FCD restoration demonstrate the 
potential benefits of biomimetic aggrecan injections on IVD mechanical function.   
Another major element of the aggrecan molecule in imparting mechanical 
properties to IVD tissue is the arrangement of fixed charges in the bottle brush 
arrangement.  The distance between adjacent CS molecules effects their physical 
resistance to force.  Electrostatic repulsion forces occur when intermolecular distance 
between CS chains is 2-4nm (69).   These electrostatic forces between CS chains account 
for 50% (290kPa) of the equilibrium compressive elastic modulus as predicted by 
theoretical modeling (70, 72).  The arrangement of fixed charges in proteoglycans has 
also been associated with higher osmotic pressure generation than CS alone (268).  
Additionally, the brush structure of aggrecan has been demonstrated to act as an ion 
reservoir further providing osmotic resistance to applied loads (274).  However, FCD 
arrangement is not taken into account in the modeling of FCD restoration to the NP.    It 
is also assumed that the FCD carriers remain immobilized in the matrix once inputed.  It 
is therefore important to continue to work towards large MW bottle brush like CS-
macromolecules in order to capture the 50% contribution to modulus of electrostatic 
repulsions as well as maintain FCD immobilization in the NP matrix.    Strategies which 
immobilize CS bottle brush macromolecules in the NP matrix and thereby restore NP 
FCD and electrostatic forces may lessen the need for nucleus pulposus and annulus 
fibrosus tissue to remodel and accommodate abnormal stresses experienced during 
degeneration, thereby halting the degenerative cascade. 
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7.4.2. Cytotoxicity of CS-macromolecules 
 In a therapeutic strategy, biomimetic aggrecan would be injected into the nucleus 
without removal of the nucleus tissue (i.e. augmentation).  In this scenario, cells in NP 
would be directly exposed to the injected macromolecules.  NP cells are not highly 
active, however they are capable of producing biomolecules in order to maintain the NP 
extracellular environment (76).  The synthesis process of the cells is balanced by the 
expression on MMPs and aggrecanses which break down the matrix for ECM turnover 
(7).  In the degenerated case, there is an imbalance in matrix molecule synthesis and 
breakdown, resulting in a decrease in matrix material properties.  If the cells of the NP 
are removed or adversely affected by the interventional strategy, any matrix conservation 
capacity of the NP will be severely hindered, possibly causing greater long term damage.   
Therefore it is important to ensure that CS-macromolecule formulations do not have 
cytotoxic effects on the cells of the NP.  Initial cytotoxicity studies were conducted on a 
fibroblast cell line. EG-DGE and PEG-DGE were investigated for their direct effect on 
cell cytotoxicity.  Both EG-DGE and PEG-DGE were cytocompatible at trace amounts 
(0.001mM) while PEG-DGE was slightly more cytocompatible than EG-DGE (PEG-
DGE maintained cytocompatibility at 0.01mM concentrations) (Figure 7.13).  Therefore it 
is reasonable to assume, that if trace amounts of EG-DGE or PEG-DGE remain in the 
CS-macromolecule formulations, no significant cytotoxic effects would be expected.  
This is an important point as 1H-NMR investigates demonstrate that the bulk of excess 
DGE is removed from the CS-macromolecules, but there may be trace amounts of DGE 
in the final formulations that are un-detectable by the 1H-NMR spectral analysis Figure 
6.14 and Figure 6.16).  DGE cytotoxicity is in agreement with previous studies on the 
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cytotoxicity of a range of diepoxy compounds where higher MW DGEs were more 
cytocompatible than smaller MW species (234).  Cytotoxicity of the DGE monomers is 
likely due to irreversible chemical modification of proteins or polysaccharides present on 
cells by the epoxides of the diepoxide compound (234).     
 EG-CS and PEG-CS macromolecule cytotoxicity was investigated for both 
fibroblast and NP cell cell lines.  EG-CS and PEG-CS macromolecules were not 
cytotoxic to cells at 0.2mg/ml.  This concentration is in the range typically experienced 
by cells in the NP.  If the density of cells in a relatively young NP (16-29y.o.) is 
estimated at approximately 2,780,000cells/cm3 (249) and the FCD and therefore GAG 
content of a similarly aged NP (27y.o.) is assumed to be 0.35mEq/g H2O (equivalent to 
90mg/ml of GAG) (275) then the GAG/CS ratio is approximately 3.23x10-5mg/cell of 
GAG.  In the current culture system, 2,800 cells were seeded at a density of 
10,000cells/cm2 to TCP then dosed with 0.2mg/ml of CS or CS-macromolecules resulting 
in a concentration of approximately 7.6x10-5mg/cell.  The vast majorities of studies 
which investigate the effects of in vitro CS on chondrocyte cultures (cell lines similar to 
NP cells) also investigate CS concentrations in the range of 10-1000µg/ml and have 
found that these concentrations of exogenously applied CS actually promote the 
production of proteoglycans and inhibit MMP synthesis in vitro (276-278). 
 Since CS-macromolecules would likely be introduced to the NP environment in a 
bolus, a transient period will exist where NP cells experience CS concentrations much 
higher than usually physiologically experienced.  It is therefore important to investigate 
the possible cytotoxic effects of the CS-macromolecules at higher concentrations than 
seemingly physiologically relevant.  Concentrations of CS, EG-CS and PEG-CS were 
277 
 
 
investigated up to 20mg/ml.  At 10mg/ml and 20mg/ml  (fibroblast only) CS and EG-CS 
macromolecules were found to by cytotoxic to fibroblasts after 48h of culture while PEG-
CS did not appear to significantly affect cell viability.  All macromolecules were non-
cytotoxic at 2mg/ml in fibroblasts while EG-CS showed some cytotoxic effects at this 
concentration in NP cells.  Overall, cell reaction to CS and CS macromolecule dosing 
was similar in fibroblasts and NP cells with NP cells being slightly more sensitive to the 
exogenous macromolecules.  This is not surprising as the NIH 3T3 fibroblast cell line is 
fairly robust, while primary cell lines such as the NP cells studied here are more difficult 
to maintain in culture.  NP cells cultures studied here were cultured in normal oxygen 
tension and pH while NP cells in vivo are accustomed to very specific oxygen, osmotic 
and pH environments that are unique to this tissue.  A surprising result was the increased 
cytocompatibility of PEG-CS macromolecules at high concentrations compared to both 
CS and EG-CS cultures.  PEG-CS incorporates a longer PEG linker than EG-CS.  The 
increased incorporation of the synthetic PEG backbone may have had beneficial effects 
on cell cytocompatibility.  This has been seen in a study conducted by Petersen et al 
(279) where linear PEG chains were grafted to branched  polyethleneimine (PEI) cationic 
polymers to generate cationic polyelectrolytes grafted with nonionic hydrophilic 
polymers, similar to our system.  In their study, a series of polymers were synthesized 
with varying MW PEG chains and they found that cytotoxicity of 3T3 mouse fibroblasts 
decreased with increasing PEG chain MW.  This was likely due to shielding of the 
cationic blocks by the PEG chains which reduced the cell membrane destruction caused 
by the cationic domains (279).  A similar scenario may be occurring in our PEG-CS 
macromolecule system.  PEG has been demonstrated to exclude proteins and other 
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macromolecules and particulates from its surroundings due to its high chain mobility, 
conformational flexibility and water binding ability (250).  The ability of PEG to shield 
itself from other macromolecules may have reduced the cytotoxicity of CS seen at these 
high concentrations.   These studies suggest that the initial introduction of PEG based 
CS-macromolecules to the NP at higher than physiological concentrations will not have a 
deleterious cytotoxic effect.        
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Figure 7.16:  Schematic diagram showing the fixed charges of the NP extracellular matrix and 
associated mobile counter ions (252).  
  
280 
 
 
 
 
Figure 7.17:  Extrapolated fixed charge density profiles for intervertebral disc tissue of varying 
degenerative grade (assuming 26yo represents Grade 1 (“healthy”) and 74yo represents Grade 5 
discs) (84, 270-271) 
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Table 7.1:  Predicted Restorative Masses of CS-macromolecules and Natural Aggrecan based on 
FCD of degenerated NP tissues (84, 270-271) 
Degenerativ
e Grade 
Nucleus 
Pulposus 
FCD                                        
(mEq/g wet 
tissue) 
FCD Required 
to Restore to 
Grade 1 FCD                          
(mEq/ g wet 
tissue) 
£Mass of Natural 
Aggrecan Required 
to Restore FCD                                        
(mg/g wet tissue)                                       
(FCD~3.23mEq/g) 
Mass of CS-
Macromolecule Required 
to Restore FCD                                   
(mg/g wet tissue)                                                       
( FCD ~3.5mEq/g) 
Grade 5 0.15 0.15 46.44 42.86 
Grade 4 0.19 0.11 58.05 32.14 
Grade 3 0.23 0.08 69.66 21.43 
Grade 2 0.26 0.04 81.27 10.71 
Grade 1 0.3 N/A N/A N/A 
 
£FCD of natural aggrecan calculated from Blyscan Assay analysis of bovine cartilage 
aggrecan (sigma) sulfated GAG content (data not shown).  GAG estimated to comprise of 
77% CS chains and 23% KS Chains (7).  FCD (mEq/g aggrecan) estimated based 
on(253): 
𝑐𝐹 = ��2 𝑚𝑜𝑙 𝑐ℎ𝑎𝑟𝑔𝑒𝑠 𝐶𝑆
502.5𝑔 ∗ 0.77∗𝑊𝐺𝐴𝐺𝑔 𝑚𝑎𝑐𝑟𝑜𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒� + �1 𝑚𝑜𝑙 𝑐ℎ𝑎𝑟𝑔𝑒𝑠 𝐾𝑆454𝑔 ∗ 0.23∗𝑊𝐺𝐴𝐺𝑔 𝑚𝑎𝑐𝑟𝑜𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒�� ∗ 103  
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Table 7.2:  Estimated Cost of CS-macromolecule for therapeutic application in comparison to 
estimated cost of restoration with natural aggrecan and current treatment option of steroid 
injections. 
Degenerative 
Grade 
£Cost of Aggrecan to 
Restore FCD (USD)                       
(assuming 3g  
NP wet weight) 
§Cost of CS-
Macromolecule to Restore 
FCD (USD) 
(assuming 3g  
NP wet weight) 
Mean Cost per Epidural 
Steroid Injection 
Treatment                       
(as estimated in 2008) 
(272) 
Grade 5 $31,347 $9.39 
$1,850 
Grade 4 $23,510 $7.04 
Grade 3 $15,673 $4.69 
Grade 2 $7,837 $2.35 
Grade 1 N/A N/A N/A 
 
£Calculated based on natural bovine cartilage aggrecan cost of $225/mg (Sigma) 
§Calculated based on the following figures: 
"Grafting-Through" 
Synthesis Supplies 
Estimated Cost to 
Synthesize 1g 
SBB Buffer $0.07 
Dialysis Tubing $3.82 
Chondroitin Sulfate $54.20 
PEG-DGE $0.12 
EG-DGE $0.22 
25% Loss due to Purification $14.55 
Total Cost PEG-CS $72.76 
Total Cost EG-CS $72.89 
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The results presented here demonstrate that CS-macromolecules incorporating a 
synthetic polyethylene glycol component have functional properties which make them 
suitable for NP proteoglycan restoration.  CS-macromolecules were demonstrated to have 
structural features distinct from that of natural CS, indicating the formation of larger 
structures.  These macromolecules were further found to have high osmotic potential and 
fixed charge density similar to that of natural CS.  The osmotic function of CS-
macromolecules is critical in the restoration of NP hydration and hydrostatic pressure.  
CS-macromolecules were also found to be non-cytotoxic at both physiological 
concentrations and higher concentrations that may occur as a result of CS-macromolecule 
delivery to the NP.  The incorporation of a synthetic polymeric linkage between CS 
chains had effects on several CS properties including specific viscosity, osmotic pressure 
and cytotoxicity.  The linkage of CS with relatively short PEG chains resulted in an 
increase in solution viscosity compared to natural CS while incorporation of relatively 
long PEG chains resulted in a decrease in solution osmotic pressure.  Cytotoxicity of CS 
was decreased the incorporation of PEG chains.  CS-macromolecule properties are 
clearly dominated by the CS component however deviations in properties from natural 
CS can be directly attributed to properties of the incorporated synthetic polyethylene 
glycol backbones.    Therefore, the choice of synthetic backbone in the synthesis of 
biomimetic aggrecan will be critical in the function of the biomimetic macromolecule.  
CS-macromolecules investigated in this study have functional properties which will be 
beneficial in a biomimetic aggrecan approach to the replacement of depleted 
proteoglycan content in the NP.  In a completely biomimetic strategy, larger structures 
7.5 Conclusions 
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which incorporate closely packed CS chains will need to be synthesized in order to 
ensure macromolecule immobilization in the NP matrix and the generation of 
electrostatic forces critical in NP mechanical function.   
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Chapter 8 :  Conclusions 
 
The goal of this study was to develop an enzymatically resistant, hybrid 
synthetic/bio-based biomimetic aggrecan macromolecule for use in the treatment of 
intervertebral disc degeneration.  Biomimetic aggrecan was designed such that it 
incorporates a synthetic polymeric core to resist enzymatic degradation while maintaining 
natural CS bristles which are biological activity and carry high fixed charge density.  In 
order to synthesize bottle-brush like macromolecules from natural CS a terminal handle 
on CS was first identified then utilized in “grafting-to” and “grafting-through” strategies 
of bottle brush polymer synthesis.   
8.1 Summary 
A terminal primary amine on commercially available CS-4 was identified and 
found to be reactive to epoxides, aldehydes and carboxylic acids at varying reactivities.  
Carboxylic acid-amine reactions were investigated for the “grafting-to” strategy due to 
the high water solubility and biocompatibility of carboxylic acid polymers while epoxide-
amine reactions were investigated for the “grafting-through” strategy due to the relatively 
high reactivity of the CS primary amine to epoxides.  CS-macromonomers were 
synthesized by the covalent reaction of the epoxide allyl glycidyl ether to the CS terminal 
amine.  These vinyl terminated CS-macromonomers may be utilized in future studies for 
the free-radical polymerization of CS into bottle brush structures via the “grafting-
through” strategy.  Due to complexity involved in possible side chain reactions and harsh 
conditions generally associated with free-radical polymerization, this strategy was not 
investigated further in this study.   
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In the “grafting-to” strategy CS was covalently bound to poly(acrylic acid) 
backbones.  Several parameters including reaction time, reaction temperature, solution 
ionic strength and polymer:CS molar ratio were investigated for their effect on CS 
conjugation to the PAA backbone.  CS-PAA macromolecules were synthesized with as 
many as 9 CS chains on each 250K MW PAA backbone, resulting in sparsely grafted 
chains.  Due to the limitations of this strategy in fabricating densely grafted CS-
macromolecules with electrostatically relevant CS spacing (~2-4nm spacing), further 
synthesis strategies were investigated.     
The step-growth “grafting-through” strategy of polymer synthesis was 
investigated as a means of synthesizing CS-macromolecules with controlled CS-spacing.  
Step-growth polymerization is also desirable due to the relatively mild reaction 
conditions that may be applied.  In this study, the epoxide-amine reaction was utilized, 
employing the reactivity of epoxides to both the hydrogens of the CS terminal amine 
(primary amine then secondary amine reactions).  Poly(ethylene glycol) based di-
epoxides, EG-DGE and PEG-DGE were utilized in order to respectively impart ~ 0.5 and 
5nm spacing between CS chains in the final CS-macromolecule.  Several parameters 
including reaction time, reaction temperature, reactant ratio, and DGE MW were 
investigated for their effect on CS primary amine to DGE epoxide reaction rate and CS-
macromolecule synthesis.  CS macromolecules were synthesized that incorporated 
synthetic PEG components, likely at the terminal end of CS, linking CS chains together.  
Molecular weight and structural analysis of EG-CS and PEG-CS macromolecules suggest 
that the macromolecules consist of a mix of CS monomers, dimmers and possibly some 
larger molecular weight species.  Osmotic properties and cytocompatibility of CS-
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macromolecules suggest that CS-macromolecules with poly(ethylene glycol) based 
backbones may be useful in the restoration of proteoglycan function in degenerated 
nucleus pulposus.   
Several parameters were set fourth for the design of a biomimetic aggrecan 
macromolecule that can restore the function of the nucleus pulposus in the early stages of 
disc degeneration.  Table 8.1 summarizes the properties of CS-macromolecules 
synthesized via both the “grafting-to” and “grafting-through” strategies as they relate to 
the criteria for a functional biomimetic aggrecan macromolecule and as they compare to 
natural aggrecan and chondroitin sulfate.  CS-PAA macromolecules were lacking in their 
CS grafting density, resulting in widely spaced CS chains, thereby not fulfilling a key 
functional requirement of a biomimetic aggrecan.  A major limitation in our study of the 
“grafting-to” technique was the utilization of a covalent binding chemistry that has a 
short reactivity window.  Higher grafting density may be achieved if a backbone is 
utilized which has reactive groups that can remain reactive over a long period of time, 
thereby allowing dense brush formation.  In our studies, we have found that the epoxy 
amine reaction remains reactive through the full 96h time frame investigated.  Therefore, 
a poly-epoxide polymeric backbone is recommended for further investigation of the 
“grafting-to” strategy of bottle brush polymer synthesis.  In order for the poly-epoxide to 
be applicable in the current reaction conditions (pH 9.4 aqueous reactions), the polymer 
must be water soluble and epoxides must have high reactivity to the CS primary amine. 
The utilization of step-growth polymerization was investigated due to the innate 
ability it affords in controlling monomer spacing.  In step-growth polymerization of CS 
with di-epoxides, the spacing between CS chains is directly controlled by the MW or 
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length of the di-epoxide monomer. EG-CS and PEG-CS macromolecules had low 
average molecular weight compared to that required for a biomimetic aggrecan 
replacement.  Studies conducted here demonstrated that the low degree of polymerization 
seen in EG-CS and PEG-CS macromolecules was likely due to low reactivity of the EG-
DGE and PEG-DGE monomers to the CS primary amine.  CS-macromolecule synthesis 
through the step-growth polymerization strategy may be improved by utilizing different 
reactive chemistries for the step growth reaction.  In the presented studies we 
demonstrated that the epoxy-primary amine reaction can go to complete reaction of the 
CS-primary amine in excess of epoxide.  This epoxy-primary amine reaction may be 
utilized to functionalize the terminal end of CS with a bi-functional step growth moiety, 
followed by step-growth polymerization of bi-functional CS with another bi-functional 
monomer in order to improve the step-growth polymerization technique and generate 
dense CS brush structures.  Although, EG-CS and PEG-CS MW was relatively low, 
structures larger than CS were observed and with improvements to the step-growth 
synthesis strategy, PEG based macromolecules may be candidate materials for a 
biomimetic aggrecan replacement of PGs in the NP.  This is further supported by the 
positive functional properties of the EG-CS and PEG-CS macromolecules including high 
fixed charge density, high osmotic potential, low cytotoxicity and low cost.  CS-
macromolecules had similar properties to that of natural CS.  
To stabilize the disc early in the degenerative cascade, we have designed a 
biomimetic aggrecan material for injection to the nucleus pulposus to enhance the 
mechanical, osmotic and hydration potential of the tissue while also serving to enhance 
the intradiscal pressure, thus “re-inflating the flat tire”. This approach is also intended to 
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mechanically protect the annulus fibrosus from abnormally high stresses which may be 
responsible for the formation of tears and fissures.  In this study, we have synthesized, for 
the first time, hybrid bio/synthetic CS macromolecules with properties necessary for the 
restoration of proteoglycan function in the nucleus pulposus of the intervertebral disc.  In 
this work we have set a stable foundation for the synthesis and characterization of 
biomimetic aggrecan macromolecules via both the “grafting-to” and “grafting-through” 
techniques of brush polymer synthesis.  From these studies, several synthesis strategies 
may be approached for the synthesis of large molecular weight densely grafted CS-
macromolecules for the restoration of NP function.           
 
 This work is the first proposal of an enzymatically resistant hybrid bio/synthetic 
biomimetic aggrecan macromolecule for treatment of early degenerative changes 
to the intervertebral disc 
8.2 Novel Contributions 
 Prior to this study, natural chondroitin sulfate had not been utilized in the 
synthesis of biomimetic macromolecules 
 This is the first report of the CS terminal primary amine being utilized for the 
immobilization of CS into brush structures  
 This is the first report of the synthesis of vinyl terminated CS  
 This is the first report of the synthesis of CS macromolecules via the “grafting-to” 
strategy (CS-PAA macromolecules) 
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 This is the first report of the synthesis of CS-macromolecules via a step-growth 
“grafting-through” strategy (EG-CS and PEG-CS macromolecules) 
 This is the first account of the effect of a synthetic polymeric linker 
(poly(ethylene glycol)) on CS-macromolecule function. 
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Table 8.1:  Properties of “Grafting-to” and “Grafting-through” CS-macromolecules as they relate 
to the criteria for a functional biomimetic aggrecan macromolecule  
(red: does not meet criteria, green: may meet criteria) 
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Notes for Table 8.1 
1 Aggrecan fragments in the range of 100kDa to as low as 55kDa have been found in NP 
tissues at both early (Grade 2) and advanced (Grade 4) stages of degeneration (78, 243).  
Therefore it is reasonable to assume that similarly sized biomimetic aggrecan would 
remain immobilized in the NP matrix 
2Reference (63) 
3Reference (139) 
4,7,8Reference (7) 
5Reference (89) 
6Reference (69) 
9Aggrecan osmotic pressure was extrapolated from aggrecan osmotic pressure 
measurements obtained by equilibrium dialysis against PVA gels of known osmotic 
pressure (280) 
10CS osmotic pressure was predicted using an exponential viral coefficients reported by 
Chahine et al (233) in 𝜋 ≈  𝑐1𝑐𝑓 + 𝑐2(𝑐𝑓)2. 
11Aggrecan in solution self assemble with increasing concentration and generate loose 
gel-like associations (280) 
12CS and CS-macromolecule solutions were found to be injectable through a 16 gauge 
needle up to 1g/ml (solutions took on a paste like consistency).  Data collected by 
Biomed Sr. Design Team 2010-2011 (Data not shown).  
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Chapter 9 :  Future Work and Recommendations 
 
As discussed previously, this study aimed to develop a novel biomimetic aggrecan 
macromolecule for the early-interventional treatment of low back pain. Several 
advancements were made through these investigations in the synthesis and 
characterization of an enzymatically resistant, hybrid bio/synthetic biomimetic CS 
macromolecule.  The following are recommendations for future work in order to address 
the previously stated limitations of the investigated synthesis techniques as well as 
suggestions for future investigations into the structure and function of biomimetic 
aggrecans.    
 
9.1.1. “Grafting-To” Synthesis Strategies 
9.1 Recommendations for Biomimetic Aggrecan Synthesis 
The main limitation of the “grafting-to” strategy investigated in this study was the 
limited grafting density achieved.  In the “grafting-to” synthesis strategy, a key factor in 
achieving high CS grafting density is allowing a long enough reaction window in order to 
transition through the various regimes of brush synthesis kinetics (i.e. mushroom, 
sparsely grafted, densely grafted) (171-173, 252).  The epoxide-amine chemistry which 
has a relatively long reaction window, has been suggested for use in the “grafting-to” 
synthesis strategy.  CS chain grafting to poly-epoxide backbones via the CS terminal 
primary amine may be investigated.  Possible epoxy backbones include poly(glycidyl 
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methacrylate),  polyglycerol polyglycidyl ether and sorbitol polyglycidyl ether (234, 
281). 
 
9.1.2. Step-Growth “Grafting-Through” Synthesis Strategies 
The main limitation of the step-growth “grafting-through” synthesis strategy 
investigated in this study was the low degree of polymerization achieved, likely due to 
low reactivity of the diglycidyl ether epoxide to the CS terminal primary amine.  
Although it may be possible to increase epoxy-amine reactivity by using a different form 
of diglycidyl ether and further optimizing reaction conditions (i.e. adjusting the solvent 
system and solution pH), the utilization of the CS terminal amine as a direct reactive 
group in polymerization, limits the potential of this strategy.  Reaction kinetics will 
continue to depend on CS primary amine reaction kinetics followed by the reaction 
kinetics of the generated secondary amine.  
Step-growth polymerization strategies however are desirable due to the high 
control over CS spacing possible as well as mild aqueous reaction conditions associated 
with this technique.  It is therefore recommended that CS-macromolecule synthesis 
through step-growth polymerization be further investigated using different reactive 
chemistries for the step growth reaction.  The epoxy-primary amine reaction may be 
utilized to functionalize the terminal end of CS with a bi-functional step growth moiety, 
followed by step-growth polymerization of bi-functional CS with another bi-functional 
monomer resulting in linear brush polymers.  As an example, trimethylolpropane 
triglycidyl ether (TMP), a tri-epoxide molecule, may be used to introduce two epoxide 
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molecules to the terminal end of CS (i.e. reaction of the CS terminal amine with one 
epoxide of the TMP).  Di-epoxide CS-TMP monomers can then be reacted with di-amine 
monomers (i.e. Poly(ethylene glycol) bis(amine) (PEG-bis-amine)), again utilizing the 
more facile epoxide-primary amine reaction.  Resulting brush CS-macromolecules would 
still incorporate a PEG spacer, however reaction kinetics would only depend on TMP and 
PEG-bis-amine epoxy-primary amine reactions.  Reaction kinetics could be modulated by 
varying both tri-epoxide and di-amine chemistry and structure.  Alternatively, highly 
chemo-selective reactive chemistries such as the azide–alkyne click reactions may be 
utilized as step-growth reactive monomers (118, 282-283).        
 
9.1.3. Alternative “Grafting-Through” Synthesis Strategies:  Free-Radical 
Polymerization 
In this study, CS macromonomers were synthesized via the reaction of the CS 
terminal primary amine with the epoxide of allyl glycidyl ether (AGE), resulting in vinyl 
terminated CS.  AGE- CS may be polymerized via free-radical polymerization using 
either classical or controlled methods of APS/TMEDA radical initiation or cyanoxyl-
mediated initiation respectively (123, 126).  Co-polymerization of AGE-CS with other 
vinyl monomers such as acrylic acid would allow for the control of CS spacing in the 
final brush macromolecule and result in the incorporation of a synthetic polymeric 
backbone (i.e. poly(acrylic acid)) linking CS chains.  In this technique must be taken to 
protect from possible side reactions and CS degradation.  Additionally, degree of 
polymerization may be limited.  
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9.1.4. Alternative Biomimetic Aggrecan Structures 
In the case that high molecular weight densely grafted linear brush CS- 
macromolecules are difficult to achieve, alternative macromolecule geometries may be 
considered.  For example, “grafting-to” of amine terminated CS to epoxy functionalized 
nanoparticles or dendrimers may allow for the synthesis of densely grafted CS 
nanoparticles or star-like polymers. These structures, although they do not mimic the 
linear bottle brush structure of aggrecan, would be large in molecular size and still 
maintain close packing of CS chains, as well as the osmotic and biological function of 
CS.  Mechanical consequence of the particle like configuration of CS would need to be 
investigated as well as cytocompatibility.   
 
As larger MW CS-macromolecules are synthesized and families of CS-
macromolecules with varying architecture are designed, studies may be conducted on the 
effect of CS brush architecture (i.e. CS spacing, backbone rigidity, and macromolecule 
length) on macromolecule properties.  Previously, investigations into these effects were 
only based on theoretical modeling, approximations of CS interactions based on CS 
immobilization onto flat substrates or via the synthesis of model synthetic polyelectrolyte 
brushes (69, 71, 73, 284).   Structure-function investigations are of utmost importance 
since changes in aggrecan synthesis and architecture have been observed with aging and 
degeneration (93); however, the direct consequences of these changes on tissue function 
9.2 Recommendations for Biomimetic Aggrecan Characterization 
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are still largely unknown.  In addition, biomimetic aggrecan structural properties may be 
optimized through structure-function analysis to impart the greatest effect on NP 
mechanics.   
In order to draw the relationship between biomimetic aggrecan function and structure, 
it will be critical to accurately characterize the macromolecule size and structure.  To 
further characterize biomimetic aggrecan size, dynamic light scattering (DLS) techniques 
are suggested (241).  Solvent systems developed in this study for GPC analysis will 
provide a good starting point for CS-macromolecule solubilization for DLS analysis.  In 
DLS analysis it will be important to maintain high enough macromolecule concentration 
for detection while avoiding aggregation.  For further characterization of biomimetic 
aggrecan structure, visualization with atomic force microscopy is recommended due to 
the high resolution of this imaging technique and its prior utilization for aggrecan 
imaging (75).  In addition, characterization of biomimetic aggrecan hydrodynamic 
properties via viscosity and osmotic measurements in varying conditions (i.e. varying 
concentrations and no-salt/varying salt conditions) are recommended for the 
determination of biomimetic aggrecan conformation and brush properties (205, 261, 263, 
265-267, 269).  
 
In this study, key functional characteristics of the synthesized CS-macromolecules 
were investigated including fixed charge density, osmotic potential and cytotoxicity.  
These characteristics are critical for the potential function of the CS-macromolecules in a 
9.3 Recommendations for Biomimetic Aggrecan Functional Characterization 
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biomimetic strategy for the restoration of NP function.  In addition to the direct properties 
of CS-macromolecules, it will be important to their function with respect to the cells and 
tissue structures of the intervertebral disc and spinal unit.  CS is often used as a 
component in pharmaceutical osteoarthritis treatments, and CS has been demonstrated to 
promote aggrecan synthesis in chondrocyte cultures while decreasing MMP expression 
(89, 278).  These properties of CS may allow CS-macromolecules to not only have a 
mechanical benefit to the NP but also a regenerative one.  It is therefore recommended 
that the biosynthetic activity of biomimetic aggrecan macromolecules be investigated.  
Investigations into aggrecan synthesis and MMP gene expression profiles may be 
conducted on 3-D nucleus pulposus cell cultures or alternatively on whole intervertebral 
disc organ cultures where appropriate oxygen tensions and culture pH is maintained (255, 
285).   
In addition to the biosynthetic activity of CS, the distribution of CS in NP tissue as 
well as the resulting mechanical effect on spinal column function should be investigated.  
Finite element modeling has demonstrated the benefit of the restoration of FCD on stress 
distributions in the IVD; however, these results are based on the assumption that the 
replaced FCD is physiologically distributed throughout the IVD matrix and permanently 
integrated into the matrix (270).  The FCD restoration model also does not take into 
account the impact of electrostatic repulsive forces (generated by closely arranged fixed 
charges) and their contribution to NP tissue mechanical properties.  A mechanically 
loaded cadaveric tissue model, consisting of an intact intervertebral disc isolated between 
two vertebrae (anterior column unit) may be used for monitoring biomimetic aggrecan 
distribution in the disc as well as the contribution of a biomimetic aggrecan injection to 
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disc height, stiffness, and pressurization (286). Changes in these properties of the 
intervertebral disc have been demonstrated previously to be associated with disc 
degeneration and may be associated with back pain (2).  In order to properly assess 
biomimetic aggrecan distribution, and distinguish it from natural aggrecan, the 
biomimetic aggrecan may be tagged for in situ monitoring.  For example, for distribution 
analysis via microcomputed tomography (micro-CT) a radiological contrast agent such as 
meglumine diatrizoate may be covalently bound to oxidized chondroitin sulfate in the 
CS-macromolecule in order to enable post-injection visualization of the macromolecule 
in the IVD.  Techniques such this will allow for the monitoring of biomimetic aggrecan 
distribution in IVD tissue with concurrent analysis of disc mechanical properties, thereby 
describing the functional impact of the biomimetic aggrecan on IVD function.  In a 
tagging technique, the influence of the tag on biomimetic aggrecan structure and function 
must be monitored and minimized. 
The recommendations for future work presented here should aid in the synthesis of a 
biomimetic aggrecan macromolecule that meets all of the criteria set forth in this study.  
Improvements to the synthesis technique have been suggested along with methods for 
structural and functional characterization of the novel biomimetic biomacromolecules.     
Functional studies which monitor the impact of biomimetic aggrecan injection into the 
IVD will aid in the translation of this technology to animal models and the clinical 
setting.   
A vast number of additional applications are also foreseen for the CS-
macromolecules designed in this study.  Aggrecan itself has been implicated in other 
degenerative processes including osteoarthritis and biomimetic aggrecan may be useful in 
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treatment strategies for this and other degenerative conditions.  In addition to mimicing 
aggrecan, the techniques developed here will allow for the synthesis of other 
proteoglycan mimetics with varied GAG grafting density and core length (i.e. versican).  
Any GAG demonstrated to have a reactive terminal primary amine may be utilized in the 
synthesis of biomimetic proteoglycans.  For example, studies in our lab have already 
demonstrated that dermatan sulfate, an isomer of CS also has a terminal primary amine 
and can be covalently bound to synthetic polymeric backbones.  These new classes of 
proteoglycan mimetics may be useful as versican replacements in skin tissue in order to 
restore tissue resilience and act as scaffolding in skin tissue engineering (8).  Versican 
has also been found to decrease in the intervertebral disc, making this proteoglycan 
another target for disc treatment (91).  With the large diversity of proteoglycans and their 
implication in biological function, the techniques and materials developed in this study 
can have far reaching effects in restorative and regenerative medicine.   
  
301 
 
 
Appendix 1:  Select Literature Review of Key Relevant Technologies 
 
 
A Brief Review of Key Advancements in GAG/Charge Density restorative/utilization 
strategies 
Growth factor injections into the IVD.  The growth factor, osteogenic protein-1 (OP-1, 
also known as BMP-7) has been investigated as a possible intradiscal injection treatment 
for the restoration of GAG content and hydration in degenerated discs.  OP-1 has been 
injected into rabbit stab models for degenerative disc disease and disc height, hydration 
as well as proteoglycan content was found to be restored after 6 weeks and maintained 
through the investigation period of 24 weeks (287).  In addition, discs isolated after OP-1 
injection (100µg/10µl, 8 weeks), were found to have higher elastic modulus as well as 
viscous modulus than those injected with control solutions (lactose, 10µl) (288).  These 
results were concurrent with an increase in proteoglycan content in the NP and AF as 
well as collagen content in the NP (288).   Application of OP-1 to degenerated NP discs 
was demonstrated to have an anabolic effect on cells which also manifested as 
biomechanical restoration.  These results however have not been demonstrated in human 
degenerated discs.  Cellular response in rabbit discs may be very different from that in 
humans as rabbit discs contain a large number of notochordal cells that have metabolic 
activities different from that of the human adult NP cells (289).   
Key Advancement:  Induced increase in NP PG content with concurrent increase in disc 
height, hydration, and mechanical properties. 
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Limitation in function as restorative treatment for PG loss in NP:  Reliant on NP cell 
activity and nutrient supply which is compromised in an adult human disc.      
Negatively charged Hydrogels(290).  Negatively charged polyelectrolyte gels are 
charged polymer networks with ions fixed on the polymer chains and counter-ions 
localized withing the network frame.  Generally polyelectrolyte gels are able to absorb 
significant amounts of water (up to ~2000 times the polymer weight) without dissolving 
in water itself (290).  In addition, these gels can respond to external stimuli such as 
changes to pH, ionic strength and electrical stimuli.  Generally, hydrogels made from 
either natural or synthetic sources, especially polyelectrolyte gels, have low mechanical 
strength, however, gels with double network structures (i.e. composed of two 
independently cross-linked networks) have been demonstrated have fracture strengths as 
high as several tens of megapascals, comparable to that of articular cartilage (290).  
Double network gels (DN gels) composed of anionic poly 2-acrylamido-2-methly-1-
propanesulfonic acid (PAMPS) and neutral poly-acrylamide) PAAm sustain higher 
compression while PAMPS gels alone break down easily (290).  PAMPS gels were 
broken at stress of 0.4 MPa, while DN gel sustained stresses of 17.2 MPa. These 
materials, due to their high strength, low surface friction and high water content have 
been suggested for articular cartilage and other bio-tissue replacements (290).   
Key Advancement:  Mechanically strong hydrogel with high water content and 
immobilized fixed charges (anionic groups). 
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Limitation in function as restorative treatment for PG loss in NP:  Synthetic system which 
does not incorporate biologically active components and also does not maintain critical 
arrangement of charges      
 
Chondroitin Sulfate Containing Hydrogels.  Chondroitin sulfate has been applied to 
many biomaterial and biological applications as a bioactive material, a natural polymer 
scaffold for tissue engineering and as a carrier polymer network for cell therapies.  CS 
scaffolds have also been applied in cartilage tissue regeneration by combining CS with 
biodegradable and natural components (291).  In addition, hydrogels composed of 
collagen/HA and CS-6 have been synthesized as scaffolds for NP tissue engineering 
(292).   These systems were primarily investigated for their biological function.   
The CS-PEO(polyethylene oxide) cross-liked hydrogel system has been 
investigated for mechanical properties as well as physiochemical properties (293).  
Hydrogels were synthesized by the modification of the CS carboxylic acid with adipic 
dihydrazide followed by modification with acrylate groups (Figure 18)(293).  Acrylated-
CS was then crosslinked with PEO-hexa thiols solution where CS-PEO hydrogels formed 
spontaneously via Michael type addition reactions without further treatment.  CS-PEO 
hydrogel swelling was measure in water and at different pHs at 37̊C for up to 24h.  
Compression strength of the hydrogels was investigated with an apparatus (MT-LQ 
material tester), 5kg load cell) which applied a circular probe (~12mm in diameter) onto 
the surface of the hydrogel moving at a rate of 0.2mm/sec (293). CS-PEO hydrogels had 
high swelling capacity.  5% CS-PEO hydrogel swelled to 170% in water at pH 2, 224% 
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in pH 4, 324% in pH 7.4, and 525% in pH 9, while the 10% hydrogel swelled to 166% in 
pH 2, 218% in pH 4, 319% in pH 7.4, and 456% in pH 9 (293). Hydrogel fabricated with 
lower concentration imbibed higher water content and swelling increased when the water 
environment was changed from pH 2 to 9. The higher swelling under basic condition was 
attributed to the repulsive force between the negatively charged carboxylic acid groups of 
the chondroitin sulfate network at pH 9.  At 10% CS-PEO gel concentrations, the fully 
hydrated hydrogel had an approximately 3Pa yield strength (293).  This is a low value 
compared to the 50kPa compressive modulus generally estimated to be required for the 
restoration of normal compressive disc mechanics (as determined by cadaveric testing 
and mathematical modeling (43).   
In a separate study, CS hydrogel was applied as an intradiscal injection to the 
rabbit degenerated disc stab model (294).  Cross-linked CS hydrogels were formed by 
first conjugating cinnamic acid to the carboxyls groups of CS then exposing the CS 
derivative to UV light for crosslinking (5.0 wt%) (294).  Intradiscal injection of sodium 
hyaluronate, cross-linked hyaluronate hydrogels and cross linked CS-hydrogels (300µl) 
were conducted two weeks after puncture injury.  Before therapeutic injections, a 
reduction in signal intensity on T2-weighted MR images was detected, indicating loss of 
water content in the disc.  One month after injection, all IVDs maintained normal 
intensity levels.  Three months after injection only IVDs injected with cross-linked 
hyaluronate hydrogels or cross-linked CS hydrogels showed normal MR imaging signal 
intensities.  After six months, all IVDs lost signal intensity (294).    
Key Advancement:  Fabrication of biocompatible and regenerative chondroitin sulfate 
hydrogels and application of cross-linked CS hydrogels to IVD restoration. 
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Limitation in function as restorative treatment for PG loss in NP:  Low mechanical 
properties of CS hydrogels or otherwise uncharacterized.  CS arrangement in the bottle 
brush structure not maintained in the hydrogel configuration.   
 
Aggrecan Containing Hydrogels (295).  Agarose hydrogels (2% low melting 
temperature) have been synthesized with variable ratios of aggrecan (generally 2mg/ml), 
hyaluronan and link protein embedded in the agarose matrix (295).  Aggrecan aggregates 
were assembled in situ and resulting hydrogels were investigated for aggrecan retention 
as well as mechanical properties and biological function.  Compressive properties of the 
constructs increased with the content of aggrecan retained (constructs soaked and agitated 
in PBS, ph 7.0 for 3 days) in the matrix with equilibrium stress increasing from ~18kPa 
in control agarose gels to ~20kPa in aggrecan containing gels and ~30 in highly 
aggregating aggrecan hydrogels under 90% compressive strain (constructs placed 
between two porous platens filled with PBS and tested at 30-90% compressive strains of 
initial thickness to equilibrium relaxation times) (295).  Transport of the aggrecan 
components from the 2% agarose gel was consistent with diffusion processes and on the 
basis of the hydrodynamic radius estimations for the aggrecan and aggregates (295).  
Aggregate assembly was compatible with chondrocytes and chondrocytes maintained 
epression of the chondrogenic phenotype (i.e. secreting type II collagen) (295).  These 
studies demonstrated the biomechanically relevant retention of aggrecan in hydrogel 
constructs and their potential as scaffolds for cartilage tissue engineering.     
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Key Advancement:  Fabrication of biocompatible hydrogel with embedded and retained 
aggrecan. 
Limitation in function as restorative treatment for PG loss in NP:  Incorporation of 
natural aggrecan which is susceptible to proteolytic degradation.  Function in IVD has 
not been demonstrated. 
Summary.  CS hydrogels have been formed via the cross-linking of CS into networks.  
CS cross-linking and immobilization is primarily obtained by the modification of the CS 
backbone and CS is immobilized in random arrangements.  CS hydrogels have shown 
highly promising biological properties in both cartilage and NP tissue engineering 
applications.  The mechanical properties and physical properties of CS hydrogels have 
not however been thoroughly demonstrated.  Synthetic polyelectrolyte hydrogels may 
provide an alternative more mechanically stable hydrogel for replacement of fixed 
charges in the IVD however their application as an injectable integrative material for NP 
stabilization has not been demonstrated and charges remain unorganized.   
 
A Brief Review of Key Advancements in the Synthesis of Biomimetic Aggrecan 
Macromolecule:  Literature Landscape 
A polymer bottle/cylindrical brush is defined as an assembly of polymer chains which are 
densely tethered by one end to a polymeric backbone (106).  As a result of high steric 
crowding, the chains are forced to stretch away from the surface to avoid overlap, 
elongating the polymer backbone and stiffening the molecule (106, 296).  Synthetic 
routes for the preparation of polymer brushes include: (1) “grafting-to”, (2) “grafting-
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through” and (3) “grafting-from”.  Glycopolymers can be defined as synthetic polymers 
possessing a non-carbohydrate backbone that carry carbohydrate (sugar) moieties as 
pendant groups (106, 296).  
Synthetic polysulfonated comb aggrecan mimetic polymers.  Synthetic polysulfated 
cylindrical bottle brush polymers have been synthesized using atom transfer radical 
polymeriziation (ATRP) techniques (297).  Styrene sulfonated ethyl ester (SSE) and 
styrene sulfonated dodecyl ester (SSD) polymer brushes were synthesized using the 
“grafting-from” technique after first synthesizing the styrene sulfonate ethyl ester 
macroinitiator (Figure 19) (117, 297).  This method was advantageous as incomplete 
sulfation, crosslinking, and degradation are avoided in comparison to polymer-analogous 
sulfonation (297).  Brushes with backbone length of approximately 600 and 1,600 repeat 
units and grafting densities from 10 to 40% and 10 to 100% for  SSD and SSE polymers 
respectively were synthesized (297).  Molar mass determinations were made by analytical 
ultracentrifugation, GPC-MALLS and 1H-NMR spectroscopy (SSD polymers could not 
be analyzed via GPC due to lack of elution of this polymer).  Brush like structure was 
confirmed via AFM and TEM imaging and AFM measurements revealed that polymer 
length increased with increasing grafting density (Figure 19) (297).  Both polymers were 
presented as intermediates to obtaining corresponding styrene sulfonated polyelectrolyte 
brushes for model compounds mimicking the polyelectrolyte brushes of human cartilage 
(297).  No studies have been presented however on the application of these polymer 
brushes to biological systems.  Similar sulfated comb polymers however have been 
compared to natural aggrecan regarding solution properties and were found to exhibit 
similar viscosities and shear moduli to that of natural aggrecan (240, 263-264, 284).    
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Key Advancement:  Synthesis of synthetic densly grafted high fixed charge density 
cylindrical bottle brushes with solution properties similar to natural aggrecan. 
Limitation in function as restorative treatment for PG loss in NP:  Biocompatibility has 
not been demonstrated and does not incorporate biologically active chondroitin sulfate 
chains.      
 
“Grafting-To” click chemistry polymerization of glycopolymer brushes (298-299).  A 
library of glycopolymers was synthesized through the “grafting-to” method of polymer 
synthesis utilizing facile “click” chemistry reactions(299).  Click chemistry describes 
several classes of chemical reactions which have very high efficiency in conversion and 
selectivity (i.e. stereoselective reactions, excellent functional group compatibility) under 
mild reaction conditions (298, 300).  These features have allowed for the tailor-made 
synthesis of complex materials including dendrimers, bioconjugates, therapeutics, 
functionalized polymers and sugar derivatives(299).  First a clickable alkyne polymeric 
backbone was synthesized via ATRP (atom transfer radical polymerization) (Figure 20).  
Mannose- and galactose based azidosugar derivatives were then synthesized (Figure 21) 
in order to develop glycopolymers with concavalin A lectin binding ability (299).  
Concavalin A is an α-mannose-binding lectin involved in a number of biological 
processes.  Click reaction of the sugar azides to the alkyne polymer was achieved using 
[(PPh3)3CuBr] as the catalyst in the presence of DIPEA (Figure 21)(299).  After 
conjugation, an increase in the polymer hydrodynamic volume (size exclusion 
chromatography) was observed with little change in the molecular weight distribution.  
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Complete (~100%) conversion of the alkyne groups into triazoles was demonstrated with 
1H-NMR and FT-IR analysis and final mannose to galactose ratios in to polymer were 
similar to the intial feed ratios (299).  Glycopolymers synthesized in this study were 
demonstrated to successfully precipitate Concavalin A present in solution (i.e. high 
binding) (299). 
Key Advancement:  Synthesis of biologically active high grafting density glycopolymer 
brushes via facile and selective reaction chemistries without protection of sugar 
functional groups. 
Limitation in function as restorative treatment for PG loss in NP:  Requires complex 
synthesis techniques to generate the polymeric backbone as well as clickable sugars.  
Has not been demonstrated with high MW sugars such as chondroitin sulfate.      
 
“Grafting-From” synthesis of cylindrical glycopolymers (“Molecular Sugar Sticks”) 
(116).  Glycocylindrical brushes have been synthesized with poly-(3-O-methacryloyl-α,β-
D-glucopyranose (PMAGlc) side chains using the “grafting from” approach via atom 
transfer radical polymerization (ATRP) of the protected monomer, 3-O-methacryloyl-
1,2:5,6-di-O-isopropylidiene-D-glucofuranose (MAIGlc) (Figure 22).  After deprotection, 
water soluble glycopolymer brushes were obtained.  For synthesis, CuBr and MAIGlc 
were combined in ethyl acetate and added to polyinitiator PBIEM-II (poly(2-(2-
bromoisobutyryloxy)ethyl methacrylate).  HMTETA was added to initiate 
polymerization.  Monomer conversion was detected by H-NMR to be 10%.  Solution was 
dissolved in THF, passed through a silica column, and precipitated from THF into 
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methanol, then precipitated into petroleum ether to remove unreacted monomer (116).  
Products had a Mn of 58.6E4 and a Mw/Mn = 1.07 with conventional GPC using PS 
calibration and Mn = 1120E4 and Mw/Mn = 1.09 using GPC with multiangle light 
scattering detector measurements (116).  Products were then deprotected to transform 
poly(MAIGlc) to poly(MPAGlc) using mildly acidic conditions.  Polymer was then 
purified by dailysis against 1000MWCO membrane.  Solution properties of the polymer 
were investigated using dynamic light scattering and polymers were visualized using 
scanning force microscopy and cryo-TEM.  Polymers were confirmed to have stretched 
wormlike structure and grafting efficiency was 0.20 < f < 0.40 (initiation efficiencies, i.e. 
not as densely spaced as those for some PS and polyacrylate brushes) (116).  Behavior 
was found to be typical for cylindrical brushes rather than comb-shaped polymers.  
Investigations were reported to be in progress for biological and medicinal application 
but no such reports have been made yet (116). 
Key Advancement:  “grafting-from” synthesis of densly grafted glycopolymer brushes 
with bottle brush properties. 
Limitation in function as restorative treatment for PG loss in NP:  Utilizes synthetic 
sugars and requires complex synthesis technique including protection and de-protection 
of sugar functional groups.  Length of sugar chains limited.     
“Grafting-Through” controlled free radical polymerization of glycopolymers.  Grande 
and Chaikof et al. polymerized model vinyl derivatized sulfated glycomonomers using 
both the cyanoxyl mediated and APS/TMEDA mediated polymerizations (123).  The 
Grande group has also synthesized several other mono- and di-saccharide GAG-mimetic 
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polymers using these methods (123-126, 301).  Vinyl terminated glycomonomers were 
synthesized from N-acetyl-D-glucosamine by treatment with 4-penten-1-ol or 10-
undecene-1-ol in the presence of 10-camphorsulfonic acid (CSA) as catalyst (123) 
(Figure 23).  These two vinyl monomers provided varying spacing length between the 
sugar and vinyl moieties of the glycomonomers.  For controlled free-radical 
polymerization of the glycomonomers (Figure 23), Cyanoxyl radicals were generated in 
situ by an electron-transfer reaction between cyanate anions and p-
chlorobenzenediazonium cations (prepared in water through the diazotization reaction of 
p-chloroanaline) (123).  The purified, degassed, vinyl-CS glycomonomer were then 
added to the reaction medium along with acrylamide as a spacer, and sodium cyanate.  
Polymerization was carried out at 50°C and reactions were isolated by precipitation in 
10-fold excess cold methanol.  Weight proportions of sugar residues reached as high as 
50%, however, carbohydrate content in the resulting polymer was also associated with an 
increase in polydispersity index, indicating loss of control over the copolymerization 
process in the presence of increasing glycomonomer (123).  Additionally, it was noted 
that shorter spacer arm length actually resulted in increased incorporation of carbohydrate 
(123).  Biological application of these polymers was suggested by the authors to lie in 
areas of wound repair and tissue regeneration (123).  Specifically, glycopolymers were 
prepared for anti-coagulant, heparin mimetic applications (124).   
Key Advancement:  Synthesis of sulfated glycopolymer brushes in mild conditions without 
protection of functional groups. 
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Limitation in function as restorative treatment for PG loss in NP:  Complex synthesis of 
glycomonomers.  Some limitations in glycosylation and high MW polymer generation.  
Has not been demonstrated with chondroitin sulfate or other similarly sized GAGs.     
 
Step-growth polymerization of glycoproteins.  Glycoproteins have been synthesized via 
step-growth polymerization for use as antifreeze glycoprotein analogues (302-303).  
Step-growth polymerization reactions can be used to produce glycopolymers which have 
structural homogeneity while chain length is not as well controlled (compared to 
controlled free radical polymerization strategies) (118).  In the synthesis of antifreeze 
glycoproteins, Ala-Thr-Ala peptide sequences are first synthesized coupled to mono and 
disaccharide at the Thr residue (O-linked).  The glycopeptides monomers are then linked 
in a polycondensation reaction (step-growth polymerization) using conventional DPPA 
(diphenylphosphoryl azide) or other peptide coupling methods (303) (Figure 24).  These 
methods have also been used to produce sulfated glycopolypeptides (303).  Functional 
properties of these glycoproteins have been investigated with regard to function as an 
antifreeze agent (i.e. thermal hysteresis and the effect of glycopolypeptide on ice crystal 
formation).  Glycopolypeptides with as little as two repeat units (i.e.dimers)were found to 
have effective antifreeze properties (304) and the observed effects were found to be 
highly dependent on the primary structure of the polypeptide backbone (118, 304).   
Key Advancement:  Facile step-growth synthesis of amino acid terminated sugars to 
generate synthetic glycoproteins demonstrated to have similar properties to their natural 
counterparts. 
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Limitation in function as restorative treatment for PG loss in NP:  Synthetic 
glycoproteins will have protein backbones that may be susceptible to proteolytic 
degradation.  Synthesis with large MW sugar side chains (i.e. Chondroitin sulfates) has 
not been demonstrated. 
Summary.  In recent reviews of glycopolymers and cylindrical bottle brush synthesis and 
applications (106, 118, 298, 300, 305-306), advancements have been made in the 
synthetic strategies for brush and glycopolymer synthesis, resulting in more controlled 
synthesis techniques as well as higher degrees of glycosylation.  In addition advances in 
polymer end-functionalization, synthesis of complex architectures, polymer 
characterization, and glycomonomer synthesis has been noted.  Advancements have also 
been made in the application of glycopolymers in the area of therapeutics, particularly as 
HIV and Alzheimer’s therapeutics as well as polymers for drug delivery (307).   No 
reports have been made however on the incorporation of chondroitin sulfate in 
glycopolymer synthesis and the direct utilization of aggrecan and glycosaminoglycan 
mimetics in the restoration of tissue mechanical function has not yet been investigated.    
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Figure 18:  Schematics of CS-acrylate synthesis by sequential grafting of adipic dihydrazide and 
then acrylic acid to CS (293). 
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Figure 19:  Synthesis schematic of Styrene sulfonated ethyl ester (SSE) and styrene sulfonated 
dodecyl ester (SSD) polymer brushes and resulting polymer brush structure as seen with atomic 
force microscopy imaging. (297) 
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Figure 20:  Synthesis of poly-alkyne click-able polymer from protected a protected alkyne 
functional monomer (trimethylsilyl mechacrylate).  (299) 
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Figure 21:  Synthesis of click-able sugars (sugar containing azide groups) and their “Grafting-to” 
click conjugation to an alkyne polymeric backbone. (298-299) 
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Figure 22:  Synthesis schematic for fabrication of “molecular sugar sticks” using the “grafting 
from” approach via atom transfer radical polymerization (ATRP) of the protected monomer 
(bottom) scanning force microscopy height image of molecular sugar sticks. (116) 
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Figure 23:  Synthesis of sulfated and non-sulfated vinyl glycomonomers and subsequent cyanoxyl 
mediated free-radical polymerization for the synthesis of biomimetic polymers with chemically 
stable hydrocarbon backbones and biologically active pendant hydrophilic saccharides. (123) 
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Figure 24:  Polycondensation step-growth polymerization of glycopeptides for the synthesis of 
sulfated glycopolypeptides as antifreeze glycoprotein analogs (303). 
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Appendix 2:  Alternate views of Chondroitin Sulfate Disaccharide with Linkage 
Region and Terminal Amino Acid Residue (demonstrating glycosidic linkages) 
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